Medical specialties, branches of medicine Books

Book SynopsisThe Handbook of Psychiatric Drugs is a comprehensive, clear, concise and quick reference to psychiatric drug therapies, designed to guide the clinician on the selection and implementation of treatment for mental illness.Trade Review"...an excellent little book...small enough that busy clinicians can easily read it cover to cover." (Psychiatric Times, June 2007) "…a basic guide to drugs used to treat mental disorders…at a reasonable cost and in a handy format." (American Reference Books Annual, March 2007) "…a welcome addition…well-written, easy to use, and thorough in its coverage…psychiatry residents as well as practicing clinicians will find this a useful, quick referral source." (Doody's Health Services)Table of ContentsPreface. Acknowledgements. Disclaimer. 1 Antipsychotic Drugs. Introduction. Pharmacology. Chemistry. Mechanism of Action. Pharmacokinetics. Indications for Use of Antipsychotic Drugs. Drug Selection and Initiation of Treatment. Drug Selection for the Treatment of Schizophrenia. Effects of Antipsychotic Agents on Symptoms of Schizophrenia. Drug Selection for the Treatment of Bipolar Disorder. Drug Selection for the Treatment of Major Depression With Psychotic Features. Drug Selection for the Treatment of Delusional Disorder. Drug Selection for the Treatment of Delirium. Drug Selection for the Treatment of Psychosis and Agitation Associated with Dementia. Drug Selection for the Treatment of Mental Retardation and Developmental Disorders. Drug Selection for Huntington’s Disease and Tourette’s Disorder. Substance-induced Psychoses. Adverse Effects of Antipsychotics. Acute Extrapyramidal Side Effects (Dystonia, Parkinsonism, Akathisia). Tardive Dyskinesia and Other Tardive Syndromes. Neuroleptic Malignant Syndrome. Endocrine and Sexual Effects. Metabolic Effects. Cardiovascular Effects. Gastrointestinal Effects. Hepatic Effects. Hematological Effects. Other Side Effects. Drug Interactions and Antipsychotic Agents. Antipsychotic Medications and Pregnancy. Additional Reading. 2 Antidepressants. Introduction. Pharmacology. Mechanisms of Action. Pharmacokinetics. Indications for Use of Antidepressants. Panic Disorder (PD). Obsessive–Compulsive Disorder (OCD). Generalized Anxiety Disorder (GAD). Social Phobias and Posttraumatic Stress Disorder (PTSD). Bulimia. Anorexia Nervosa. Body Dysmorphic Disorder (BDD). Premenstrual Dysphoria (PMDD). Childhood Disorders. Other Psychiatric Disorders. Other Medical Conditions. Drug Selection and Initiation of Treatment for Major Depression. Special Considerations in the Selection of an Antidepressant. Initiation of Treatment. Therapeutic Drug Monitoring. Early, or Pre-response, Period. Response, or Acute Treatment, Period. Treatment of Partially Responsive and Nonresponsive Patients. Antidepressant Augmentation. Changing to a New Agent. Continuation and Maintenance Periods, and Discontinuation. Side Effects. Anticholinergic Effects. Autonomic Effects. Neurologic Effects. Weight Gain. Gastrointestinal Symptoms. Sexual Dysfunction. Cardiac Conduction. Suicide Risk. Allergic and Hematologic Effects. Other Effects. Central Serotonergic Syndrome. Monoamine Oxidase Inhibitors. Drug Interactions. Tricyclic Antidepressants. Pharmacokinetic Effects. Monoamine Oxidase Inhibitors. Serotonin Reuptake Inhibitors. Other Second-Generation Antidepressants. Third-Generation Antidepressants. Summary. Recommendations for the Use of Antidepressants. Additional Reading. 3 Mood Stabilizers. Introduction. Pharmacology. Chemistry. Mechanism of Action. Pharmacokinetics. Indications. Drug Selection and Initiation of Treatment. Acute Mania. Drug Selection. Relative Efficacy of Different Agents. Treatment Initiation and Dose Titration. Acute Depression. Drug Selection. Treatment Initiation and Dose Titration. Breakthrough Episodes. Maintenance. Rapid Cycling. Costs. Adverse Effects. Drug Interactions. Pregnancy. Summary. Additional Reading. 4 Anxiolytic Drugs. Introduction. A General Approach to Using Medication with Anxious Patients. Pharmacology. Antidepressants. Benzodiazepines. Buspirone. Beta-Blocker Medications. Anticonvulsants. Antipsychotics. Indications for Use. Antidepressants. Benzodiazepines. Buspirone. Beta-blocker Medications. Anticonvulsants. Antipsychotics. Augmentation/Adjuvant Treatments. Drug Selection, Dose, and Initiation of Treatment. Side Effects. Drug Interactions. Contraindications and Special Precautions. Summary. Additional Reading. 5 Sedative–Hypnotic Agents. Introduction. Diagnosis. Treatment Options. Non-prescription Agents. Prescription Medications. Pharmacology. Benzodiazepines. Chloral Hydrate. Zolpidem. Zaleplon. Eszopiclone. Ramelteon. Drug Selection. Other Prescription Hypnotics. Treatment Implementation. Adverse Effects. Benzodiazepines. Chloral Hydrate. Zolpidem. Zaleplon. Eszopiclone. Ramelteon. Drug Interactions and Special Precautions. Summary. Additional Reading. 6 Psychostimulants. Introduction. Pharmacology. Chemistry. Mechanism of Action. Pharmacokinetics. Indications and Contraindications. Drug Selection. Treatment Initiation and Dose Titration. Treatment Evaluation. Maintenance Treatment. Treatment Resistance. Effects of Treatment on Symptoms. ADHD in Adults. Alternative Preparations to the Standard Stimulant Medications. Narcolepsy. Other Indications. Costs. Adverse Effects. Drug Interactions. Summary. Additional Reading. 7 Cognitive Enhancers and Treatments for Alzheimer’s Disease. Introduction. Pharmacology. Mechanism of Action. Pharmacokinetics. Indications. Drug Selection. Treatment Initiation. Maintenance Treatment. Treatment Evaluation. Adverse Effects. Cholinesterase Inhibitors. Drug Interactions. Summary. Additional Reading. 8 Drugs for Treating Substance Abuse Disorders. Introduction. Syndromes Associated with Intoxication. Alcohol Intoxication. Sedative–Hypnotic Intoxication. Opiate Intoxication. Cocaine and Amphetamine Intoxication. Intoxication by LSD, Mescaline, MDMA (‘Ecstasy’), and Psilocybin. Phencyclidine Intoxication. Drug Treatment of Withdrawal Syndromes. Alcohol Withdrawal. Withdrawal from Sedative–Hypnotics. Withdrawal from Opiates. Management of Withdrawal in Patients with Multiple Dependencies. Agents to Aid Relapse Prevention. Medications for Alcohol Dependence. Medications for Cocaine Dependence. Medications for Opiate Dependence. Special Considerations. Drug Treatments for Nicotine Dependence. Pharmacotherapies for Substance Abusers with Additional Psychiatric Illness. Pharmacotherapy for Specific Psychiatric Disorders. Drug Interactions in Chemical Dependency. Additional Reading. Index.

Read more less

Book SynopsisThe Textbook of Pharmacoepidemiology provides a streamlined text for evaluating the safety and effectiveness of medicines. It includes a brief introduction to pharmacoepidemiology as well as sections on data sources, methodology and applications. Each chapter includes key points, case studies and essential references.Trade Review"…a useful textbook for upper-level undergraduate, graduate, and postdoctoral fellows in pharmacy, medical, and public health programs." (The Annals of Pharmacotherapy, June 2007) "This is a major text with far-reaching impact…recommended for all courses in public health or pharmacology…" (Electric Review, March/April 2007)Table of ContentsList of Contributors. Preface. Acknowledgments. Acknowledgments from Pharmacoepidemiology, Fourth Edition. SECTION I INTRODUCTION TO PHARMACOEPIDEMIOLOGY. 1. What is Pharmacoepidemiology? (Brian L. Strom). 2. Study Designs Available for Pharmacoepidemiology Studies (Brian L. Strom). 3. Sample Size Considerations for Pharmacoepidemiology Studies (Brian L. Strom). 4. Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiology Studies (Sean Hennessy). 5. When Should One Perform Pharmacoepidemiology Studies? (Brian L. Strom). 6. Views from Academia, Industry, and Regulatory Agencies (Leanne K. Madre, Robert M. Califf, Robert F. Reynolds, Peter Arlett, and Jane Moseley). SECTION II SOURCES OF PHARMACOEPIDEMIOLOGY DATA. 7. Spontaneous Reporting in the United States (Syed Rizwanuddin Ahmad, Norman S. Marks, and Roger A. Goetsch). 8. Global Drug Surveillance: The WHO Programme for International Drug Monitoring (I. Ralph Edwards, Sten Olsson, Marie Lindquist, and Bruce Hugman). 9. Case–Control Surveillance (Lynn Rosenberg, Patricia F. Coogan, and Julie R. Palmer). 10. Prescription-Event Monitoring (Saad A.W. Shakir). 11. Overview of Automated Databases in Pharmacoepidemiology (Brian L. Strom). 12. Examples of Automated Databases (Andy Stergachis, Kathleen W. Saunders, Robert L. Davis, Stephen E. Kimmel, Rita Schinnar, K. Arnold Chan, Deborah Shatin, Nigel S.B. Rawson, Sean Hennessy, Winanne Downey, MaryRose Stang, Patricia Beck, William Osei, Hubert G. Leufkens, Thomas M. MacDonald, and Joel M. Gelfand). 13. Other Approaches to Pharmacoepidemiology Studies (Brian L. Strom). 14. How Should One Perform Pharmacoepidemiology Studies? Choosing Among the Available Alternatives (Brian L. Strom). 15. Validity of Pharmacoepidemiologic Drug and Diagnosis Data (Suzanne L. West, Brian L. Strom, and Charles Poole). SECTION III SPECIAL ISSUES IN PHARMACOEPIDEMIOLOGY METHODOLOGY. 16. Bias and Confounding in Pharmacoepidemiology (Ilona Csizmadi and Jean-Paul Collet). 17. Determining Causation from Case Reports (Judith K. Jones). 18. Molecular Pharmacoepidemiology (Stephen E. Kimmel). 19. Bioethical Issues in Pharmacoepidemiologic Research (Kevin Haynes, Jason Karlawish, and Elizabeth B. Andrews). 20. The Use of Randomized Controlled Trials for Pharmacoepidemiology Studies (Samuel M. Lesko and Allen A. Mitchell). 21. The Use of Pharmacoepidemiology to Study Beneficial Drug Effects (Brian L. Strom). 22. Pharmacoeconomics: Economic Evaluation of Pharmaceuticals (Kevin A. Schulman, Henry A. Glick, and Daniel Polsky). 23. Using Quality-of-Life Measurements in Pharmacoepidemiologic Research (Holger Schünemann, Gordon H. Guyatt, and Roman Jaeschke). 24. The Use of Meta-analysis in Pharmacoepidemiology (Carin J. Kim and Jesse A. Berlin). 25. Patient Adherence to Prescribed Drug Dosing Regimens in Ambulatory Pharmacotherapy (John Urquhart and Bernard Vrijens). 26. Novel Approaches to Pharmacoepidemiology Study Design and Statistical Analysis (Samy Suissa). SECTION IV SPECIAL APPLICATIONS OF PHARMACOEPIDEMIOLOGY. 27. Special Applications of Pharmacoepidemiology (David Lee, Sumit R. Majumdar, Helene Levens Lipton, Stephen B. Soumerai, Sean Hennessy, Robert L. Davis, Robert T. Chen, Roselie A. Bright, Allen A. Mitchell, David J. Graham, David W. Bates, and Brian L. Strom). 28. The Future of Pharmacoepidemiology (Brian L. Strom and Stephen E. Kimmel). Appendix A Sample Size Tables. Appendix B Glossary. Index.

Read more less

Book SynopsisHughes' Outline of Psychiatry, Fifth Edition presents a comprehensive account of current practice in psychiatry, summarising up-to-date knowledge of the subject in a concise way. Part I touches on general classification, causes and prevention of mental disorders.Table of ContentsPreface. PART I: THE NATURE AND ASSESSMENT OF PSYCHIATRIC DISORDER. 1 Classification. The basis of classification. Reliability and validity. Limitations and problems of classification. Common terms in psychiatric classification. Classification systems. 2 Causes and Prevention. Causation in clinical practice. Historical background. Genetics. Neurochemistry. Neuroradiology. Epidemiology. Individual life experience. Prevention of psychiatric disorder. 3 Assessment. Circumstances of referral. The psychiatric interview. Mental state examination. Physical examination. Structured interviews and questionnaires. Further assessments. Physical investigations. PART II: CLINICAL SYNDROMES. 4 Schizophrenia. Definition. Frequency. Epidemiology. Causation. Clinical features. Clinical types. Diagnostic criteria. Differential diagnosis. Treatment. Prognosis. 5 Mood Disorders: Depressive Illness and Mania. Frequency. Epidemiology. Causes. Clinical features of depressive illness. Types of depressive illness. Diagnosis of depressive illness. Clinical features of mania. Differential diagnosis of mood disorders. Treatment of depressive illness. Treatment of mania. Prophylaxis of affective disorder. 6 Anxiety and Stress-Related Disorders. Boundaries of anxiety disorder. Hierarchy of diagnosis. Frequency. Epidemiology. Causes. Clinical features. Differential diagnosis. Treatment. Prognosis. Generalized anxiety disorder (anxiety state). Panic disorder. Agoraphobia. Social phobia. Simple phobias (specific phobias, monophobias). Obsessive-compulsive disorders. Conversion and dissociative disorders. Post-traumatic stress disorder (PTSD). Adjustment disorders. Bereavement. 7 Personality Disorders. Definition. Classification. Types of personality disorder. Epidemiology. Differential diagnosis. Treatment. Prognosis. Sociopathic (dissocial) personality disorder. 8 Paranoid States. Definition. Predisposing factors. Differential diagnosis of paranoid states. Management. Culture-bound syndromes. 9 Physical Symptoms and Psychiatric Disorder. Introduction. Assessing physical symptoms in psychiatric practice. Unexplainedphysical symptoms. Management. Malingering and exaggeration. 10 Organic Brain Syndromes. Causes. Clinical features. Delirium. Dementia. Focal brain damage. 11 Liaison Psychiatry. Psychological influences on the course of physical disease. The stresses of physical illness. Adjustment and coping. Clinical depression in medically ill patients. Management and prevention. Liaison psychiatry. 12 Drug Misuse. Definitions. Epidemiology. Causes. Psychiatric and physical complications. Legal aspects. Pharmacology. Prevention. Treatment. Opiates. Amphetamines (speed). Cocaine and crack. Cannabis (Indian hemp, hashish, pot). Lysergic acid diethylamide (LSD, acid). MDMA (Ecstasy). Glues and solvents. Tobacco. Caffeine. Barbiturates. Benzodiazepines. 13 Alcohol Misuse. Safe limits of drinking. Frequency. Epidemiology. Causes. Effects of alcohol. Course of alcohol abuse. Recognition. Treatment. Prognosis. Prevention. 14 Deliberate Self-Harm. Suicide. Non-fatal deliberate self-harm (parasuicide, attempted suicide). 15 Eating Disorders: Anorexia Nervosa and Bulimia Nervosa. Introduction. Anorexia nervosa. Bulimia nervosa. Obesity. 16 Disorders of Female Reproductive Life. Pregnancy. Puerperal psychosis. Post-natal depression and other neurotic syndromes. Abortion. Stillbirth and perinatal death. Premenstrual syndrome. The menopause. Hysterectomy. 17 Sexual Problems. Sexual dysfunctions. Sexual deviations. Gender-identity disorders. Homosexuality. 18 Child and Adolescent Psychiatry. Predisposing factors. Classification. History taking and examination. Treatment. Relationship with adult disorder. Neurotic (emotional) disorders. Conduct disorders. Attention deficit disorder. Psychoses. Delays in development. Symptomatic disorders. Child abuse. Psychiatry of adolescence. 19 Learning disability. Frequency. Causes. Diagnosis of learning disability. Associated phenomena. Management. Prognosis. Prevention. Chromosomal abnormalities. Gene abnormalities. Acquired handicap. Miscellaneous. 20 Psychiatry of Old Age. Frequency. Clinical syndromes. Assessment. Specific treatments. Organization of services. 21 Forensic Psychiatry. Offending behaviour. Predicting violence and dangerousness. Psychiatric aspects of specific offences. Treatment: general considerations. Facilities for mentally disordered offenders. Psychiatric reports: criminal. PART III: TREATMENT. 22 Psychological Treatment. Historical background. Principles of psychotherapy today. Counselling. Cognitive-behavioural therapy (CBT). Psychodynamic psychotherapy. Group therapy. Family and marital therapy. Recent advances. 23 Psychopharmacology. General principles of using psychotropic drugs. Antipsychotics. Antidepressants. Antidepressants: tricyclic group. Antidepressants: SSRI group. Antidepressants: MAOI group. Other antidepressant drugs. Benzodiazepines. Mood stabilizers. Lithium. 24 Electroconvulsive Therapy (ECT) and Psychosurgery. Indications. Mode of action. Efficacy and prediction of response. Timing and number of treatments. Practicalities of treatment. Contraindications. Bilateral versus unilateral ECT. Unwanted effects. Consent for ECT. Myths. For the future. Psychosurgery. 25 Organization of Services. Introduction . Background and history. Community care. The psychiatric multidisciplinary team. Psychiatry in primary care. Inpatient services. Outpatient clinics. Crisis and home treatment. Day hospitals. Resource centres and day centres. Recovery and rehabilitation. The care programme approach. Assertive outreach teams. Non-NHS health-care facilities. 26 The Mental Health Act 1983. Introduction. Background. Compulsory admission. Patients already in hospital. Patients in the community. Relatives. Approved social workers (ASWs). Police powers. Mentally abnormal offenders. Consent to treatment. Information for detained patients. Mental Health Act Commission. Glossary. Index.

Read more less

Book SynopsisThe Handbook of Neural Engineering provides the theoretical foundations and current applications from the leading researchers in this emerging new field. It focuses on the brain-computer interface, nano-neural engineering, neural prostheses, imaging the brain, neural signal processing, the brain and neurons.Trade Review"This handbook is an excellent and informative technical reference for researchers and undergraduate students with a basic background in electrical or biomedical engineering." (IEEE Engineering in Medicine and Biology Magazine, January/February 2009) "…a comprehensive summary of the latest trends and is an essential resource for researchers in this field." (Journal of the American Medical Association, August 22/29, 2007) "…very useful…for those already working in the discipline. It fills a void in the pertinent literature; there are few works that compare." (Doody's Book Reviews) "This is a good quality book…useful as a current survey and resource for ideas, and the state of the art." (Doody's Book Reviews) "...useful as a current survey and resource for ideas, and the state of the art." (Doody's Health Services)Table of ContentsPREFACE. CONTRIBUTORS. PART I: NEURAL SIGNAL AND IMAGE PROCESSING AND MODELING. CHAPTER 1: OPTIMAL SIGNAL PROCESSING FOR BRAIN–MACHINE INTERFACES (Justin C. Sanchez and Jose C. Principe). CHAPTER 2: MODULATION OF ELECTROPHYSIOLOGICAL ACTIVITY IN NEURAL NETWORKS: TOWARD A BIOARTIFICIAL LIVING SYSTEM (Laura Bonzano, Alessandro Vato, Michela Chiappalone, and Sergio Martinoia). CHAPTER 3: ESTIMATION OF POSTERIOR PROBABILITIES WITH NEURAL NETWORKS: APPLICATION TO MICROCALCIFICATION DETECTION IN BREAST CANCER DIAGNOSIS (Juan Ignacio Arribas, Jesús Cid-Sueiro, and Carlos Alberola-López). CHAPTER 4: IDENTIFICATION OF CENTRAL AUDITORY PROCESSING DISORDERS BY BINAURALLY EVOKED BRAINSTEM RESPONSES (Daniel J. Strauss, Wolfgang Delb, and Peter K. Plinkert). CHAPTER 5: FUNCTIONAL CHARACTERIZATION OF ADAPTIVE VISUAL ENCODING (Nicholas A. Lesica and Garrett B. Stanley). CHAPTER 6: DECONVOLUTION OF OVERLAPPING AUDITORY BRAINSTEM RESPONSES OBTAINED AT HIGH STIMULUS RATES (O. Ozdamar, R. E. Delgado, E. Yavuz, and N. Acikgoz). CHAPTER 7: AUTONOMIC CARDIAC MODULATION AT SINOATRIAL AND ATRIOVENTRICULAR NODES: OBSERVATIONS AND MODELS (S. Ward, R. Shouldice, C. Heneghan, P. Nolan, and G. McDarby). CHAPTER 8: NEURAL NETWORKS AND TIME–FREQUENCY ANALYSIS OF SURFACE ELECTROMYOGRAPHIC SIGNALS FOR MUSCLE CEREBRAL CONTROL (Bruno Azzerboni, Maurizio Ipsale, Fabio La Foresta, and Francesco Carlo Morabito). CHAPTER 9: MULTIRESOLUTION FRACTAL ANALYSIS OF MEDICAL IMAGES (Khan M. Iftekharuddin and Carlos Parra). CHAPTER 10: METHODS FOR NEURAL-NETWORK-BASED SEGMENTATION OF MAGNETIC RESONANCE IMAGES (Lia Morra, Silvia Delsanto, and Fabrizio Lamberti). CHAPTER 11: HIGH-RESOLUTION EEG AND ESTIMATION OF CORTICAL ACTIVITY FOR BRAIN–COMPUTER INTERFACE APPLICATIONS (F. Cincotti, M. Mattiocco, D. Mattia, F. Babiloni, and L. Astolfi) CHAPTER 12: ESTIMATION OF CORTICAL SOURCES RELATED TO SHORT-TERM MEMORY IN HUMANS WITH HIGHRESOLUTION EEG RECORDINGS AND STATISTICAL PROBABILITY MAPPING (L. Astolfi, D. Mattia, F. Babiloni, and F. Cincotti). CHAPTER 13: EXPLORING SEMANTIC MEMORY AREAS BY FUNCTIONAL MRI (G. Rizzo, P. Vitali, G. Baselli, M. Tettamanti, P. Scifo, S. Cerutti, D. Perani, and F. Fazio). PART II: NEURO–NANOTECHNOLOGY: ARTIFICIAL IMPLANTS AND NEURAL PROTHESES. CHAPTER 14: RESTORATION OF MOVEMENT BY IMPLANTABLE NEURAL MOTOR PROSTHESES (Thomas Sinkjær and Dejan B. Popovic). CHAPTER 15: HYBRID OLFACTORY BIOSENSOR USING MULTICHANNEL ELECTROANTENNOGRAM: DESIGN AND APPLICATION (John R. Hetling, Andrew J. Myrick, Kye-Chung Park, and Thomas C. Baker). CHAPTER 16: RECONFIGURABLE RETINA-LIKE PREPROCESSING PLATFORM FOR CORTICAL VISUAL NEUROPROSTHESES (Samuel Romero, Francisco J. Pelayo, Christian A. Morillas, Antonio Martı´nez, and Eduardo Ferna´ndez). CHAPTER 17: BIOMIMETIC INTEGRATION OF NEURAL AND ACOUSTIC SIGNAL PROCESSING (Rolf Müller and Herbert Peremans). CHAPTER 18: RETINAL IMAGE AND PHOSPHENE IMAGE: AN ANALOGY (Luke E. Hallum, Spencer C. Chen, Gregg J. Suaning, and Nigel H. Lovell). CHAPTER 19: BRAIN-IMPLANTABLE BIOMIMETIC ELECTRONICS AS NEURAL PROSTHESES TO RESTORE LOST COGNITIVE FUNCTION (Theodore W. Berger, Ashish Ahuja, Spiros H. Courellis, Gopal Erinjippurath, Ghassan Gholmieh, John J. Granacki, Min Chi Hsaio, Jeff LaCoss, Vasilis Z. Marmarelis, Patrick Nasiatka, Vijay Srinivasan, Dong Song, Armand R. Tanguay, Jr., and Jack Wills). CHAPTER 20: ADVANCES IN RETINAL NEUROPROSTHETICS (Nigel H. Lovell, Luke E. Hallum, Spencer C. Chen, Socrates Dokos, Philip Byrnes-Preston, Rylie Green, Laura Poole-Warren, Torsten Lehmann, and Gregg J. Suaning). CHAPTER 21: TOWARDS A CULTURED NEURAL PROBE: PATTERNING OF NETWORKS AND THEIR ELECTRICAL ACTIVITY (W. L. C. Rutten, T. G. Ruardij, E. Marani, and B. H. Roelofsen). CHAPTER 22: SPIKE SUPERPOSITION RESOLUTION IN MULTICHANNEL EXTRACELLULAR NEURAL RECORDINGS: A NOVEL APPROACH (Karim Oweiss and David Anderson). CHAPTER 23: TOWARD A BUTTON-SIZED 1024-SITE WIRELESS CORTICAL MICROSTIMULATING ARRAY (Maysam Ghovanloo and Khalil Najafi). CHAPTER 24: PRACTICAL CONSIDERATIONS IN RETINAL NEUROPROSTHESIS DESIGN (Gregg J. Suaning, Luke E. Hallum, Spencer Chen, Philip Preston, Socrates Dokos, and Nigel H. Lovell). PART III: NEUROROBOTICS AND NEURAL REHABILATION ENGINEERING. CHAPTER 25: INTERFACING NEURAL AND ARTIFICIAL SYSTEMS: FROM NEUROENGINEERING TO NEUROROBOTICS (P. Dario, C. Laschi, A. Menciassi, E. Guglielmelli, M. C. Carrozza, and S. Micera). CHAPTER 26: NEUROCONTROLLER FOR ROBOT ARMS BASED ON BIOLOGICALLY INSPIRED VISUOMOTOR COORDINATION NEURAL MODELS (E. Guglielmelli, G. Asuni, F. Leoni, A. Starita, and P. Dario). CHAPTER 27: MUSCLE SYNERGIES FOR MOTOR CONTROL (Andrea d’Avella and Matthew Tresch). CHAPTER 28: ROBOTS WITH NEURAL BUILDING BLOCKS (Henrik Hautop Lund and Jacob Nielsen) CHAPTER 29: DECODING SENSORY STIMULI FROM POPULATIONS OF NEURONS: METHODS FOR LONG-TERM LONGITUDINAL STUDIES (Guglielmo Foffani, Banu Tutunculer, Steven C. Leiser, and Karen A. Moxon) CHAPTER 30: MODEL OF MAMMALIAN VISUAL SYSTEM WITH OPTICAL LOGIC CELLS (J. A. Mart&ıacute;n-Pereda and A. González Marcos). CHAPTER 31: CNS REORGANIZATION DURING SENSORY-SUPPORTED TREADMILL TRAINING (I. Cikajlo, Z. Matjačić, and T. Bajd). CHAPTER 32: INDEPENDENT COMPONENT ANALYSIS OF SURFACE EMG FOR DETECTION OF SINGLE MOTONEURONS FIRING IN VOLUNTARY ISOMETRIC CONTRACTION (Gonzalo A. Garc&ıacute;a, Ryuhei Okuno, and Kenzo Akazawa). CHAPTER 33: RECENT ADVANCES IN COMPOSITE AEP/EEG INDICES FOR ESTIMATING HYPNOTIC DEPTH DURING GENERAL ANESTHESIA? (Erik Weber Jensen, Pablo Martinez, Hector Litvan, Hugo Vereecke, Bernardo Rodriguez, and Michel M. R. F. Struys). CHAPTER 34: ENG RECORDING AMPLIFIER CONFIGURATIONS FOR TRIPOLAR CUFF ELECTRODES (I. F. Triantis, A. Demosthenous, M. S. Rahal, and N. Donaldson). CHAPTER 35: CABLE EQUATION MODEL FOR MYELINATED NERVE FIBER (P. D. Einziger, L. M. Livshitz, and J. Mizrahi). CHAPTER 36: BAYESIAN NETWORKS FOR MODELING CORTICAL INTEGRATION Paul Sajda, Kyungim Baek and Leif Finkel). CHAPTER 37: NORMAL AND ABNORMAL AUDITORY INFORMATION PROCESSING REVEALED BY NONSTATIONARY SIGNAL ANALYSIS OF EEG (Ben H. Jansen, Anant Hegde, Jacob Ruben, and Nashaat N. Boutros). CHAPTER 38: PROBING OSCILLATORY VISUAL DYNAMICS AT THE PERCEPTUAL LEVEL (H. Fotowat, H. Ö&gcaron;men, H. E. Bedell, and B. G. Breitmeyer). CHAPTER 39: NONLINEAR APPROACHES TO LEARNING AND MEMORY (Klaus Lehnertz). CHAPTER 40: SINGLE-TRIAL ANALYSIS OF EEG FOR ENABLING COGNITIVE USER INTERFACES (Adam D. Gerson, Lucas C. Parra, and Paul Sajda). INDEX. ABOUT THE EDITOR.

Read more less

Book SynopsisThe accessible introduction to biomaterials and their applications in tissue replacement, medical devices, and more Molecular and cell biology is being increasingly integrated into the search for high-performance biomaterials and biomedical devices, transforming a formerly engineering- and materials sciencebased field into a truly interdisciplinary area of investigation. Biomimetic, Bioresponsive, and Bioactive Materials presents a comprehensive introduction to biomaterials, discussing how they are selected, designed, and modified for integration with living tissue and how they can be utilized in the development of medical devices, orthopedics, and other related areas. Examining the physico chemical properties of widely used biomaterials and their uses in different clinical fields, the book explores applications including soft and hard tissue replacement; biointeractive metals, polymers, and ceramics; and in vitro, in vivo, and ex vivo biocompatibility tests andTable of ContentsPreface xi Contributors xiii 1 HISTORY OF BIOMIMETIC, BIOACTIVE, AND BIORESPONSIVE BIOMATERIALS 1 Matteo Santin and Gary Phillips 1.1 The First Generation of Biomaterials: The Search for “The Bioinert” 1 1.1.1 Bioinert: Myth, Reality, or Utopia? 4 1.2 The Second Generation of Biomaterials: Biomimetic, Bioresponsive, Bioactive 5 1.2.1 Hydroxyapatite (HA) and Bioglass®: Cell Adhesion and Stimulation 6 1.2.2 Collagen, Fibrin Glue, and Hyaluronic Acid Hydrogels: Presenting the ECM 6 1.2.3 Chitosan and Alginate: Replacing the ECM 9 1.2.4 Poly(Lactic/Glycolic) Acid Copolymers: Encouraging Tissue Remodeling by Safe Biodegradation 10 1.2.5 Porous Metals: Favoring Mechanical Integration 11 1.3 The Third-Generation Biomaterials: Biomimicking Natural Bioactive and Bioresponsive Processes 13 1.3.1 Principal Phases of Tissue Regeneration 14 1.3.1.1 Cell Adhesion: The Cornerstone of Tissue Regeneration 16 1.3.1.2 Mechanisms of Tissue Mineralization 19 1.4 Principles of Biomimesis and Bioactivity 21 1.4.1 Biomimicking of the ECM 22 1.4.2 Biomimicking of Cell Membrane Components 24 1.4.3 Biomimicking Cell Signaling Pathways 24 1.4.3.1 Modulation of the Growth Factor Signaling by Gene Expression: Bioactive Gene Delivery Systems 25 1.5 Bioactive Biomaterials from Different Natural Sources 26 1.5.1 Silk Fibroin 26 1.5.2 Soybean-Based Biomaterials 27 1.6 Scope of This Book 29 References 30 2 SOFT TISSUE STRUCTURE AND FUNCTIONALITY 35 Gabriela Voskerician 2.1 Overview 35 2.2 Epithelial Tissue 36 2.2.1 Background 36 2.3 The Skin 37 2.3.1 Structure and Functionality 37 2.3.2 Repair, Healing, and Renewal 42 2.4 Muscle Tissue 46 2.4.1 Background 46 2.4.2 Skeletal Muscle 48 2.4.2.1 Structure and Functionality 48 2.4.2.2 Repair, Healing, and Renewal 50 2.4.3 Smooth Muscle 51 2.4.3.1 Structure and Functionality 51 2.4.3.2 Repair, Healing, and Renewal 52 2.4.4 Cardiac Muscle 54 2.4.4.1 Structure and Functionality 54 2.4.4.2 Repair, Healing, and Renewal 55 2.5 Connective Tissue 56 2.5.1 Background 56 2.5.2 Embryonic Connective Tissue 57 2.5.3 Connective Tissue Proper 58 2.5.3.1 Cells of the Connective Tissue Proper 59 2.5.3.2 Connective Tissue Proper Fibers 60 2.5.3.3 Ground Substance 63 2.5.4 Specialized Connective Tissues 64 2.5.4.1 Structure and Function 64 2.5.4.2 Repair, Healing, and Renewal of Hyaline Cartilage 66 2.6 The Foreign Body Response 68 Exercises/Questions for Chapter 2 76 References 76 3 HARD TISSUE STRUCTURE AND FUNCTIONALITY 81 Antonio Merolli and Paolo Tranquilli Leali 3.1 Definition of Hard Tissues 81 3.2 Articular Cartilage 81 3.2.1 Structure of the Articular Cartilage 82 3.2.2 Specifi c Mechanism Repair of the Articular Cartilage 83 3.3 Bone Tissue 84 3.3.1 The Structure of the Bony Tissues 85 3.3.2 The Functions of Bone Tissue 86 3.3.3 Cell Types Involved in Bone Homeostasis: The Osteoblasts and the Osteoclasts 88 3.3.4 Ossifi cation, Turnover, and Remodeling 89 3.3.5 Bone Composite Structure and Its Effect on Mechanical Performance 91 3.4 Concluding Remarks 92 Exercises/Questions for Chapter 3 92 References 93 4 BIOMEDICAL APPLICATIONS OF BIOMIMETIC POLYMERS: THE PHOSPHORYLCHOLINE-CONTAINING POLYMERS 95 Andrew L. Lewis and Andrew W. Lloyd 4.1 Historical Perspective 95 4.2 Synthesis of PC-Containing Polymers 97 4.3 Physicochemical Properties of PC-Containing Polymers 98 4.3.1 Antifouling Mechanisms of Action 98 4.3.2 Swelling Phenomena and Structural Aspects of PC Coatings 100 4.4 Stability and Mechanical Property Considerations 102 4.4.1 PC Coatings and Surface Treatments 102 4.4.2 Bulk Hydrogels and Blends 104 4.5 Biological Compatibility 105 4.5.1 Interactions with Proteins, Eukaryotic Cells, and Bacteria 105 4.5.2 Interaction with Other Tissues 107 4.6. Applications of PC Polymers 107 4.6.1 Cardiovascular Applications 107 4.6.1.1 PC-Coated Coronary Stents 108 4.6.1.2 Vascular Grafts 108 4.6.1.3 Extracorporeal Circuits 109 4.6.2 Ophthalmic Applications 110 4.6.2.1 Intraocular Lenses 110 4.6.2.2 Contact Lenses 111 4.6.2.3 Other Ocular Devices 112 4.6.3 Anti-Infective Applications 112 4.6.3.1 Urological Devices 112 4.6.3.2 Tympanostomy Tubes 112 4.6.4 Orthopedic Applications 113 4.6.5 Biosensors and Diagnostics 113 4.6.6 Separation Systems 115 4.6.7 PC Polymers for Drug Delivery 116 4.6.7.1 Drug Delivery Coatings 116 4.6.7.2 Gel-Based Drug Delivery Systems 119 4.6.7.3 Nano/Micro Particulate Drug and Gene Delivery 119 4.6.7.4 Drug Conjugates 122 4.6.8 Emerging Applications 122 4.7 Summary 123 Exercises/Questions for Chapter 4 124 References 125 5 BIOMIMETIC, BIORESPONSIVE, AND BIOACTIVE MATERIALS: INTEGRATING MATERIALS WITH TISSUE 141 Roberto Chiesa and Alberto Cigada 5.1 Introduction 141 5.2 Mandatory Requirements for Metals as Implantable Materials 142 5.2.1 Stiffness 142 5.2.2 Strength 143 5.2.3 Corrosion Resistance 144 5.2.3.1 General Corrosion 144 5.2.3.2 Crevice Corrosion 145 5.2.3.3 Fretting Corrosion 145 5.2.3.4 Galvanic Corrosion 145 5.3 Biocompatibility of Metals 145 5.3.1 ISO Standardized Metal Family 146 5.3.1.1 Stainless Steels 146 5.3.1.2 Cobalt Alloys 148 5.3.1.3 Titanium and Titanium Alloys 149 5.4 Surface Treatments of Metals for Biomedical Applications 150 5.4.1 Cathodic Deposition Treatments 152 5.4.2 Anodic Oxidation 152 Exercises/Questions for Chapter 5 157 References 157 6 CERAMICS 161 Montserrat Espanol, Román A. Pérez, Edgar B. Montufar, and Maria-Pau Ginebra 6.1 Historical Perspective 161 6.2 Biostable Ceramics 162 6.2.1 Alumina 163 6.2.2 Zirconia 164 6.3 Bioactive and Resorbable Ceramics 165 6.3.1 Basic Concepts 165 6.3.2 Glasses and Glass–Ceramics 166 6.3.2.1 Physicochemical Properties of Bioactive Glasses 167 6.3.2.2 Silicate-Based Glasses 168 6.3.2.3 Phosphate-Based Glasses 170 6.3.2.4 Processing of Glass and Glass–Ceramics 170 6.3.3 Calcium Phosphates 172 6.3.3.1 Physicochemistry of Calcium Phosphates 172 6.3.3.2 Processing of Calcium Orthophosphates 175 6.3.4 New Trends in Bioactive and Resorbable Materials Integration 178 Exercises/Questions for Chapter 6 183 References 184 7 BIOFUNCTIONAL BIOMATERIALS OF THE FUTURE 191 Mário Barbosa, Gary Phillips, and Matteo Santin 7.1 Clinically Led Next Generation Biomaterials 191 7.1.1 Wound Dressings and Dermal Substitutes 192 7.1.2 Vascular Grafts and Cardiovascular Stents 193 7.1.3 Joint Implants and Cartilage Tissue Engineering 194 7.1.4 Bone Fillers 195 7.1.5 Nerve Guides 195 7.1.6 Ophthalmologic Devices 195 7.2 Biomacromolecule-Inspired Biomaterials 196 7.2.1 Artificial Laminin 196 7.2.2 Artificial Elastin 197 7.2.3 Artificial Collagen 197 7.2.4 GAG- and PGN-Mimicking Biomaterials 197 7.3 Nanostructured Biomimetic, Bioresponsive, and Bioactive Biomaterials 198 7.3.1 Nanofabrication of Biomaterials 198 7.3.1.1 2D Techniques 199 7.3.1.2 3D Techniques 199 7.3.1.3 Polymeric Dendrimers 200 7.3.1.4 Self-Assembling Peptides 201 7.4 Conclusions 202 Exercises/Questions for Chapter 7 203 References 203 Index 207

Read more less

Book SynopsisEthics in Speech and Language Therapy is a key text for students, practitioners and managers alike. The demands of practice, legislation, registration and the recognition of competencies all point to the need for speech and language therapists to be explicitly educated about ethics.Trade Review"This is really thought-provoking - far from a dry, dull book about ethical theories and principles . . . this book is an excellent resource for helping us think more deeply about our work-related ethical challenges." (Speech & Language Therapy in Practice, 1 July 2011)Table of ContentsList of contributors. Preface. Acknowledgements. 1. Introduction. 2. Practising Ethically. 3. Dysphagia. 4. Intellectual and Sensory Impairment. 5. Acquired Language Disorders. 6. Paediatric Speech and Language Disorders. 7. Degenerative Conditions in Ageing. 8. Service Provision and Management. 9. Common Themes and Emerging Trends.

Read more less

Book SynopsisThis guide offers an overview of the most common types of trial undertaken in early clinical development. The coverage discusses the different methodologies and the impact of new technologies, both clinical and statistical, on clinical development.Trade Review"An Introduction to Statistics in Early Phase Trials" is an admirably concise and practical guide to the pertinent context, principles and formulae for statisticians inexpert in the application of their discipline to Phase I and II clinical research". (Journal of Clinical Research Best Practices, 1 March 2011) “An Introduction to Statistics in Early Phase Trials provides concise descriptions of many early phase trial designs, along with the statistical equations necessary to gather and analyze the data” (Annals of Pharmacotherapy, 2010) "I enjoyed reading the work of Dr. Julious, Tan, and Machin,found it quite useful, and recommend it to others teaching about, working with, or considering work in the learning phase of drug development." (Journal of Biopharmaceutical Statistics, 2011) Table of ContentsChapter 1 Early phase trials 1 Chapter 2 Introduction to pharmacokinetics 13 Chapter 3 Sample size calculations for clinical trials 37 Chapter 4 Crossover trial basics 55 Chapter 5 Multi-period crossover trials 71 Chapter 6 First time into man 87 Chapter 7 Bayesian and frequentist methods 113 Chapter 8 First-time-into-new-population studies 125 Chapter 9 Bioequivalence studies 139 Chapter 10 Other Phase I trials 169 Chapter 11 Phase II trials: general issues 187 Chapter 12 Dose–response studies 197 Chapter 13 Phase II trials with toxic therapies 211 Chapter 14 Interpreting and applying early phase trial results 223 Chapter 15 Go/No-Go criteria 231 Appendix 245 References 251 Index 257

Read more less

Book SynopsisThe Old Age Psychiatry Handbook provides a comprehensive but concise overview of psychiatric, medical and practical issues that may arise within the speciality. The book is written in an easy assimilated format, ideal for use in the clinic and on the ward.Trade Review"A practical guide to “coal-face” old age psychiatry. The book is packed with the kind of information it takes many years of practice to accumulate, and presents the information in a very easily digestible form. If the giants of old age psychiatry had told stories to trainees, this is what they would have told. It is clearly and concisely written." (International Journal of Geriatric Psychiatry, February 2009) "The book is written in an easy assimilated format, ideal for use in the clinic and on the ward." (Doody's, June 2008)Table of ContentsPreface. Acknowledgements. 1 The Assessment of Patients in Old Age Psychiatry. Introduction. Setting. The psychiatric history in older patients. The Mental State Examination (MSE). Assessing cognition with limited time. Assessment of everyday functioning. Physical examination. Investigations. Neuropsychiatric testing and the memory clinic. Assessment of carers. Summary. Further reading. 2 Dementia. Definition and diagnosis of dementia. Assessment of a patient with dementia. General management of dementia. Behavioural and psychological symptoms of dementia. Why differentiate between the dementias? Alzheimer’s disease. Vascular dementia. Dementia with Lewy bodies. Frontotemporal dementia. Less common causes of dementia. Mild cognitive impairment. Functional and molecular neuroimaging in dementia. Further reading. 3 Depression. Epidemiology. Clinical features and diagnosis. Risk factors for depression in old age. Treatment. Outcome. Prevention of depression in the elderly. Depression and dementia. Bereavement. Suicide. Further reading. 4 Bipolar Affective Disorder. Epidemiology. Aetiology. Clinical features and diagnosis. Management. 5 Anxiety Disorders and Obsessive Compulsive Disorder. Anxiety in the elderly. Generalised anxiety disorder. Panic disorder. Phobic disorders. Post-traumatic stress disorder. Other reactions to stress. Obsessive compulsive disorder. Further reading. 6 Psychotic Illness. Schizophrenia. Schizoaffective disorder. Delusional disorder. Further reading. 7 Personality Disorders. Personality. Personality and age. Definition and classification of personality disorders. Personality disorders in old age. Management of personality disorder in old age. Further reading. 8 Alcohol. Current guidelines for alcohol consumption. Definitions. Epidemiology. Detection and screening. Consequences. Management. Further reading. 9 Insomnia. Sleep architecture. Circadian rhythm. Insomnia and consequences in the elderly. Causes of insomnia. Assessment of a patient with insomnia. Non-pharmacological management. Pharmacological management. Further reading. 10 Psychopharmacology. Principles of drug treatment in old age psychiatry. Adherence. Pharmacokinetics and pharmacodynamics. Adverse drug reactions and interactions. Antidepressant drugs. Lithium. Anticonvulsant mood stabilisers. Antipsychotic drugs. Anxiolytics and hypnotics. Drugs used in dementia. Further reading. 11 Electroconvulsive Therapy. Indications. Mechanism of action. Efficacy. Adverse effects. Cautions. Consent. ECT and the Mental Health Act. Pre-ECT physical work-up. Medication and ECT. ECT procedure. Prevention of relapse. Further reading. 12 Psychological Therapies. Cognitive behavioural therapy. Behavioural therapy. Psychoanalytic psychotherapy. Further reading. 13 Practical, Legal and Social Issues. Provision of services. Legal issues in old age psychiatry. Social and financial issues in old age. Further reading. 14 Physical Illness and Old Age Psychiatry. Delirium. Vascular disease. Neurological disease. Rheumatological disease. Endocrinological disease. Nutritional deficit. Neoplastic disease. Palliative care. Further reading. Appendices. Index.

Read more less

Book SynopsisBioengineering is a broad-based engineering discipline that applies engineering principles and design to challenges in human health and medicine, dealing with bio-molecular and molecular processes, product design, sustainability and analysis of biological systems. Applications that benefit from bioengineering include medical devices, diagnostic equipment and biocompatible materials, amongst others. Computer Modeling in Bioengineering offers a comprehensive reference for a large number of bioengineering topics, presenting important computer modeling problems and solutions for research and medical practice. Starting with basic theory and fundamentals, the book progresses to more advanced methods and applications, allowing the reader to become familiar with different topics to the desired extent. It includes unique and original topics alongside classical computational modeling methods, and each application is structured to explain the physiological background, phenomena that arTable of ContentsContributors. Preface. Part I: Theoretical Background of Computational Methods. 1. Notation - Matrices and Tensors. 2. Fundamentals of Continuum Mechanics. 3. Heat Transfer, Diffusion, Fluid Mechanics, and Fluid Flow through Porous Deformable Media. Part II: Fundamentals of Computational Methods. 4. Isoparametric Formulation of Finite Elements. 5. Dynamic Finite Element Analysis. 6. Introduction to Nonlinear Finite Element Analysis. 7. Finite Element Modeling of Field Problems. 8. Discrete Particle Methods for Modeling of Solids and Fluids. Part III: Computational Methods in Bioengineering. 9. Introduction to Bioengineering. 10. Bone Modeling. 11. Biological Soft Tissue. 12. Skeletal Muscles. 13. Blood Flow and Blood Vessels. 14. Modeling Mass Transport and Thrombosis in Arteries. 15. Cartilage Mechanics. 16. Cell Mechanics. 17. Extracellular Mechanotransduction: Modeling Ligand Concentration Dynamics in the Lateral Intercellular Space of Compressed Airway Epithelial Cells. 18. Spider Silk: Modeling Solvent Removal during Synthetic and Nephila clavipes Fiber Spinning. 19. Modeling in Cancer Nanotechnology. Index.

Read more less

Book SynopsisThis book offers the speech and language therapist studying or working in the field of psychogenic voice disorders a comprehensive understanding of how they present, a classification system and guidance on assessment and treatment.Trade Review"This text is value for money, easy to dip into and a comprehensive resource for any level of experience.... Its style is accessible and it is widely referenced with an invaluable summary at the end of each chapter." (Speech & Language Therapy in Practice, Summer 2009) "This book fleshes out areas which have been ignored and malnourished in the understanding and treatment of voice." (Doody's Health Services)Table of ContentsAbout the Authors ix Foreword xi Foreword xiii Preface xv Acknowledgements xvii 1 Psychogenic Voice Disorders – A New Model 1 2 Introducing the Cognitive Behaviour Therapy Model 31 3 Cognitive Behaviour Therapy: Essential Assessment Principles and Therapist Skills 39 4 Assessment of Voice and Personal History 57 5 Symptomatic Voice Therapy Approaches 89 6 Assessing Anxiety in Voice Patients 105 7 Treating Anxiety in Voice Patients 119 8 Treating Lowered Mood in Voice Patients 139 9 Psychological Disorders: Deciding When Not to Treat 157 10 Case Studies 175 References 207 Index 213

Read more less

Book SynopsisWith this book as their guide, readers will discover how to design better protective equipment and devices such as helmets, seat belts, and wheelchairs in order to minimize the risk or the extent of injury to people subjected to impact loads. It is based on the theory of optimal shock isolation, first developed in the 1950s to protect missile systems from intensive shock loads. Using examples from automotive, aviation, and military areas, the authors demonstrate how optimal shock isolation theory enables designers to improve the performance of protective equipment by incorporating control and optimization methods developed for shock isolation systems. The first part of Injury Biomechanics and Control lays down the engineering foundation, setting forth core principles and techniques, including: Fundamentals of impact and shock isolation systems Basic optimal shock isolation for single-degree-of-freedom systems OptimaTable of ContentsPREFACE. BASIC TERMINOLOGY. CHAPTER 1 INTRODUCTION. 1.1 The Structure of the Book. 1.2 Related Studies. References. CHAPTER 2 FUNDAMENTALS OF IMPACT AND SHOCK ISOLATION. 2.1 Shock Loading: Basic Models and Characteristics. 2.2 Shock Isolation. 2.3 The Isolator as a Control Medium: Active and Passive Isolators. 2.4 Does Isolation of an Object from the Base Always Lead to a Reduction in the Shock Load Transmitted to the Object?. References. CHAPTER 3 BASIC OPTIMAL SHOCK ISOLATION: SINGLE DEGREE OF FREEDOM SYSTEMS. 3.1 Basic Problems. 3.2 Limiting Performance Analysis: Basic Concept and Analytical Results. 3.3 Limiting Performance Analysis: Computational Approach. 3.4 Parametric Optimization. 3.5 Pre-Acting Control for Shock Isolators. 3.6 Best and Worst Disturbance Analyses. References. CHAPTER 4 OPTIMAL SHOCK ISOLATION FOR MULTI-DEGREE-OF-FREEDOM SYSTEMS. 4.1 Optimal Shock Isolation for a Two-Component Viscoelastic Object. 4.2 Optimal Shock Isolation for Three-Component Structures. References. CHAPTER 5 SPINAL INJURY CONTROL. 5.1 Description of the Model. 5.2 Minimization of the Occupant’s Displacement subject to a Constraint Imposed on the Spinal Compressive Force. 5.3 Spinal Injury Control System with two Shock Isolators. 5.4 MADYMO Simulation for the Limiting Performance Analysis. References. CHAPTER 6 THORACIC INJURY CONTROL. 6.1 Smart Restraint Systems. 6.2 Basic Concept of Restraint Force Control. 6.3 Limiting Performance Analysis for the Prevention of Thoracic Injuries in a Frontal Car Crash. 6.4 Feedback Control of the Elastic Restraint Force on the Basis of the Two-Mass Thorax Injury Model. 6.5 Conclusions. References. CHAPTER 7 HEAD INJURY CONTROL. 7.1 Head Injury Criterion: Historical Perspectives. 7.2 Minimization of the Deceleration Distance for Constrained HIC. 7.3 Minimization of the HIC for Constrained Deceleration Distance. 7.4 Alternative Control Laws. References. CHAPTER 8 INJURY CONTROL FOR WHEELCHAIR OCCUPANTS. 8.1 Introduction. 8.2 Optimal Shock Isolation of Single-Degree-of-Freedom System. 8.3 Simulation Using MADYMO. 8.4 Discussion. References. Index.

Read more less

Book SynopsisThis book presents chapters written by leading clinical researchers in the field of lung cancer, where high resolution 3-D imaging technology appears to hold the greatest near-term promise.Table of ContentsPreface (Thomas M. Baer and James L. Mulshine). Chapter 1: Incorporating Imaging into Drug Development: An Industry Perspective (Philip S. Murphy and Debasish Roychowdhury). Chapter 2: Developing Imaging Tools for Drug Development: Critical Technology, Clinical Data and Regulatory (Rafal Dziadziuszko, Fred R. Hirsch and Paul A. Bunn, Jr). Chapter 3: Quantitative Imaging in CT Lung Cancer Drug Development and Evaluation (Ricardo S. Avila). Chapter 4: Volumetric CT Imaging for Response Assessment in Lung Cancer: A Platform for Translational Research (Binsheng Zhao and Lawrence H. Scwhartz). Chapter 5: Emerging Radiological Software Standards and Development Technologies: Impact on Clinical Translation and Trials (John Pearson, Lawrence Tarbox, Gianluca Paladini, John G. Wolodzko, Paula M. Jacobs, and Zhenghong Lee). Chapter 6: Statistical Considerations Underlying Therapeutic Response Criteria for Lung Cancer: A Review in the Context of Emergence of Multi-Slice CT Scanner and Computer Assisted Diagnostic Algorithm for Volumetric Assessment (Madhu Mazumdar and Xi Kathy Zhou). Chapter 7: Programs Supporting Quantitative Imaging in Biomedicine at the National Institute for Standards and Technology (Thomas M. Baer and Charles W. Clark). Appendix A: Evolving Imaging Resources: Public Access Databases (Laurence Clarke). Appendix B: Biomedical Imaging Archive Network (Thomas M. Baer and James L. Mulshine). Appendix C: Developing CT Image-Processing Tools to Accelerate Progress in Lung Cancer Drug Development (James L. Mulshine, Ricardo S. Avila, Fred R. Hirsch, and David Yankelevitz).

Read more less

Book SynopsisThis book introduces novel concepts in the area of bioanalysis based on nanomaterials, opening new opportunities for basic research and new tools for real bioanalytical applications. Each chapter provides a theoretical overview of a different topic and includes an annex that describes the most interesting aspect related to the bioanalytical system.Table of ContentsCONTRIBUTORS. SERIES PREFACE. PREFACE. PART I CARBON NANOTUBES. 1. Carbon Nanotube–Based Sensors and Biosensors (Richard G. Compton, Gregory G. Wildgoose, and Elicia L. S. Wong). 1.1. Introduction to the Structure of Carbon Nanotubes. 1.2. Electroanalysis Using CNT-Modified Electrodes. 1.3. Advantageous Application of CNTs in Sensors: pH Sensing. 1.4. Carbon Nanotube–Based Biosensors. 1.5. Using CNTs in Biosensor Production for Medical Diagnostics and Environmental Applications. References. 2. Isotropic Display of Biomolecules on CNT-Arrayed Nanostructures (Mark R. Contarino, Gary Withey, and Irwin Chaiken). 2.1. Introduction: CNT Arrays for Biosensing. 2.2. Functionalization of CNTs: Controlling Display Through Covalent Attachment. 2.3. Self-Assembling Interfaces: Anchor-Probe Approach. 2.4. Molecular Wiring of Redox Enzymes. 2.5. Multiplexing Biomolecules on Nanoscale CNT Arrays. 2.6. Conclusions. References. 3. Interaction of DNA with CNTs: Properties and Prospects for Electronic Sequencing (Sheng Meng and Efthimios Kaxiras). 3.1. Introduction. 3.2. Structural Properties of Combined DNA–CNT Systems. 3.3. Electronic Structure. 3.4. Optical Properties. 3.5. Biosensing and Sequencing of DNA Using CNTs. 3.6. Summary. References. PART II NANOPARTICLES. 4. Improved Electrochemistry of Biomolecules Using Nanomaterials (Jianxiu Wang, Andrew J. Wain, Xu Zhu, and Feimeng Zhou). 4.1. Introduction. 4.2. CNT-Based Electrochemical Biosensors. 4.3. Nanoparticle-Based Electrochemical Biosensors. 4.4. Quantum Dot–Based Electrochemical Biosensors. 4.5. Conclusions and Outlook. References. 5. The Metal Nanoparticle Plasmon Band as a Powerful Tool for Chemo- and Biosensing (Audrey Moores and Pascal Le Floch). 5.1. Introduction. 5.2. The SPB: An Optical Property of Metal NPs. 5.3. Plasmon Band Variation Upon Aggregation of Nanoparticles. 5.4. Plasmon Band Variation on the Environment or Ligand Alteration. 5.5. Metal Nanoparticles as Labels. 5.6. Conclusions. References. 6. Gold Nanoparticles: A Versatile Label for Affinity Electrochemical Biosensors (Adriano Ambrosi, Alfredo de la Escosura-Mun˜ iz, Maria Teresa Castaneda, and Arben Merkoci). 6.1. Introduction. 6.2. Synthesis of AuNPs. 6.3. Characterization of AuNPs. 6.4. AuNPs as Detecting Labels for Affinity Biosensors. 6.5. Conclusions. References. 7. Quantum Dots for the Development of Optical Biosensors Based on Fluorescence (W. Russ Algar and Ulrich J. Krull). 7.1. Introduction. 7.2. Quantum Dots. 7.3. Basic Photophysics and Quantum Confinement. 7.4. Quantum Dot Surface Chemistry and Bioconjugation. 7.5. Bioanalytical Applications of Quantum Dots as Fluorescent Labels. 7.6. Fluorescence Resonance Energy Transfer and Quantum Dot Biosensing. 7.7. Summary. References. 8. Nanoparticle-Based Delivery and Biosensing Systems: An Example (Almudena Mun˜oz Javier, Pablo del Pino, Stefan Kudera, and Wolfgang J. Parak). 8.1. Introduction. 8.2. Functional Colloidal Nanoparticles. 8.3. Polyelectrolyte Capsules as a Functional Carrier System. 8.4. Uptake of Capsules by Cells. 8.5. Delivery and Sensing with Polyelectrolyte Capsules. 8.6. Conclusions. References. 9. Luminescent Quantum Dot FRET-Based Probes in Cellular and Biological Assays (Lifang Shi, Nitsa Rosenzweig, and Zeev Rosenzweig). 9.1. Introduction. 9.2. Luminescent Quantum Dots. 9.3. Fluorescence Resonance Energy Transfer. 9.4. Quantum Dot FRET-Based Protease Probes. 9.5. Summary and Conclusions. References. 10. Quantum Dot–Polymer Bead Composites for Biological Sensing Applications (Jonathan M. Behrendt and Andrew J. Sutherland). 10.1. Introduction. 10.2. Quantum Dot–Composite Construction. 10.3. Applications of QD Composites. 10.4. Future Directions. References. 11. Quantum Dot Applications in Biomolecule Assays (Ying Xu, Pingang He, and Yuzhi Fang). 11.1. Introduction to QDs and Their Applications. 11.2. Preparation of QDs for Conjugation with Biomolecules and Cells. 11.3. Special Optoelectronic Properties in the Bioemployment of QDs. 11.4. Employment of QDs as Biosensing Indicators. References. 12. Nanoparticles and Inductively Coupled Plasma Mass Spectroscopy–Based Biosensing (Arben Merkoc¸i, Roza Allabashi, and Alfredo de la Escosura-Muniz). 12.1. ICP-MS and Application Possibilities. 12.2. Detection of Metal Ions. 12.3. Detection of Nanoparticles. 12.4. Analysis of Metal-Containing Biomolecules. 12.5. Bioanalysis Based on Labeling with Metal Nanoparticles. 12.6. Conclusions. References. PART III NANOSTRUCTURED SURFACES. 13. Integration Between Template-Based Nanostructured Surfaces and Biosensors (Walter Vastarella, Jan Maly, Mihaela Ilie, and Roberto Pilloton). 13.1. Introduction. 13.2. Nanosphere Lithography. 13.3. Nanoelectrodes Ensemble for Biosensing Devices. 13.4. Concluding Remarks. References. 14. Nanostructured Affinity Surfaces for MALDI-TOF-MS–Based Protein Profiling and Biomarker Discovery (R. M. Vallant, M. Rainer, M. Najam-Ul-Haq, R. Bakry, C. Petter, N. Heigl, G. K. Bonn, and C. W. Huck). 14.1. Proteomics and Biomarkers. 14.2. MALDI in Theory and Practice. 14.3. Carbon Nanomaterials. 14.4. Near-Infrared Diffuse Reflection Spectroscopy of Carbon Nanomaterials. References. PART IV NANOPORES. 15. Biosensing with Nanopores (Ivan Vlassiouk and Sergei Smirnov). 15.1. Nanoporous Materials in Sensing. 15.2. Nanochannel and Nanopore Fabrication. 15.3. Surface Modification Chemistry 15.4. Nonelectrical Nanoporous Biosensors. 15.5. Electrical Nanoporous Biosensors. 15.6. Summary. References. INDEX.

Read more less

Book Synopsis* Mass Spectrometry is a major tool to characterize, identify and detect hundreds of known and unknown drugs.Trade Review“Mass Spectrometry in Sports Drug Testing is an excellent textbook for anyone involved in the analytical characterization of illicit substances and abused drugs.” (Anal Bioanal Chem, 2011) Table of ContentsPreface. Acknowledgments. 1 History of Sports Drug Testing. 1.1 Historical Attempts of Artificial Performance Enhancement. 1.2 Background and Rationale of Doping Controls. 1.3 Early Detection Methods: Possibilities and Limitations of Assays Without Mass Spectrometry. 1.4 Introduction of Mass Spectrometry to Doping Control Analysis. References. 2. Mass Spectrometry and the List of Prohibited Substances and Methods of Doping. 2.1 Criteria for the Mass Spectrometric Identification of Prohibited Compounds. 2.2 Modern Mass Spectrometers in Doping Controls: Advantages and Disadvantages of Available Techniques. References. 3. Structure Characterization of Low Molecular Weight Target Analytes —Electron Ionization. 3.1 Stimulants. 3.2 Narcotics. 3.3 Anabolic Androgenic Steroids. 3.4 Selective Androgen Receptor Modulators (SARMs). 3.5 Diuretics. 3.6 β2-Agonists. 3.7 β-Receptor Blocking Agents. 3.8 Calcium-Channel Modulators (RYCALS). 3.9 Carbohydrate-Based Agents. References. 4. Structure Characterization of Low Molecular Weight Target Analytes: Electrospray Ionization. 4.1 Stimulants. 4.2 Narcotics. 4.3 Anabolic Androgenic Steroids. 4.4 Selective Androgen Receptor Modulators (SARMs). 4.5 Diuretics. 4.6 β2-Agonists. 4.7 Calcium-Channel Modulators (RYCALS). 4.8 Peroxisome-Proliferator Activated Receptor-δ (PPARδ) And Adenosine Monophosphate Activated Protein Kinase (AMPK) Agonists. 4.9 Hypoxia-Inducible Factor (HIF)-Stabilizers And Sirtuin Activators. 4.10 β-Receptor Blocking Agents. 4.11 Glucuronic Acid and Sulfate Conjugates of Target Analytes. References. 5. Structure Characterization of High Molecular Weight Target Analytes: Electrospray Ionization. 5.1 Human Chorionic Gonadotrophin (hCG). 5.2 Erythropoietins (EPO). 5.3 Synacthen. 5.4 Insulins. 5.5 Hemoglobin-Based Oxygen Carriers (HBOCs). 5.6 Human Growth Hormone (hGH). 5.7 Sermorelin (Geref). 5.8 Insulin-Like Growth Factor-1 (IGF-1). 5.9 Gonadorelin (LHRH). References. 6. Modern Mass Spectrometry-Based Analytical Assays. 6.1 GC-MS and Isotope Ratio Mass Spectrometry. 6.2 LC-MS/MS. References. 7. Limitations and Perspectives of Mass Spectrometry-Based Procedures in Doping Control Analysis. 7.1 Recombinant Biomolecules. 7.2 Unknown Compounds. 7.3 Profiling of Urine and/or Blood. 7.4 Alternative Specimens. References. Index.

Read more less

Book SynopsisBalanced coverage of natural cosmetics, and what it really means to be green The use of natural ingredients and functional botanical compounds in cosmetic products is on the rise. According to industry estimates, sales of natural personal care products have exceeded $7 billion in recent years. Nonetheless, many misconceptions about natural products?for instance, what green and organic really mean?continue to exist within the industry. Formulating, Packaging, and Marketing of Natural Cosmetic Products addresses this confusion head-on, exploring and detailing the sources, processing, safety, efficacy, stability, and formulation aspects of natural compounds in cosmetic and personal care products. Designed to provide industry professionals and natural product development experts with the essential perspective and market information needed to develop truly green cosmetics, the book covers timely issues like biodegradable packaging and the potential microbial risks they presTrade Review"I highly recommend this book for professionals interested in cosmetics as well as physicians, pharmacists, and naturopathic doctors, and those interested in knowing the intricate world regarding the production, regulation, packaging, benefits, and risks inherent to various natural products used as cosmetics." (Herbalgram, 1 November 2013) "Chapters are strengthened by comprehensive referencing. From pharmacology to packaging, from Ayurvedic medicine to composting of containers, it is all here. This comprehensive text may well become the definitive work on this subject." (Journal of Cosmetic Dermatology, 8 November 2011)Table of ContentsPreface Contributors Part I Market and Trends. Chapter 1. The natural personal care market (Darrin C. Duber Smith). Chapter 2. Consumer and formulator of natural cosmetic products: understanding and integrating each other needs (Yi Hsin Chang). Chapter 3. The Mechanics of Developing a Natural/Organic Non-governmental Cosmetic Standard (Amy B. Olson). Part II Regulatory Aspects. Chapter 4. Regulatory perspective of natural and organic claims for cosmetic products (Azalea Rosholt). Chapter 5. The US legal perspective on making natural and organic claims for cosmetic products (Miriam Guggenheim and Mary Joy Ballantyne). Chapter 6. Regulatory and safety aspects of natural fragrance ingredients (Anne Marrie Api and Matthias Vey). Chapter 7. Advertising self regulation- a review of cosmetic claims and natural/organic claims (Annie Ugurlayan). Part III Safety Aspects. Chapter 8. The safety assessment of plant derived ingredients in cosmetics (Viny Srinivasam and Eric Antignac). Chapter 9. Approaches to assessing consumer safety of botanical ingredients with emphasis to type I allergy (Esperanza Troyano, Donna Mc Millan, Katherine Sarlo, Lijuan Li. Rohan Wimalasena). Chapter 10. Preserving cosmetics with natural preservatives and preserving natural cometics (James Flanagan). Chapter 11. Microbial risks for Eco-friendly packaging (John Yablonki, Sharon Mancuso). Part IV Use of Natural Ingredients. Chapter 12. Formulating Natural Cosmetics with Oils, Fats, Butters, and Waxes (Mark Garrison and Nava Dayan). Chapter 13. Natural Antioxidants and their Effects on the Skin (Anne Pouillot, Luigi L. Polla, Philippe Tacchini, Alice Neequaye, Ada Polla, Barbara Polla). Chapter 14. The use of quercetin and curcumin in skin care and consumer products (Brian Kilfoyle, Dishka Kausjik, Jenna Terebeski, Sonali Bose, Bo Michniak Kohn). Chapter 15. Ayruvedic Ingredients in cosmetics (Raja Sivalenka and Mangathayaru Putrevu). Chapter 16. Formulating with traditional Chinese medicine herbs (Ina Scienoff and Robin Choi). Chapter 17. The inside-out concept as complement to the use of topical sunscreen: The case for endogenous skin photoprotection form sunlight by natural dietary actives such as tomato carotenoids (Joseph Levi and Yoav Sharoni). Part V Analysis of Naturals. Chapter 18. Chromatographic Techniques for the Analysis of Natural Products in Cosmetics (Stefan Gafner Jacquelyn R. Villinski). Chapter 19. The use of nuclear magnetic resonance spectroscopy for the identification of biomarkers for quality control of plant extracts (Kan He and Marc Roller). Part IV Biodegradation. Chapter 20. Biodegredability evaluation for cosmetic ingredients and finished products (Jennifer K. Saxe). Cahpter 21. Overview of Biodegradable Packaging, Methods and Current Trends (Gaurav Kale). Index

Read more less

Book SynopsisAt last a new edition of the highly acclaimed book Clinical Trials in Psychiatry This book provides a concise but thorough overview of clinical trials in psychiatry, invaluable to those seeking solutions to numerous problems relating to design, methodology and analysis of such trials.Practical examples and applications are used to ground theory whenever possible. The Second Edition includes new information regarding: Recent important psychiatric trials More specific discussion of psychiatry in the USA and the particular problems of trials in the USA, including comments about the FDA (U.S. Food and Drug Administration) An extended chapter on meta-analysis Further discussion of sub-group analysis Special features include appendices outlining how to design and report clinical trials, what websites and software programs are appropriate and an extensive reference section. From the reviews of the First EdiTrade Review"A book to read from beginning to end.... Clinical Trials in Psychiatry covers all the most important issues and will be useful to all clinicians who are involved in conducting, or using the results of, clinical trials. It provides a highly persuasive account of the unique scientific advantages of randomised trials for those who remain unconvinced. It is very readable." (British Journal of Psychiatry, February 2009) "On balance, readers looking for a practical text to introduce them to the key issues will be well-satisfied with Clinical Trials in Psychiatry." (Journal of Biopharmaceutical Statistics, Volume 19, Issue 1, 2009) "On balance, readers looking for a practical text to introduce them to the key issues will be well-satisfied with Clinical Trials in Psychiatry." (Journal of Biopharmaceutical Statistics, Volume 19, Issue 1, 2009)Table of ContentsPreface to the first edition. Preface to the second edition. 1. Treatments, good, bad or worthless – and how do we tell? 1.1 Treatments worthless – and worse. 1.2 A brief history of treating the mentally ill. 1.3 Summary. 2. The randomized clinical trial. 2.1 Introduction. 2.2 The clinical trial. 2.3 Ethical issues in clinical trials. 2.4 Informed consent. 2.5 Compliance. 2.6 Summary. 3. Design issues in clinical trials. 3.1 Introduction. 3.2 Clinical trial designs. 3.3 Methods of randomization. 3.4 Methods of masking treatments. 3.5 The size of a clinical trial. 3.6 Interim analysis. 3.7 Summary. 4. Special problems of trials in psychiatry. 4.1 Introduction. 4.2 Explanatory versus pragmatic trials. 4.3 Complex interventions. 4.4 Outcome measures in psychiatry. 4.5 Summary. 5. Some statistical issues in the analysis of psychiatric trials. 5.1 Introduction. 5.2 P-values and confidence intervals. 5.3 Using baseline data. 5.4 Longitudinal data. 5.5 Missing values and dropouts in longitudinal data. 5.6 Multiple outcome measures. 5.7 Intention-to-treat. 5.8 Economic evaluation of trials. 5.9 Number needed to treat. 6. Analysing data from a psychiatric trial: an example. 6.1 Introduction. 6.2 Beating the Blues. 6.3 Analysis of the post-treatment BDI scores. 6.4 Graphical displays and summary measure analysis of longitudinal data. 6.5 Random effects models for the BtB data. 6.6 The dropout problem in the BtB data. 6.7 Summary. 7. Systematic reviews and meta-analysis. 7.1 Introduction. 7.2 Study selection. 7.3 Publication bias. 7.4 The statistics of meta-analysis. 7.5 Some examples of meta-analysis of psychiatric trials. 7.6 Summary. 8. RCTs in psychiatry: threats, challenges and the future. 8.1 Introduction. 8.2 Can randomized clinical trials in psychiatry be justified? 8.3 Are randomized clinical trials really necessary? 8.4 Conflicts of interest. 8.5 Scandals, trials and tribulations. 8.6 The future of psychiatric trials. 8.7 Defending the clinical trial. 8.8 Summary. Appendix A. Issues in the management of clinical trials- 'how to do it'. A.1 Introduction. A.2 Clinical trial protocols. A.3 Getting the costs right. A.4 Collecting and managing the data. A.5 Writing the patient information sheet. A.6 Getting informed consent. A.7 Maintaining recruitment. A.8 Useful web sites. Appendix B. Writing a trial report. B.1 Introduction. Appendix C. Useful software for clinical trials. C.1 Introduction. C.2 Data management. C.3Design. C.4 Analysis. Bibliography. Index.

Read more less

Book SynopsisSince the first edition was published in 1998, considerable advances have been made in the fields of pitch perception and speech perception. In addition, there have been major changes in the way that hearing aids work, and the features they offer. This book will provide an understanding of the changes in perception that take place when a person has cochlear hearing loss so the reader understands not only what does happen, but why it happens. It interrelates physiological and perceptual data and presents both this and basic concepts in an integrated manner. The goal is to convey an understanding of the perceptual changes associated with cochlear hearing loss, of the difficulties faced by the hearing-impaired person, and the limitations of current hearing aids.Table of ContentsPreface. Chapter 1. Physiological Aspects of Cochlear Hearing Loss. I. INTRODUCTION. II.LINEAR AND NONLINEAR SYSTEMS. III. STRUCTURE AND FUNCTION OF THE OUTER AND MIDDLE EAR. IV. STRUCTURE AND FUNCTION OF THE NORMAL COCHLEA. 1. The cochlea, the basilar membrane and the organ of Corti. 2. Tuning on the basilar membrane. 3. The nonlinearity of input-output functions on the BM. 4. Two-tone suppression. 5. Combination tone generation. 6. Responses of the BM to complex sounds. 7. Otoacoustic emissions. V. NEURAL RESPONSES IN THE NORMAL AUDITORY NERVE. 1. Spontaneous firing rates and thresholds. 2. Tuning curves and iso-rate contours. 3. Rate-versus-level functions. 4. Two-tone suppression. 5. Phase locking. VI. TYPES OF HEARING LOSS. VII. PHYSIOLOGY OF THE DAMAGED COCHLEA. 1. BM responses. 2. Neural responses. 3. Structure-function correlation. 4. Otoacoustic emissions. 5. Phase locking. VIII. CONCLUSIONS. Chapter 2. Absolute Thresholds. I. INTRODUCTION. II. MEASURES OF ABSOLUTE THRESHOLD. 1. Minimum audible pressure (MAP). 2. Minimum audible field (MAF). 3. Comparison of MAP and MAF. 4. The audiogram. III. DESCRIPTIONS OF THE SEVERITY OF HEARING LOSS. IV. CAUSES OF HEARING LOSS DUE TO COCHLEAR DAMAGE. V. PERCEPTUAL CONSEQUENCES OF ELEVATED ABSOLUTE THRESHOLDS. Chapter 3. Masking, Frequency Selectivity and BM Nonlinearity. I. INTRODUCTION. II. THE MEASUREMENT OF FREQUENCY SELECTIVITY USING MASKING. 1. Introduction. 2. The power spectrum model. 3. Estimating the shape of a filter. III. ESTIMATING FREQUENCY SELECTIVITY FROM MASKING EXPERIMENTS. 1. Psychophysical tuning curves. 2. The notched-noise method. IV. CHARACTERISTICS OF THE AUDITORY FILTER IN NORMAL HEARING. 1. Variation with centre frequency. 2. Variation with level. 3. Summary. V. MASKING PATTERNS AND EXCITATION PATTERNS. 1. Masking patterns. 2. Relationship of the auditory filter to the excitation pattern. 3. Changes in excitation patterns with level. 4. Possible effects of suppression. VI. NON-SIMULTANEOUS MASKING. 1. Basic properties of non-simultaneous masking. 2. Evidence for suppression from non-simultaneous masking. 3. The enhancement of frequency selectivity revealed in non-simultaneous masking. 4. Relation between the growth of forward masking and the BM input-output function. VII. THE AUDIBILITY OF PARTIALS IN COMPLEX TONES. VIII. EFFECTS OF COCHLEAR DAMAGE ON FREQUENCY SELECTIVITY IN SIMULTANEOUS MASKING. 1. Complicating factors. 2. Psychophysical tuning curves. 3. Auditory filter shapes measured with notched noise. IX. THE USE OF MASKING TO DIAGNOSE DEAD REGIONS. 1. The TEN test. 2. The TEN(HL) test. 3. Prevalence of dead regions assessed using the TEN(HL) test. X. EFFECTS OF COCHLEAR DAMAGE ON FORWARD MASKING AND SUPPRESSION . XI. EFFECTS OF COCHLEAR HEARING LOSS ON BM INPUT-OUTPUT FUNCTIONS. XII. PERCEPTUAL CONSEQUENCES OF REDUCED FREQUENCY SELECTIVITY, LOSS OF SUPPRESSION AND STEEPER BM INPUT-OUTPUT FUNCTIONS. 1. Susceptibility to masking. 2. Timbre perception. 3. Perceptual consequences of dead regions. Chapter 4. Loudness Perception and Intensity Resolution. I. INTRODUCTION. II. LOUDNESS PERCEPTION FOR NORMALLY HEARING PEOPLE. 1. Equal-loudness contours and loudness level. 2. The scaling of loudness. 3. The detection of intensity changes. III. EFFECTS OF COCHLEAR HEARING LOSS ON LOUDNESS PERCEPTION. IV. A MODEL OF NORMAL LOUDNESS PERCEPTION. V. A MODEL OF LOUDNESS PERCEPTION APPLIED TO COCHLEAR HEARING LOSS. 1. Introduction. 2. Elevation of absolute threshold. 3. Reduced compressive nonlinearity. 4. Reduced IHC/neural function. 5. Reduced frequency selectivity. 6. Complete loss of functioning IHCs or neurones (dead regions). 7. Using the model to account for loudness recruitment. VI. EFFECTS OF BANDWIDTH ON LOUDNESS . 1. Normal hearing. 2. Impaired hearing. VII. EFFECTS OF COCHLEAR HEARING LOSS ON INTENSITY RESOLUTION. VIII. PERCEPTUAL CONSEQUENCES OF ALTERED LOUDNESS PERCEPTION. 1. Consequences of loudness recruitment and reduced dynamic range. 2. Perceptual consequences of reduced loudness summation. 3. Perceptual consequences of altered intensity discrimination. Chapter 5. Temporal Resolution and Temporal Integration. I. INTRODUCTION. II. MODELLING WITHIN-CHANNEL TEMPORAL RESOLUTION IN NORMAL HEARING. 1. Bandpass filtering. 2. The nonlinearity. 3. The sliding temporal integrator. 4. The decision device. 5. Characterising the nonlinear device and the sliding temporal integrator. III. TEMPORAL RESOLUTION IN NORMAL HEARING. 1. The effect of centre frequency on gap detection. 2. Temporal modulation transfer functions. 3. The rate of recovery from forward masking. IV. TEMPORAL RESOLUTION IN PEOPLE WITH COCHLEAR DAMAGE. 1. The influence of sound level on gap detection and the rate of decay of forward masking. 2. The influence of audible bandwidth on TMTFs and gap detection. 3. The influence of changes in the compressive nonlinearity. V. TEMPORAL INTEGRATION AT THRESHOLD. 1. Temporal integration in normally hearing people. 2. Temporal integration in people with cochlear hearing loss. 3. Explanations for reduced temporal integration in people with cochlear hearing loss. VI. TEMPORAL INTEGRATION AT SUPRATHRESHOLD LEVELS. VII. PERCEPTUAL CONSEQUENCES OF ABNORMAL TEMPORAL PROCESSING IN PEOPLE WITH COCHLEAR HEARING LOSS. 1. Consequences of abnormal temporal resolution. 2. Consequences of reduced temporal integration. Chapter 6. Pitch Perception and Frequency Discrimination. I. INTRODUCTION. II. THEORIES OF PITCH PERCEPTION. III. THE PERCEPTION OF THE PITCH OF PURE TONES BY NORMALLY HEARING PEOPLE. 1. The frequency discrimination of pure tones. 2. The perception of musical intervals. 3. The effect of level on pitch. IV. FREQUENCY DISCRIMINATION OF PURE TONES BY PEOPLE WITH COCHLEAR HEARING LOSS. 1. Difference limens for frequency (DLFs). 2. Frequency modulation detection limens (FMDLs). V. THE PERCEPTION OF PURE-TONE PITCH FOR FREQUENCIES FALLING IN A DEAD REGION. VI. PITCH ANOMALIES IN THE PERCEPTION OF PURE TONES. VII. THE PITCH PERCEPTION OF COMPLEX TONES BY NORMALLY HEARING PEOPLE. 1. The phenomenon of the missing fundamental. 2. Discrimination of the repetition rate of complex tones. VIII. THEORIES OF PITCH PERCEPTION FOR COMPLEX TONES. 1. The representation of a complex tone in the peripheral auditory system. 2. Spectro-temporal pitch theories. 3. The relative importance of envelope and temporal fine structure. IX. PITCH PERCEPTION OF COMPLEX TONES BY PEOPLE WITH COCHLEAR HEARING LOSS. 1. Theoretical considerations. 2. Experimental studies. X. PERCEPTUAL CONSEQUENCES OF ALTERED FREQUENCY DISCRIMINATION AND PITCH PERCEPTION. 1. Effects on speech perception. 2. Effects on music perception. Chapter 7. Spatial Hearing and Advantages of Binaural Hearing. I. INTRODUCTION. II. THE LOCALISATION OF SINUSOIDS. 1. Cues for localisation. 2. Performance of normally hearing people in localisation and lateralisation. 3. Performance of hearing-impaired people in localisation and lateralisation. III. THE LOCALISATION OF COMPLEX SOUNDS. 1. The role of transients and across-frequency comparisons. 2. Performance of normally hearing people. 3. Performance of people with cochlear hearing loss. 4. Reasons for large ITD and IID thresholds in people with cochlear hearing loss. IV. THE CONE OF CONFUSION, HEAD MOVEMENTS, AND PINNA CUES. 1. The cone of confusion. 2. The role of head movements. 3. Information provided by the pinnae. 4. Localisation using pinna cues by normal and hearing-impaired people. V. GENERAL CONCLUSIONS ON SOUND LOCALISATION. VI. THE PRECEDENCE EFFECT. 1. The precedence effect for normal hearing. 2. The precedence effect for impaired hearing. VII. BINAURAL MASKING LEVEL DIFFERENCES (MLDS). 1. MLDs for normally hearing people. 2. Mechanisms underlying MLDs. 3. MLDs for people with cochlear hearing loss. 4. Possible reasons for smaller MLDs in people with cochlear damage. VIII. HEAD SHADOW EFFECTS. 1. Benefits of head shadow for normally hearing people. 2. Benefits of head shadow for hearing-impaired people. IX. RELEASE FROM INFORMATIONAL MASKING. X. DIOTIC ADVANTAGES. XI. PERCEPTUAL CONSEQUENCES OF ABNORMAL BINAURAL AND SPATIAL HEARING IN PEOPLE WITH COCHLEAR DAMAGE. Chapter 8. Speech Perception. I. INTRODUCTION. II. THE MAGNITUDE OF THE NOISE PROBLEM. III. THE ROLE OF AUDIBILITY. 1. The Articulation Index and Speech Intelligibility Index. 2. Use of the AI or SII to predict speech intelligibility for the hearing impaired. 3. The intelligibility of speech in noise at high overall levels. 4. Comparison of detection and recognition for speech in noise. 5. The intelligibility of speech in quiet at high overall levels. 6. Simulation of hearing loss by selective filtering (frequency-dependant attenuation). 7. Simulation of hearing loss by masking. 8. Comparison of speech intelligibility for conductive and cochlear losses. 9. Conclusions on the role of audibility. IV. INFLUENCE OF DEAD REGIONS ON SPEECH PERCEPTION. V. CORRELATION BETWEEN PSYCHOACOUSTIC ABILITIES AND SPEECH PERCEPTION. VI. ASSESSING THE EFFECTS OF FREQUENCY SELECTIVITY ON VOWEL AND CONSONANT PERCEPTION. 1. Consonant perception. 2. Vowel perception. VII. INFLUENCE OF LOSS OF SENSITIVITY TO TEMPORAL FINE STRUCTURE. VIII. THE USE OF SIMULATIONS TO ASSESS THE IMPORTANCE OF PSYCHOACOUSTIC FACTORS IN SPEECH PERCEPTION. 1. Simulations of loudness recruitment combined with threshold elevation. 2. Simulations of reduced frequency selectivity. 3. Simulation of the combined effects of threshold elevation, recruitment and reduced frequency selectivity. 4. Simulation of reduced temporal resolution. IX. CONCLUSIONS. Chapter 9. Hearing Aids. I. INTRODUCTION. II. LINEAR AMPLIFICATION. 1. The difficulty of restoring audibility using linear aids. 2. Prescriptive fitting rules for linear hearing aids. III. COMPRESSION AMPLIFICATION. 1. Basic characteristics of AGC systems. 2. Varieties of AGC systems. 3. Rationales for the use of multi-band compression (and noise reduction). 4. Research on the effectiveness of multi-band syllabic compression. 5. Methods of initial fitting of hearing aids with multi-band compression. 6. Methods for fine tuning hearing aids with multi-band compression. 7. Slow-acting AGC systems. 8. Comparisons of ssslow-acting and fast-acting systems. 9. General conclusions about compression. IV. SOME GENERAL PROBLEMS WITH HEARING AIDS. 1. Inadequate gain at high frequencies. 2. Acoustic feedback. 3. Peakiness of frequency response. 4. The occlusion effect. 5. Time delays. V. METHODS FOR IMPROVING THE SPEECH-TO-NOISE RATIO. 1. Multi-channel noise reduction. 2. Directional microphones. 3. Binaural processing algorithms. VI. TRANSPOSITION AIDS FOR SEVERE AND PROFOUND HEARING LOSS. VII. COCHLEAR IMPLANTS. VIII. CONCLUDING REMARKS. Glossary. References.

Read more less

Book SynopsisAddressing the exploding interest in bioengineering for healthcare applications, this book provides readers with detailed yet easy-to-understand guidance on biomedical device engineering. Written by prominent physicians and engineers, Medical Devices: Surgical and Image-Guided Technologies is organized into stand-alone chapters covering devices and systems in diagnostic, surgical, and implant procedures. Assuming only basic background in math and science, the authors clearly explain the fundamentals for different systems along with such topics as engineering considerations, therapeutic techniques and applications, future trends, and more. After describing how to manage a design project for medical devices, the book examines the following: Instruments for laparoscopic and ophthalmic surgery, plus surgical robotics Catheters in vascular therapy and energy-based hemostatic surgical devices Tissue ablation systems and the varied uses of laserTable of ContentsPREFACE xvii CONTRIBUTORS xix PART I INTRODUCTION TO MEDICAL DEVICES 1 1. Introduction 3 Martin Culjat 1.1 History of Medical Devices 3 1.2 Medical Device Terminology 6 1.3 Purpose of the Book 10 2. Design of Medical Devices 11 Gregory Nighswonger 2.1 Introduction 11 2.2 The Medical Device Design Environment 11 2.2.1 US Regulation 12 2.2.2 Differences in European Regulation 13 2.2.3 Standards 14 2.3 Basic Design Phases 15 2.3.1 Feasibility 15 2.3.2 Planning and Organization—Assembling the Design Team 16 2.3.3 When to Involve Regulatory Affairs 17 2.3.4 Conceptualizing and Review 17 2.3.5 Testing and Refinement 20 2.3.6 Proving the Concept 20 2.3.7 Pilot Testing and Release to Manufacturing 22 2.4 Postmarket Activities 25 2.5 Final Note 25 PART II MINIMALLY INVASIVE DEVICES AND TECHNIQUES 27 3. Instrumentation for Laparoscopic Surgery 29 Camellia Racu-Keefer, Scott Um, Martin Culjat, and Erik Dutson 3.1 Introduction 29 3.2 Basic Principles 31 3.3 Laparoscopic Instrumentation 34 3.3.1 Trocars 34 3.3.2 Standard Laparoscopic Instruments 37 3.3.3 Additional Laparoscopic Instruments 42 3.3.4 Specimen Retrieval Bags 44 3.3.5 Disposable Instruments 44 3.4 Innovative Applications 45 3.5 Summary and Future Applications 46 4. Surgical Instruments in Ophthalmology 49 Allen Y. Hu, Robert M. Beardsley, and Jean-Pierre Hubschman 4.1 Introduction 49 4.2 Cataract Surgery 51 4.2.1 Basic Technique 51 4.2.2 Principles of Phacoemulsification 52 4.2.3 Phacoemulsification Instruments 54 4.2.4 Phacoemulsification Systems 55 4.2.5 Future Directions 56 4.3 Vitreoretinal Surgery 56 4.3.1 Basic Techniques 56 4.3.2 Principles of Vitrectomy 57 4.3.3 Vitrectomy Instruments 58 4.3.4 Vitrectomy Systems 60 4.3.5 Future Directions 60 4.4 Other Ophthalmic Surgical Procedures 61 4.5 Conclusion 62 5. Surgical Robotics 63 Jacob Rosen 5.1 Introduction 63 5.2 Background and Leading Concepts 63 5.2.1 Human–Machine Interfaces: System Approach 65 5.2.2 Tissue Biomechanics 70 5.2.3 Teleoperation 72 5.2.4 Image-Guided Surgery 78 5.2.5 Objective Assessment of Skill 79 5.3 Commercial Systems 80 5.3.1 ROBODOC® (Curexo Technology Corporation) 80 5.3.2 daVinci (Intuitive Surgical) 83 5.3.3 Sensei® X (Hansen Medical) 84 5.3.4 RIO® MAKOplasty (MAKO Surgical Corporation) 86 5.3.5 CyberKnife (Accuray) 89 5.3.6 Renaissance™ (Mazor Robotics) 91 5.3.7 ARTAS® System (Restoration Robotics, Inc.) 92 5.4 Trends and Future Directions 93 6. Catheters in Vascular Therapy 99 Axel Boese 6.1 Introduction 99 6.2 Historic Overview 100 6.3 Catheter Interventions 102 6.4 Catheter and Guide Wire Shapes and Configurations 105 6.4.1 Catheters 105 6.4.2 Guide Wires 113 6.5 Conclusion 116 PART III ENERGY DELIVERY DEVICES AND SYSTEMS 119 7. Energy-Based Hemostatic Surgical Devices 121 Amit P. Mulgaonkar, Warren Grundfest, and Rahul Singh 7.1 Introduction 121 7.2 History of Energy-Based Hemostasis 122 7.3 Energy-Based Surgical Methods and Their Effects on Tissues 125 7.3.1 Disambiguation 126 7.3.2 Thermal Effects on Tissues 127 7.4 Electrosurgery 128 7.4.1 Electrosurgical Theory 128 7.4.2 Cutting and Coagulation Techniques 130 7.4.3 Equipment 131 7.4.4 Considerations and Complications 133 7.5 Future Of Electrosurgery 134 7.6 Conclusion 135 8. Tissue Ablation Systems 137 Michael Douek, Justin McWilliams, and David Lu 8.1 Introduction 137 8.2 Evolving Paradigms in Cancer Therapy 138 8.3 Basic Ablation Categories and Nomenclature 140 8.4 Hyperthermic Ablation 140 8.5 Fundamentals of In Vivo Energy Deposition 141 8.6 Hyperthermic Ablation: Optimizing Tissue Ablation 143 8.7 Radiofrequency Ablation 144 8.8 RFA: Basic Principles 145 8.9 RFA: In Vivo Energy Deposition 145 8.10 Optimizing RFA 147 8.11 Other Hyperthermic Ablation Techniques 149 8.11.1 Microwave Ablation (MWA) 149 8.11.2 MWA: Basic Principles 149 8.11.3 MWA: In Vivo Energy Deposition 151 8.11.4 Optimizing MWA 152 8.12 Laser Ablation 153 8.13 Hypothermic Ablation 154 8.13.1 Cryoablation: Basic Concepts 154 8.13.2 Cryoablation: In Vivo Considerations 154 8.13.3 Optimizing Cryoablation Systems 154 8.14 Chemical Ablation 157 8.15 Novel Techniques 158 8.15.1 High Intensity Focused Ultrasound (HIFU) 158 8.15.2 Irreversible Electroporation (IRE) 159 8.16 Tumor Ablation and Beyond 160 9. Lasers in Medicine 163 Zachary Taylor, Asael Papour, Oscar Stafsudd, and Warren Grundfest 9.1 Introduction 163 9.1.1 Historical Perspective 164 9.1.2 Basic Operational Concepts 165 9.1.3 First Experimental MASER (Microwave Amplification by Stimulated Emission of Radiation) 166 9.2 Laser Fundamentals 167 9.2.1 Two-Level Systems and Population Inversion 167 9.2.2 Multiple Energy Levels 167 9.2.3 Mode of Operation 169 9.2.4 Beams and Optics 171 9.3 Laser Light Compared to Other Sources of Light 174 9.3.1 Temporal Coherence 174 9.3.2 Spectral Coherence (Line Width) 175 9.3.3 Beam Collimation 177 9.3.4 Short Pulse Duration 177 9.3.5 Summary 178 9.4 Laser–Tissue Interactions 178 9.4.1 Biostimulation 178 9.4.2 Photochemical Interactions 179 9.4.3 Photothermal Interactions 180 9.4.4 Ablation 180 9.4.5 Photodisruption 181 9.5 Lasers in Diagnostics 181 9.5.1 Optical Coherence Tomography 181 9.5.2 Fluorescence Angiography 184 9.5.3 Near Infrared Spectroscopy 185 9.6 Laser Treatments and Therapy 186 9.6.1 Overview of Current Medical Applications of Laser Technology 186 9.6.2 Retinal Photodynamic Therapy (Photochemical) 188 9.6.3 Transpupillary Thermal Therapy (TTT) (Photothermal) 188 9.6.4 Vascular Birth Marks (Photocoagulation) 190 9.6.5 Laser Assisted Corneal Refractive Surgery (Ablation) 191 9.7 Conclusions 196 PART IV IMPLANTABLE DEVICES AND SYSTEMS 197 10. Vascular and Cardiovascular Devices 199 Dan Levi, Allan Tulloch, John Ho, Colin Kealey, and David Rigberg 10.1 Introduction 199 10.2 Biocompatibility Considerations 200 10.3 Materials 202 10.3.1 316L Stainless Steel 203 10.3.2 Nitinol 203 10.3.3 Cobalt–Chromium Alloys 204 10.4 Stents 204 10.5 Closure Devices 206 10.6 Transcatheter Heart Valves 208 10.7 Inferior Vena Cava Filters 212 10.8 Future Directions–Thin Film Nitinol 214 10.9 Conclusion 216 11. Mechanical Circulatory Support Devices 219 Colin Kealey, Paymon Rahgozar, and Murray Kwon 11.1 Introduction 219 11.2 History 220 11.3 Basic Principles 221 11.3.1 Biocompatibility and Mechanical Circulatory Support Devices 221 11.3.2 Hemocompatibility: Microscopic Considerations 222 11.3.3 Hemocompatibility: Macroscopic Considerations 223 11.4 Engineering Considerations in Mechanical Circulatory Support 223 11.4.1 Overview 223 11.4.2 Pump Design 225 11.4.3 Positive Displacement Pumps 225 11.4.4 Rotary Pumps 226 11.4.5 Pulsatile Versus Nonpulsatile Flow 228 11.5 Devices 228 11.5.1 The HeartMate XVE Left Ventricular Assist System 228 11.5.2 The HeartMate II Left Ventricular Assist System 231 11.5.3 Short-Term Mechanical Circulatory Support: The Intraaortic Balloon Pump 234 11.5.4 Pediatric Mechanical Circulatory Support: The Berlin Heart 237 11.6 The Future of MCS Devices 239 11.6.1 CorAide 239 11.6.2 HeartMate III 239 11.6.3 HeartWare 240 11.6.4 VentrAssist 240 11.7 Summary 240 12. Orthopedic Implants 241 Sophia N. Sangiorgio, Todd S. Johnson, Jon Moseley, G. Bryan Cornwall, and Edward Ebramzadeh 12.1 Introduction 241 12.1.1 Overview 241 12.1.2 History 243 12.2 Basic Principles 244 12.2.1 Optimization for Strength and Stiffness 245 12.2.2 Maximization of Implant Fixation to Host Bone 250 12.2.3 Minimization of Degradation 251 12.2.4 Sterilization of Implants and Instrumentation 253 12.3 Implant Technologies 253 12.3.1 Total Hip Replacement 254 12.3.2 Technology in Total Knee Replacement 263 12.3.3 Technology in Spine Surgery 268 12.4 Summary 272 PART V IMAGING AND IMAGE-GUIDED TECHNIQUES 275 13. Endoscopy 277 Gregory Nighswonger 13.1 Introduction 277 13.2 Ancient Origins 278 13.3 Modern Endoscopy 280 13.3.1 Creating Cold Light 280 13.3.2 Introduction of Rod-Lens Technology 280 13.4 Principles of Modern Endoscopy 283 13.4.1 Optics 284 13.4.2 Mechanics 284 13.4.3 Electronics 284 13.4.4 Software 285 13.5 The Imaging Chain 285 13.5.1 Light Source (1) 286 13.5.2 Telescope (2) 286 13.5.3 Camera Head (3) 287 13.5.4 Camera CCU (4) 287 13.5.5 Video Cables (5) 287 13.5.6 Monitor (6) 287 13.5.7 Image Management Systems (7) 288 13.6 Endoscopes for Today 288 13.6.1 Rigid Endoscopes—Designs to Enhance Functionality 289 13.6.2 Less Traumatic Ureterorenoscopes 290 13.6.3 Advances in Flexible Endoscope Design 291 13.6.4 Broader Functionality with New Technologies 294 13.6.5 Enhancing Video Capabilities 299 13.7 Endoscopy’s Future 301 14. Medical Ultrasound Devices 303 Rahul Singh and Martin Culjat 14.1 Introduction 303 14.2 Basic Principles of Ultrasound 304 14.2.1 Basic Acoustic Physics 304 14.2.2 Reflection and Refraction 307 14.2.3 Attenuation 307 14.2.4 Piezoelectricity 308 14.2.5 Ultrasound Systems 310 14.2.6 Resolution and Bandwidth 312 14.2.7 Beam Characteristics 314 14.3 Ultrasound Transducer Design 316 14.3.1 Piezoelectric Material 317 14.3.2 Backing Layers and Damping 318 14.3.3 Matching Layers 318 14.3.4 Mechanical Focusing 319 14.3.5 Electrical Matching 320 14.3.6 Sector Scanners 320 14.3.7 Array Transducers 322 14.3.8 Transducer Array Fabrication 325 14.3.9 Regulatory Considerations 327 14.4 Applications of Medical Ultrasound 329 14.4.1 Image Guidance Applications 330 14.4.2 Intravascular and Intracardiac Applications 332 14.4.3 Intraoral and Endocavity Applications 333 14.4.4 Surgical Applications 334 14.4.5 Ophthalmic Ultrasound 335 14.4.6 Doppler and Doppler Applications 336 14.4.7 Therapeutic Applications 336 14.5 The Future of Medical Ultrasound 338 15. Medical X-ray Imaging 341 Mark Roden 15.1 Introduction 341 15.2 X-ray Physics 342 15.2.1 Photon Interactions with Matter 342 15.2.2 Clinical Production of X-rays 343 15.2.3 Patient Dose Considerations 346 15.3 Two-Dimensional Image Acquisition 348 15.4 Image Acquisition Technologies and Techniques 351 15.4.1 Film 351 15.4.2 Computed Radiography 354 15.4.3 Digital Radiography 358 15.4.4 Clinical Applications of 2D X-ray Techniques 360 15.5 Basic 2D Processing Techniques 361 15.5.1 Independent Pixel Operations 362 15.5.2 Grouped Pixel Operations 363 15.5.3 Image Transformation Operations 366 15.6 Real-Time X-ray Imaging 367 15.6.1 Fluoroscopy Technology 367 15.6.2 Angiography 370 15.7 Three-Dimensional X-ray Imaging 372 15.8 Conclusion 373 16. Navigation in Neurosurgery 375 Jean-Jacques Lemaire, Eric J. Behnke, Andrew J. Frew, and Antonio A. F. DeSalles 16.1 Basics of Neurosurgery 375 16.1.1 General Technical Issues in Neurosurgery 375 16.1.2 Instrumentation in Neurosurgery 376 16.1.3 Complications 377 16.1.4 Functional Neurosurgery 378 16.1.5 Stereotactic Neurosurgery 378 16.1.6 Neuroimaging for Neurosurgery 379 16.2 Introduction to Neuronavigation 381 16.3 Neuronavigation Systems 381 16.3.1 The Tracking System 382 16.3.2 The Display Unit 383 16.3.3 The Control Unit 385 16.4 Implementation of Neuronavigation 386 16.4.1 Surgical Planning 386 16.4.2 Patient Registration 387 16.4.3 Navigation 389 16.5 Augmented Reality and Virtual Reality 390 16.6 Summary/Future 391 REFERENCES 395 INDEX 425

Read more less

Book SynopsisThe expanded and revised edition will split Chapter 4 to include more details and examples in FMRI, DTI, and DWI for MR image modalities. The book will also expand ultrasound imaging to 3-D dynamic contrast ultrasound imaging in a separate chapter. A new chapter on Optical Imaging Modalities elaborating microscopy, confocal microscopy, endoscopy, optical coherent tomography, fluorescence and molecular imaging will be added. Another new chapter on Simultaneous Multi-Modality Medical Imaging including CT-SPECT and CT-PET will also be added. In the image analysis part, chapters on image reconstructions and visualizations will be significantly enhanced to include, respectively, 3-D fast statistical estimation based reconstruction methods, and 3-D image fusion and visualization overlaying multi-modality imaging and information. A new chapter on Computer-Aided Diagnosis and image guided surgery, and surgical and therapeutic intervention will also be added. A companion site cTable of ContentsPreface to the Second Edition xiii Chapter 1 Introduction 1 1.1. Medical Imaging: A Collaborative Paradigm 2 1.2. Medical Imaging Modalities 3 1.3. Medical Imaging: from Physiology to Information Processing 6 1.3.1 Understanding Physiology and Imaging Medium 6 1.3.2 Physics of Imaging 7 1.3.3 Imaging Instrumentation 7 1.3.4 Data Acquisition and Image Reconstruction 7 1.3.5 Image Analysis and Applications 8 1.4. General Performance Measures 8 1.4.1 An Example of Performance Measure 10 1.5. Biomedical Image Processing and Analysis 11 1.6. Matlab Image Processing Toolbox 14 1.6.1 Digital Image Representation 14 1.6.2 Basic MATLAB Image Toolbox Commands 16 1.7. Imagepro Interface in Matlab Environment and Image Databases 19 1.7.1 Imagepro Image Processing Interface 19 1.7.2 Installation Instructions 20 1.8. Imagej and Other Image Processing Software Packages 20 1.9. Exercises 21 1.10. References 22 1.11. Definitions 22 Chapter 2 Image Formation23 2.1. Image Coordinate System 24 2.1.1 2-D Image Rotation 25 2.1.2 3-D Image Rotation and Translation Transformation 26 2.2. Linear Systems 27 2.3. Point Source and Impulse Functions 27 2.4. Probability and Random Variable Functions 29 2.4.1 Conditional and Joint Probability Density Functions 30 2.4.2 Independent and Orthogonal Random Variables 31 2.5. Image Formation 32 2.5.1 PSF and Spatial Resolution 35 2.5.2 Signal-to-Noise Ratio 37 2.5.3 Contrast-to-Noise Ratio 39 2.6. Pin-hole Imaging 39 2.7. Fourier Transform 40 2.7.1 Sinc Function 43 2.8. Radon Transform 44 2.9. Sampling 46 2.10. Discrete Fourier Transform 50 2.11. Wavelet Transform 52 2.12. Exercises 60 2.13. References 62 Chapter 3 Interaction of Electromagnetic Radiation with Matter in Medical Imaging 65 3.1. Electromagnetic Radiation 65 3.2. Electromagnetic Radiation for Image Formation 66 3.3. Radiation Interaction with Matter 67 3.3.1 Coherent or Rayleigh Scattering 67 3.3.2 Photoelectric Absorption 68 3.3.3 Compton Scattering 69 3.3.4 Pair Production 69 3.4. Linear Attenuation Coefficient 70 3.5. Radiation Detection 70 3.5.1 Ionized Chambers and Proportional Counters 70 3.5.2 Semiconductor Detectors 72 3.5.3 Advantages of Semiconductor Detectors 73 3.5.4 Scintillation Detectors 73 3.6. Detector Subsystem Output Voltage Pulse 76 3.7. Exercises 78 3.8. References 78 Chapter 4 Medical Imaging Modalities: X-Ray Imaging 79 4.1. X-Ray Imaging 80 4.2. X-Ray Generation 81 4.3. X-Ray 2-D Projection Imaging 84 4.4. X-Ray Mammography 86 4.5. X-Ray CT 88 4.6. Spiral X-Ray CT 92 4.7. Contrast Agent, Spatial Resolution, and SNR 95 4.8. Exercises 96 4.9. References 97 Chapter 5 Medical Imaging Modalities: Magnetic Resonance Imaging 99 5.1. MRI Principles 100 5.2. MR Instrumentation 110 5.3. MRI Pulse Sequences 112 5.3.1 Spin-Echo Imaging 114 5.3.2 Inversion Recovery Imaging 118 5.3.3 Echo Planar Imaging 119 5.3.4 Gradient Echo Imaging 123 5.4. Flow Imaging 125 5.5. fMRI 129 5.6. Diffusion Imaging 130 5.7. Contrast, Spatial Resolution, and SNR 135 5.8. Exercises 137 5.9. References 138 Chapter 6 Nuclear Medicine Imaging Modalities 139 6.1. Radioactivity 139 6.2. SPECT 140 6.2.1 Detectors and Data Acquisition System 142 6.2.2 Contrast, Spatial Resolution, and Signal-to-Noise Ratio in SPECT Imaging 145 6.3. PET 148 6.3.1 Detectors and Data Acquisition Systems 150 6.3.2 Contrast, Spatial Resolution, and SNR in PET Imaging 150 6.4. Dual-Modality Spect–CT and PET–CT Scanners 151 6.5. Exercises 154 6.6. References 155 Chapter 7 Medical Imaging Modalities: Ultrasound Imaging 157 7.1. Propagation of Sound in a Medium 157 7.2. Reflection and Refraction 159 7.3. Transmission of Ultrasound Waves in a Multilayered Medium 160 7.4. Attenuation 162 7.5. Ultrasound Reflection Imaging 163 7.6. Ultrasound Imaging Instrumentation 164 7.7. Imaging with Ultrasound: A-Mode 166 7.8. Imaging with Ultrasound: M-Mode 167 7.9. Imaging with Ultrasound: B-Mode 168 7.10. Doppler Ultrasound Imaging 169 7.11. Contrast, Spatial Resolution, and SNR 170 7.12. Exercises 171 7.13. References 172 Chapter 8 Image Reconstruction 173 8.1. Radon Transform and Image Reconstruction 174 8.1.1 The Central Slice Theorem 174 8.1.2 Inverse Radon Transform 176 8.1.3 Backprojection Method 176 8.2. Iterative Algebraic Reconstruction Methods 180 8.3. Estimation Methods 182 8.4. Fourier Reconstruction Methods 185 8.5. Image Reconstruction in Medical Imaging Modalities 186 8.5.1 Image Reconstruction in X-Ray CT 186 8.5.2 Image Reconstruction in Nuclear Emission Computed Tomography: SPECT and PET 188 8.5.2.1 A General Approach to ML–EM Algorithms 189 8.5.2.2 A Multigrid EM Algorithm 190 8.5.3 Image Reconstruction in Magnetic Resonance Imaging 192 8.5.4 Image Reconstruction in Ultrasound Imaging 193 8.6. Exercises 194 8.7. References 195 Chapter 9 Image Processing and Enhancement 199 9.1. Spatial Domain Methods 200 9.1.1 Histogram Transformation and Equalization 201 9.1.2 Histogram Modification 203 9.1.3 Image Averaging 204 9.1.4 Image Subtraction 204 9.1.5 Neighborhood Operations 205 9.1.5.1 Median Filter 207 9.1.5.2 Adaptive Arithmetic Mean Filter 207 9.1.5.3 Image Sharpening and Edge Enhancement 208 9.1.5.4 Feature Enhancement Using Adaptive Neighborhood Processing 209 9.2. Frequency Domain Filtering 212 9.2.1 Wiener Filtering 213 9.2.2 Constrained Least Square Filtering 214 9.2.3 Low-Pass Filtering 215 9.2.4 High-Pass Filtering 217 9.2.5 Homomorphic Filtering 217 9.3. Wavelet Transform for Image Processing 220 9.3.1 Image Smoothing and Enhancement Using Wavelet Transform 223 9.4. Exercises 226 9.5. References 228 Chapter 10 Image Segmentation 229 10.1. Edge-Based Image Segmentation 229 10.1.1 Edge Detection Operations 230 10.1.2 Boundary Tracking 231 10.1.3 Hough Transform 233 10.2. Pixel-Based Direct Classification Methods 235 10.2.1 Optimal Global Thresholding 237 10.2.2 Pixel Classification Through Clustering 239 10.2.2.1 Data Clustering 239 10.2.2.2 k-Means Clustering 241 10.2.2.3 Fuzzy c-Means Clustering 242 10.2.2.4 An Adaptive FCM Algorithm 244 10.3. Region-Based Segmentation 245 10.3.1 Region-Growing 245 10.3.2 Region-Splitting 247 10.4. Advanced Segmentation Methods 248 10.4.1 Estimation-Model Based Adaptive Segmentation 249 10.4.2 Image Segmentation Using Neural Networks 254 10.4.2.1 Backpropagation Neural Network for Classification 255 10.4.2.2 The RBF Network 258 10.4.2.3 Segmentation of Arterial Structure in Digital Subtraction Angiograms 259 10.5. Exercises 261 10.6. References 262 Chapter 11 Image Representation, Analysis, and Classification 265 11.1. Feature Extraction and Representation 268 11.1.1 Statistical Pixel-Level Features 268 11.1.2 Shape Features 270 11.1.2.1 Boundary Encoding: Chain Code 271 11.1.2.2 Boundary Encoding: Fourier Descriptor 273 11.1.2.3 Moments for Shape Description 273 11.1.2.4 Morphological Processing for Shape Description 274 11.1.3 Texture Features 280 11.1.4 Relational Features 282 11.2. Feature Selection for Classification 283 11.2.1 Linear Discriminant Analysis 285 11.2.2 PCA 288 11.2.3 GA-Based Optimization 289 11.3. Feature and Image Classification 292 11.3.1 Statistical Classification Methods 292 11.3.1.1 Nearest Neighbor Classifier 293 11.3.1.2 Bayesian Classifier 293 11.3.2 Rule-Based Systems 294 11.3.3 Neural Network Classifiers 296 11.3.3.1 Neuro-Fuzzy Pattern Classification 296 11.3.4 Support Vector Machine for Classification 302 11.4. Image Analysis and Classification Example: “Difficult-To-Diagnose” Mammographic Microcalcifications 303 11.5. Exercises 306 11.6. References 307 Chapter 12 Image Registration 311 12.1. Rigid-Body Transformation 314 12.1.1 Affine Transformation 316 12.2. Principal Axes Registration 316 12.3. Iterative Principal Axes Registration 319 12.4. Image Landmarks and Features-Based Registration 323 12.4.1 Similarity Transformation for Point-Based Registration 323 12.4.2 Weighted Features-Based Registration 324 12.5. Elastic Deformation-Based Registration 325 12.6. Exercises 330 12.7. References 331 Chapter 13 Image Visualization 335 13.1. Feature-Enhanced 2-D Image Display Methods 336 13.2. Stereo Vision and Semi-3-D Display Methods 336 13.3. Surface- and Volume-Based 3-D Display Methods 338 13.3.1 Surface Visualization 339 13.3.2 Volume Visualization 344 13.4. VR-Based Interactive Visualization 347 13.4.1 Virtual Endoscopy 349 13.5. Exercises 349 13.6. References 350 Chapter 14 Current and Future Trends in Medical Imaging and Image Analysis 353 14.1. Multiparameter Medical Imaging and Analysis 353 14.2. Targeted Imaging 357 14.3. Optical Imaging and Other Emerging Modalities 357 14.3.1 Optical Microscopy 358 14.3.2 Optical Endoscopy 360 14.3.3 Optical Coherence Tomography 360 14.3.4 Diffuse Reflectance and Transillumination Imaging 362 14.3.5 Photoacoustic Imaging: An Emerging Technology 363 14.4. Model-Based and Multiscale Analysis 364 14.5. References 366 Index 503

Read more less

Book SynopsisThis book provides a unique focus on the application of nanotechnology to the sub-cellular level with respect to drug delivery and probing inter-cellular milieu. It provides a comprehensive review of the latest in this new, interdisciplinary field of biomedical research.Table of ContentsPreface. Contributors. 1. An Introduction to Subcellular Nanomedicine: Current Trends and Future Developments (Gerard G. M. D’Souza and Volkmar Weissig). 2. Delivery of Nanonsensors to Measure the Intracellular Environment (Paul G. Coupland and Jonathan W. Aylott). 3. Cytoplasmic Diffi usion of Dendrimers and Dendriplexes (Alexander T. Florence and Pakatip Ruenraroengsak). 4. Endocytosis and Intracellular Trafficking of Quantum Dot-Ligand Bioconjugates (Tore-Geir Iversen, Nadine Frerker, and Kirsten Sandvig). 5. Synthesis of Metal Nanoparticle-Based Intracellular Biosensors and Therapeutic Agents (Neil Bricklebank). 6. Subcellular Fate of Nanodelivery Systems (Dusica Maysinger, Sebastien Boridy, and Eliza Hutter). 7. Intracellular Fate of Plasmid DNA Polyplexes (Kevin Maier and Ernst Wagner). 8. Intracellular Trafficking of Membrane Receptor-Mediated Uptake of Carbon Nanotubes (Bin Kang and Yaodong Dai). 9. Real-Time Particle Tracking for Studying Intracellular Transport of Nanotherapeutics (Clive Chen and Junghae Suh). 10. Tracking Intracellular Polymer Localization Via Fluorescence Microscopy (Simon C. W. Richardson). 11. Can QSAR Models Describing Small-Molecule Xenobiotics Give Useful Tips for Predicting Uptake and Localization of Nanoparticles in Living Cells? And If Not, Why Not? (Richard W. Horobin). 12. Self-Unpacking Gene Delivery Scaffolds (Millicent O. Sullivan). 13. Cellular Trafficking of Dendrimers (Yunus Emre Kurtoglu and Rangaramanujam M. Kannan). 14. Endolysosomolytically Active pH-Sensitive Polymeric Nanotechnology (Han Chang Kang and You Han Bae). 15. Uptake and Intracellular Dynamics of Proteins Internalized by Cell-Penetrating Peptides (Arwyn T. Jones). 16. Cargo Transport by Teams of Molecular Motors: Basic Mechanisms for Intracellular Drug Delivery (Melanie J. I. Müller, Florian Berger, Stegan Klumpp, and Reinhard Lipowsky). 17. The Potential of Photochemical Internalization (PCI) for the Cytosolic Delivery of Nanomedicines (Kristian Berg, Anette Weyergang, Anders Høgset, and Pål Kristian Selbo). 18. Peptide-Based Nanocarriers for Intracellular Delivery of Biologically Active Proteins (Seong Loong Lo and Shu Wang). 19. Organelle-Specific Pharmaceutical Nanotechnology: Active Cellular Transport of Submicro- and Nanoscale Particles (Galya Orr). 20. Subcellular Targeting of Virus-Envelope-Coated Nanoparticles (Jia Wang, Mohammad F. Saeed, Andrey A. Kolokoltsov, and Robert A. Davey). 21. Mitochondria-Targeted Pharmaceutical Nanocarriers (Volkmar Weissig and Gerard G.M. D’Souza). 22. Cell-Penetrating Peptides for Cytosolic Delivery of Biomacromolecules (Camilla Foged, Xiaona Jing, and Hanne Moerck Nielsen). 23. Therapeutic Nano-object Delivery to Subdomains of Cardiac Myocytes (Valeriy Lukyanenko). 24. Design Parameters Modulating Intracellular Drug Delivery: Anchoring to Specific Cellular Epitopes, Carrier Geometry, and Use of Auxiliary Pharmacological Agents (Silvia Muro and Vladimir R. Muzykantov). 25. Uptake Pathways Dependent Intracellular Trafficking of DNA Carrying Nanodelivery Systems (Ikramy A. Khalil, Yuma Yamada, Hidetaka Akita, and Hideyoshi Harashima). 26. Cellular Interactions of Plasmon-Resonant Gold Nanorods (Qingshan Wei and Alexander Wei). 27. Quantum Dot Labeling for Assessment of Intracellular Trafficking of Therapeutically Active Molecules (Diane J. Burgess and Mamta Kapoor). Index.

Read more less

Book SynopsisThis pocket reference guide is a must for all medical students and junior doctors preparing for exams in pharmacology or needing a rapid reminder during a clinical attachment. In light of the growing pressures on those who prescribe drugs to patients, increasing emphasis has been placed on the importance of pharmacology in the undergraduate medical curriculum. RapidClinical Pharmacology, with its concise, easy-to-use approach, offers an appealing format for students to use in both clinical practice and exam preparation and its one-page per drug/class'' layout easily facilitates the generation of a personal student formulary. Each chapter of the book mirrors each section of the BNF to allow easy cross-referencing and then each chapter is divided into consistent sections as per other books in the Rapid series. Rapid Clinical Pharmacologywill also be available as a mobile application for iPhone, iPod Touch, iPad and Blackberry. See wiley.com/go/mededTrade Review"This is an excellent pocket manual on core drugs for medical practitioners, especially those practicing in a British-oriented healthcare system." (Doody's, 13 January 2012) "The book is practical and made more so by its availability for mobile electronic devices such as iPhones, iPad, and so on. This book represents an important step in application of medical knowledge and technology by the bed side." (Journal of Tropical Pediatrics, 1 November 2011) Table of ContentsPreface, ix List of Abbreviations, xi Basic pharmacokinetic concepts Gastrointestinal system Histamine type 2 receptor antagonists, 5 Laxatives, 6 Proton pump inhibitors (PPIs), 7 Cardiovascular system α-adrenoceptor antagonists (α blockers), 8 Adenosine, 9 Aldosterone antagonists, 10 Amiodarone, 11 Angiotensin-converting enzyme inhibitors (ACEIs), 12 Angiotensin II receptor blockers (ARBs), 13 Antimuscarinics, 14 Aspirin, 15 β-adrenoceptor antagonists (β blockers), 16 Calcium channel blockers (CCBs), 18 Cardiac glycosides, 19 Clopidogrel, 20 Dipyridamole, 21 Fibrates, 22 Fibrinolytics, 23 Flecainide, 24 Glycoprotein IIb/IIIa inhibitors, 25 Inotropic sympathomimetics, 26 Loop diuretics, 27 Low molecular weight heparins (LMWH), 28 Nitrates, 29 Potassium channel activators, 30 Statins, 31 Thiazide diuretics, 32 Tranexamic acid, 33 Vasoconstrictor sympathomimetics, 34 Warfarin, 35 Respiratory system β2 adrenoceptor agonists, 36 Histamine type 1 receptor antagonists, 37 Inhaled antimuscarinics, 38 Leukotriene receptor antagonists, 39 Oxygen, 40 Theophylline, 41 Central nervous system 5-HT1 agonists (triptans), 42 5-HT3 antagonists, 43 Antihistamine anti-emetics, 44 Antipsychotics – atypical, 45 Antipsychotics – typical, 46 Benzodiazepines, 47 Carbamazepine, 48 Dopamine antagonist anti-emetics, 49 Drugs for dementia, 50 Gabapentin and pregabalin, 51 Levodopa (L-dopa), 52 Lithium, 53 Monoamine oxidase inhibitors (MAOIs), 54 Non-steroidal anti-inflammatory drugs (NSAIDs), 55 Opioid analgesia, 56 Other antiepileptics, 57 Other antiparkinsonian drugs, 58 Paracetamol, 59 Phenothiazine anti-emetics, 60 Phenytoin, 61 Selective serotonin reuptake inhibitors (SSRIs), 62 Sodium valproate, 63 Tricyclic antidepressants (TCAs), 64 Infections Aciclovir, 65 Aminoglycosides, 66 Antifungals, 67 Antiretroviral agents, 68 Antituberculosis drugs, 69 Cephalosporins and other β lactams, 70 Penicillins, 71 Glycopeptide antibiotics, 72 Macrolides, 73 Metronidazole, 74 Nitrofurantoin, 75 Quinolones, 76 Tetracyclines, 77 Trimethoprim, 78 Endocrine system 5α-reductase inhibitors, 79 Antidiuretic hormone (ADH) analogues, 80 Biguanides, 81 Bisphosphonates, 82 Carbimazole, 83 Corticosteroids, 84 Dipeptidylpeptidase-4 (DDP-4) inhibitors, 85 Gonadotrophin-releasing hormone (GnRH) agonists, 86 Hormone replacement therapy (HRT), 87 Incretin mimetics, 88 Insulins, 89 Levothyroxine, 90 Propylthiouracil, 91 Sulfonylureas, 92 Thiazolidinediones, 93 Obstetrics, gynaecology and urinary tract disorders Contraceptives, 94 Mifepristone, 96 Oxybutynin, 97 Oxytocin, 98 Phosphodiesterase type 5 inhibitors, 99 Malignant disease and immunosuppression Alkylating agents, 100 Anthracyclines, 101 Anti-androgens, 102 Antimetabolites, 103 Antiproliferative immunosuppressants, 104 Calcineurin inhibitors, 105 Other antineoplastic drugs, 106 Selective oestrogen receptor modulators (SERMs), 107 Trastuzumab (Herceptin®), 108 Vinca alkaloids, 109 Musculoskeletal and joint diseases Allopurinol, 110 Aminosalicylic acid compounds (ASAs), 111 Colchicine, 112 Methotrexate, 113 Eye Antiglaucoma drugs, 114 Anaesthesia Depolarising neuromuscular blocking agents, 115 Etomidate, 116 Inhalational anaesthetics, 117 Lidocaine, 118 Non-depolarising blocking agents, 119 Propofol, 120 Thiopental sodium, 121 Intravenous fluids Blood and transfusion medicine Index of drugs, 127

Read more less

Book SynopsisEvidence-Based Neonatal Infections is expertly written by David Isaacs, an experienced author renowned forhis knowledge in both pediatric infections and evidence-based medicine. It critically analyses the evidence for decision making in neonatal infections. Evidence-Based Neonatal Infections *The first evidence-based text on neonatal infections *Provides practical guidance where evidence is poor *Complements David Isaacs' Evidence-Based Pediatric Infectious Diseases (9781405148580) Practical and evidence-based, Evidence-Based Neonatal Infections is designed to help the clinician with day-to-day decisions on the care of newborn babies with possible, probable or proven infections. It considers clinical questions relevant to neonatologists, analysing the evidence carefully and providing recommendations for optimum management of neonatal infectious diseases, whilst reflecting on: Efficacy and safety Trade Review“This is a comprehensive, brief, and very clinical approach to neonatal infections with an international flavor.” (Doody’s, 12 December 2014) “The book is a workable length and is best targeted at the neonatal fellow or pediatric resident with an interest in neonatology. It should be widely used in the resident’s work space as a quick definitive guide to management of neonatal infections and as a tool for discussion of the wisdom of starting therapeutic agents and optimal approaches to the diagnostic challenges of the sick neonate.” (Clinical Infectious Diseases, 22 August 2014) Table of ContentsAbout the Author, vi Preface, vii 1 How to search for evidence, 1 2 Epidemiology, 5 3 Clinical manifestations, 16 4 Laboratory tests, 21 5 Rational antibiotic use, 33 6 Adjunctive treatment, 48 7 Bacterial meningitis, 57 8 Respiratory tract infections, 70 9 Osteomyelitis and septic arthritis, 78 10 Urinary tract infections, 86 11 Necrotizing enterocolitis and gastrointestinal infections, 94 12 Eye Infections, 108 13 Skin and soft tissue Infections, 117 14 Bacterial infections, 128 15 Mycoplasmas, 153 16 Fungal infections, 159 17 Viral infections, 175 18 Other congenital infections, 199 19 Breast milk, 214 20 Surveillance, 223 21 Infection control, 229 22 Developing countries, 244 23 Prevention of neonatal infections, 250 24 Neonatal antimicrobials, 269 Index, 291

Read more less

Book SynopsisETHNIC DERMATOLOGY Principles and Practice Richly pigmented skin is the most common skin type internationally Historically, dermatology has focused on white skin. But rich pigmentation can lead to differences in presentation, disease course and outcome, and reaction to treatment. Some dermatologic conditions are seen either predominantly or exclusively in richly pigmented skin. Ethnic Dermatology: Principles and Practice provides a practical approach to the dermatology of nonwhite skin. Written from a global perspective to include Asian, African-Caribbean and North African skin types, it covers all the bases of dermatology including: Grading scales in dermatologic disease Pediatric dermatology Dermatology and systemic disease Drug eruptions Hair and scalp disorders Cosmetic dermatology. With a central focus on practical action from an international cast of authors, Ethnic DermatTrade Review“This book joins the library of references on skin of color. It is a good introductory textbook to learn about the special concerns and variation in clinical presentations of dermatoses in darker skinned individuals.” (Doody’s, 2 August 2013)Table of ContentsList of Contributors vii Foreword by Nina G. Jablonski ix Preface xi List of Abbreviations xiii 1 Defining Ethnic Dermatology: Challenges, Limitations, and Merits 1Ophelia E. Dadzie 2 Skin Semiology and Grading Scales 5Antoine Petit and Ameet Tailor 3 Common Skin Conditions and Ethnicity 19Antoine Petit and Moussa Diallo 4 Pediatric Dermatology and the Ethnic Patient 63Patricia A. Treadwell 5 Cutaneous Manifestations of Systemic Diseases 79Mahreen Ameen and Fatimata Ly 6 Drug Eruptions and Ethnicity 103Jean-Claude Roujeau 7 Photodermatoses and Phototherapy in the Ethnic Patient 109Richard H. Huggins and Henry W. Lim 8 HIV-related Skin Diseases 123Mahreen Ameen and Antoine Mahé 9 Benign Skin Tumors and Cysts in the Ethnic Patient 135Nita Agar and Dupe L. Odunsi 10 Malignant Skin Tumors and the Ethnic Patient 143Nita Agar, Bridget Ogawa, and Jean-Jacques Morand 11 Treatment of Keloids and Scars 159Martha H. Viera, Alejandra C. Vivas, and Brian Berman 12 Vitiligo: Clinical Presentation and Management 173Fatima Al-Faresi, Viktoria Eleftheriadou, Sanjeev V. Mulekar, and Hassan I. Galadari 13 Other Causes of Hypopigmentation: What Not to Miss 187Ousmane Faye 14 Facial Hyperpigmentation: A Practical Approach to Diagnosis and Management 199Camille Fitoussi 15 Hair and Scalp Disorders in Women of African Descent 213Ophelia E. Dadzie and Nonhlanhla P. Khumalo 16 Dermatological Disorders in Men of African Descent 241Frederick N. Quarles, Marcelyn Coley, and Andrew F. Alexis 17 Hair Transplantation in People of African Descent 257Jack Smadja 18 Lasers and the Ethnic Patient 263Heather Woolery-Lloyd and Kristian Figueras 19 Cosmetic Dermatology in Ethnic Skin 273Leila Ferguson, Anthony Rossi, Andrew F. Alexis, and Hassan I. Galadari 20 Cosmetic Use of Skin Lightening Products 287Antoine Mahé Index 293

Read more less

Book SynopsisThis handbook provides a short, contemporary text on the management of dentofacial deformities.Trade Review“This is a great introductory book for maxillofacial surgery senior house officers in particular. At a time when computer software is becoming pertinent clinically and emphasis on psychological aspects of healthcare is growing, this book succeeds in updating our basic knowledge.” (British Dental Journal, 27 June 2014) Table of ContentsList of Authors vii Foreword ix Preface xi 1 Psychological considerations for the orthognathic patient 1 2 Dentofacial assessment 16 3 The treatment planning process 51 4 The role of orthodontics 62 5 Orthognathic technical procedures 80 6 Prediction planning 94 7 Basic orthognathic surgical procedures 111 8 High level osteotomies 146 9 Case reports 155 9.1 Class II, division 2 malocclusion 157 9.2 Vertical maxillary excess 160 9.3 Class III malocclusion 163 9.4 Mandibular asymmetry with 3D planning 166 9.5 Anterior open bite 170 9.6 Class II, division 1 with hypodontia 173 Index 177

Read more less

Book SynopsisInfectious disease surveillance has evolved at an extraordinary pace during the past several decades, and continues to do so. It is increasingly used to inform public health practice in addition to its use as a tool for early detection of epidemics.Table of ContentsSection A: Introduction 1. Surveillance as a Foundation for Infectious Disease Prevention and ControlNkuchia M. M'ikanatha and John K. Iskander 2. The Legal Basis for Public Health SurveillanceGail Horlick and Jean O'Connor 3. National, State, and Local Public Health Surveillance SystemsRuth Jajosky and Jennifer Ward 4. Quarantine and the Role of Surveillance in Nineteenth-Century Public HealthDavid S. Barnes Section B: Specific Surveillance Systems 5. Surveillance for Vaccine-preventable Diseases and ImmunizationDaniel Payne 6. Surveillance for Seasonal and Novel Influenza Viruses Bruno Ciancio and Piotr Kramarz 7. Surveillance for Bacterial Infections of Public Health ImportanceLee H. Harrison and Gayle Fischer Langley 8. Surveillance for Foodborne DiseasesElaine Scallan and Casey Barton Behravesh 9. Surveillance of Healthcare-associated Infections Lennox K. Archibald and Theresa J. McCann 10. Surveillance for Zoonotic DiseasesLinda Capewell Pimentel and Ethel V.Taylor 11. Surveillance of Viral Hepatitis Infections Daniel R. Church, Gillian A. Haney, Monina Klevens, Alfred DeMaria Jr 12. Surveillance for Sexually Transmitted DiseasesElizabeth Torrone and Kyle Bernstein 13. Surveillance for HIV/AIDSEve D. Mokotoff and James J. Gibson 14. Public Health Surveillance for TuberculosisLori R. Armstrong and Roque Miramontes Section C: Methods Used in Surveillance and Data Analysis 15. Analysis and Interpretation of Surveillance DataLouisa E. Chapman and James N. Tyson 16. Global Surveillance for Emerging Infectious DiseasesJennifer Nuzzo 17. Infectious Diseases Surveillance and Global SecurityDavid L. Blazes and Sheri Lewis 18. Electronic information systems in surveillance: Implementation of the National Electronic Disease Surveillance System in South CarolinaEric Brenner 19. Electronic Information Systems in Surveillance: Electronic Laboratory ReportingRichard S. Hopkins and Nkuchia M. M'ikanatha 20. Use of Geographic Information Systems in Infectious Disease SurveillanceRebecca J. Eisen and Lars Eisen Section D: Cross-cutting Issues in Infectious Disease Surveillance 21. Communication of Surveillance FindingsBrian G. Southwell and Bridget J. Kelly 22. Lessons Learned in Epidemiology and Surveillance Training in New York CityElizabeth Chuang and Carolyn Greene

Read more less

Book SynopsisThe Textbook of Pharmaceutical Medicine is the standard reference for everyone working and learning in pharmaceutical medicine. It is a comprehensive resource covering the processes and practices by which medicines are developed, tested and approved, and the recognised text for the Diploma in Pharmaceutical Medicine from the Faculty of Pharmaceutical Medicine. This fully revised Seventh Edition, which includes two new Editors, encompasses current developments within pharmaceutical medicine with new chapters on biological therapeutics, pharmacovigilance, vaccines, drugs for cancer, drug development in paediatrics and neonatalogy, the clinical trials directive, life cycle management of medicines, counterfeit medicines and medical marketing. Also included for easy reference, and referred to throughout the text, are the Declaration of Helsinki, Guidelines and Documentation for Implementation of Clinical Trials, relevant European Directives and the Syllabus for PharmaceuticTrade Review“This comprehensive volume covers the processes by which medicines are developed, tested and approved. The chapters are written by leading academics, medical directors and legal experts in the field of harmaceutical medicine and provide authorative and in-depth information for both physicians working in and those who are currently training in the pharmaceutical industry.” (British Journal of Clinical Pharmacology, 22 April 2014) “This book is expected to be useful for pharmaceutical physicians and for anyone interested in learning about the various issues in drug discovery and development. In addition to many other topics, the regulatory aspects of drug development in the U.S., Europe, and Japan are well covered . . . Nevertheless, this is an admirable effort and the book deserves a place on the bookshelves of pharmaceutical physicians. ” (Doody’s, 30 August 2013)Table of ContentsContributors vii The editors x Acknowledgements xiii List of abbreviations xiv Preface xix Part I Research and development 1 1 Discovery of new medicines 3Yves J. Ribeill 2 Pharmaceutical development 32Michael Gamlen and Paul Cummings 3 Preclinical safety testing 42Lutz Müller and Elisabeth Husar 4 Exploratory development 82John Posner 5 Clinical pharmacokinetics 113Paul Rolan and Valéria Molnár 6 Biological therapeutics 132Peter Lloyd and Jennifer Sims 7 Objectives and design of clinical trials 143John Posner and Steve Warrington 8 Conduct of clinical trials: Good Clinical Practice 155Kate L.R. Darwin 9 Medical statistics 189Andrew P. Grieve 10 Development of medicines: full development 219Peter D. Stonier 11 Pharmacovigilance 235Stephen F. Hobbiger, Bina Patel and Elizabeth Swain 12 Vaccines 254John Beadle 13 Drugs for cancer 270James Spicer and Johann De Bono 14 Ethics of human experimentation 286Jane Barrett 15 Drug development in paediatrics and neonatology 295Nazakat M. Merchant and Denis V. Azzopardi 16 Due diligence and the role of the pharmaceutical physician 306Geoffrey R. Barker Part II Regulation 317 17 A history of drug regulation in the UK 319John P. Griffin 18 The Clinical Trials Directive 347Fergus Sweeney and Agnès Saint Raymond 19 Human medicinal products in the European Union: Regulations Directives and structures 360Agnès Saint Raymond and Anthony J. Humphreys 20 Human medicinal products in the European Union: Procedures 379Agnès Saint Raymond and Anthony J. Humphreys 21 European regulation of medical devices 418Shuna Mason 22 Paediatric regulation 435Heike Rabe and Agnès Saint-Raymond 23 Technical requirements for registration of pharmaceuticals for human use: The ICH process 447Dean W.G. Harron 24 The regulation of drug products by the US Food and Drug Administration 461Peter Barton Hutt 25 The US FDA in the drug development evaluation and approval process 501Richard N. Spivey, Judith K. Jones, William Wardell and William W. Vodra 26 Future prospects of the pharmaceutical industry and its regulation in the USA 518Richard N. Spivey, William W. Vodra, Judith K. Jones and William Wardell 27 Regulatory and clinical trial systems in Japan 537Mamiko Satake and Natsuko Hosoda 28 The regulation of therapeutic products in Australia 554Elizabeth de Somer, Deborah Monk and Janice Hirshorn Part III Health care marketplace 587 29 An Introduction to life cycle management of medicines 589David Gillen 30 Availability of medicines online and counterfeit medicines 597Ruth Diazaraque and David Gillen 31 The supply of unlicensed medicines for individual patient use 610Ian Dodds-Smith and Ewan Townsend 32 Legal and ethical issues relating to medicinal products 632Nick Beckett, Sarah Hanson and Shuna Mason 33 Medical marketing 653David B. Galloway and Bensita M.V. Thottakam 34 Information and promotion 670Charles De Wet 35 Economics of health care 692Carole A. Bradley and Jane R. Griffin 36 Controls on NHS medicines prescribing and expenditure in the UK (a historical perspective) with some international comparisons 707John P. Griffin and Geoffrey R. Barker 37 Pharmaceutical medicine in the emerging markets 728Nadarajah Sreeharan, Jennie A. Sykes and Richard B. Nieman 38 Biosimilars 744Raymond A. Huml and John Posner Appendix 1 Declaration of Helsinki 751 Appendix 2 Agreements and Guidelines for Implementation of Clinical Trials 755 Appendix 3 Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 771 Appendix 4 PharmaTrain Syllabus 2010 783 Index 788

Read more less

Book SynopsisAllan Tasman, lead editor of the critically acclaimed Psychiatry, Third Edition, has teamed up with Wanda Mohr, a Professor of Psychiatric Nursing, to produce a thorough but compact textbook for all those in training in a mental health discipline. This book is a complete reference for DSM IV-TR disorders.Trade Review"Overall the handbook is a well written, engaging, comprehensive review of the current literature on the efficacy of various interventions for alcohol and other illicit drug use disorders. It could become a useful guide for physicians and other health care professionals looking for scientific evidence for relevant interventions, as well as for researchers to better understand where their future studies need to focus on." (Asian Journal of Psychiatry, 2013) "Distilling the vast amount of psychiatric information into a foundational text is no easy task, yet the authors have masterfully accomplished it, providing a book that will be of great value to those interested in mental health."(Doody's, 2011) Table of ContentsPreface. Acknowledgments. UNIT 1 FOUNDATIONS. Chapter 1 Introduction. Chapter 2 The Therapeutic Relationship. Chapter 3 An Integrative Approach to Developmental Psychopathology. Chapter 4 Psychiatric Classifications. Chapter 5 Psychiatry and the Neurosciences. UNIT 2 THE CONTEXT OF CARE. Chapter 6 Care Settings and the Continuum of Care. Chapter 7 Cultural Context of Care. Chapter 8 The Multidisciplinary Treatment Team and Working with Other Professionals. Chapter 9 Ethical Practice. Chapter 10 Legal Context of Psychiatric Practice. UNIT 3 CLINICAL DISORDERS. Chapter 11 Pediatric Disorders. Chapter 12 Sleep Disorders. Chapter 13 Bipolar Mood Disorders. Chapter 14 Depression. Chapter 15 Anxiety Disorders. Chapter 16 Eating Disorders. Chapter 17 Cognitive Disorders. Chapter 18 Substance Use, Abuse, and Dependence. Chapter 19 Personality Disorders. Chapter 20 Stereotyped Movement Disorder and Reactive Attachment Disorder. Chapter 21 Adjustment Disorder. Chapter 22 Impulse Control Disorders. Chapter 23 Mental Disorders due to a Medical Condition. Chapter 24 Factitious Disorder. Chapter 25 Schizophrenia and Psychoses. Chapter 26 Somatoform Disorders. Chapter 27 Dissociative Disorders. Chapter 28 Psychological Factors Affecting a Medical Condition. Chapter 29 Sexual Disorders. UNIT 4 ASSESSMENT AND THERAPEUTICS. Chapter 30 Psychiatric Assessment, Treatment Planning, and the Medical Record. Chapter 31 Psychological Testing and Rating Scales. Chapter 32 Psychotherapeutic Approaches. Chapter 33 Pharmacotherapeutic Interventions. Chapter 34 Antidepressants and Mood Stabilizers. Chapter 35 Antipsychotic Agents. Chapter 36 Anxiolytics, Stimulants, and Cognitive Enhancers. Chapter 37 Somatic Therapies. UNIT 5 SPECIAL TOPICS. Chapter 38 Psychiatric Emergencies. Chapter 39 Violence. Index.

Read more less

Book SynopsisThe Textbook of Influenza is a comprehensive resource covering all aspects of influenza, from the genetic and molecular biology of the virus through to clinical aspects of the disease and the latest drug developments and treatments. This new edition has been completely revised and reflects the integration of disciplines concerning the emergence, evolution, pathogenesis and control of influenza viruses in the field of human and veterinary public health. Textbook of Influenza examines the lessons learnt from the latest pandemic and provides the current state of knowledge for many yet unresolved issues related to virus origin, spread, pathogenesis and disease severity to better prepare for future pandemics. It covers the background to recent advances in influenza genomics and reverse genetics which have allowed the identification of virus virulence factors and the analysis and reconstruction of influenza viruses such as the 1918 Spanish flu strain. This new Table of ContentsList of contributors, ix Foreword to the second edition, xiv Preface to the second edition, xvi Acknowledgments, xvii PART 1 Influenza: Perspective 1 Human influenza: One health, one world, 3 Daniel B. Jernigan and Nancy J. Cox 2 Influenza pandemics: History and lessons learned, 20 Arnold S. Monto and Robert G. Webster PART 2 Structure and replication 3 Structure, disassembly, assembly, and budding of influenza viruses, 37 Debiprosad Nayak, Sakar Shivakoti, Rilwan A. Balogun, Gwendolyn Lee, and Z. Hong Zhou 4 The virus genome and its replication, 57 Robert M. Krug and Ervin Fodor 5 Influenza glycoproteins: Hemagglutinin and neuraminidase, 67 Rupert J. Russell, Steven J. Gamblin, and John J. Skehel 6 Proton channels of influenza A and B viruses, 101 Chunlong Ma, Lawrence H. Pinto, and Robert A. Lamb 7 The NS1 protein: A master regulator of host and viral functions, 114 Robert M. Krug and Adolfo García-Sastre 8 Structure and function of the influenza virus replication machinery and PB1-F2, 133 Andrew Mehle and Jonathan A McCullers 9 The genome and its manipulation: Recovery of the 1918 virus and vaccine virus generation, 146 Gabriele Neumann and Yoshihiro Kawaoka 10 Pathogenesis, 157 Hans Dieter Klenk, Wolfgang Garten, and Mikhail Matrosovich PART 3 Evolution and ecology of influenza viruses 11 Ecology and evolution of influenza viruses in wild and domestic birds, 175 Ron A.M. Fouchier and Yi Guan 12 Influenza in swine, 190 Richard Webby and Juergen Richt 13 Equine/Canine/Feline/Seal influenza, 203 Thomas M. Chambers, Edward J. Dubovi, and Ruben O. Donis 14 Emergence and Evolution of the 1918, 1957, 1968, and 2009 pandemic virus strains, 218 Taia T. Wang and Peter Palese PART 4 Epidemiology and surveillance 15 Influenza surveillance and laboratory diagnosis, 231 Maria Zambon 16 Epidemiology of influenza, 250 Marc-Alain Widdowson and Arnold S. Monto PART 5 Immunology of influenza 17 Innate immunity, 269 Akiko Iwasaki and Malik Peiris 18 Antibody-mediated immunity, 283 Nicole Baumgarth,Michael C. Carroll, and Santiago Gonzalez 19 Cell-mediated immunity, 298 Stephen J. Turner, Peter C. Doherty, and Anne Kelso PART 6 Vaccines and vaccine development 20 Immunogenicity, efficacy of inactivated/live virus seasonal and pandemic vaccines, 313 Wendy A. Keitel, Kathleen M. Neuzil, and John Treanor 21 New approaches to vaccination, 327 Chih-Jen Wei, Damian C. Ekiert, Gary J. Nabel, and Ian A. Wilson 22 Control of influenza in animals, 337 Ilaria Capua and Dennis J. Alexander 23 Influenza vaccine production, 352 Klaus Stöhr PART 7 Clinical aspects and antivirals 24 Human influenza: Pathogenesis, clinical features, and management, 373 Frederick G. Hayden and Menno D. de Jong 25 Antivirals: Targets and use, 392 Michael G. Ison and Alan Hay 26 The control of influenza and cost-effectiveness of interventions, 419 Carolyn B. Bridges, Samuel K. Peasah, and Martin I. Meltzer 27 Applications of quantitative modeling to influenza virus transmission dynamics, antigenic and genetic evolution, and molecular structure, 434 Marc Lipsitch and Derek Smith 28 Pandemic preparedness and response, 453 Jonathan S. Nguyen-Van-Tam and Joseph Bresee 29 Influenza: The future, 470 Thomas J. Braciale PART 8 The outbreak of H7N9 30 Appendix, 479 Thomas J. Bracial

Read more less

Book SynopsisGlobal movement of people leads to the global movement of disease International travel enables skin diseases to move around the world with increasing ease. Skin diseases transmitted through casual contact with people, animal vectors and a foreign environment are particularly prone to transport. Dermatologists need to recognize the signs and symptoms of disease not native to their environment to enable proper diagnosis and care. Imported Skin Diseases provides a clinical guide to the foreign diseases increasingly seen in Western' clinics. With a focus on accurate diagnosis and effective therapy, the book covers: Differences between pigmented and non-pigmented skin Viral, bacterial and fungal Infections Parasitic infestations Sexually transmitted diseases Aquatic diseases Written by an international team of experts, with practical tips throughout, Imported Skin Diseases prepares you for tTable of ContentsContributors, ix 1 Introduction, 1 W.R. Faber, R.J. Hay, & B. Naafs 2 Precautions and Protection, 4 W.R. Faber, R.J. Hay, & B. Naafs 3 Pigmentary Disorders in Black Skin, 8 J.P.W. van der Veen & L. Nieuweboer-Krobotova 4 Difference between Pigmented and Nonpigmented Skin, 19 B. Naafs 5 Influence of the New Environment on the Skin, 31 S. Badeloe & H.E. Menke 6 Fungal Infections, 45 R.J. Hay 7 Mycobacterial Infections, 64 W.R. Faber 8 Leprosy, 79 B. Naafs & W.R. Faber 9 Buruli Ulcer, 94 D.S. Walsh, W.M. Meyers, & F. Portaels 10 Ulcerating Pyodermas, 107 J.E. Zeegelaar 11 Rickettsioses, 114 P.A. Kager & H.G. Schipper 12 Viral Diseases, 123 R.M. Mays, R.A. Gordon, S. Javed, J.M. Wilson, W.J. LaPolla, N.A. Kjar, & S.K. Tyring 13 Sexually Transmitted Infections, 149 M. Waugh & H.J.C. de Vries 14 Endemic Treponematoses, 162 H.J.H. Engelkens 15 American Tegumentary Leishmaniasis, 171 C. Talhari, J.A. de Oliveira Guerra, A. Chrusciak-Talhari, P.R.L. Machado, & S. Talhari 16 Leishmaniasis: Old World, 189 F. Vega-L´opez 17 Onchocerciasis/Filariasis, 205 M.E. Murdoch 18 Schistosomiasis, 226 A.M. Polderman & L. van Lieshout 19 Tungiasis, 234 H. Feldmeier & J. Heukelbach 20 Cutaneous Larva Migrans, 243 J. Heukelbach & H. Feldmeier 21 Myiasis, 252 R. Kapoor, T.A. McGraw, & D.M. Elston 22 Persistent Insect Bites, 264 C.L.M. van Hees 23 Beetle Dermatitis, 273 M. Glatz & P. Schmid-Grendelmeier 24 Aquatic Skin Disorders, 283 M.T.W. Gaastra 25 Geographic Distribution, 293 W.R. Faber, R.J. Hay, & B. Naafs 26 Clinical Problems, 296 W.R. Faber, R.J. Hay, & B. Naafs Index, 299

Read more less

Book SynopsisThis inexpensive, color handbook will provide urologists and urology trainees with a practical tool covering all the major urologic disorders to help them with the clinical assessment and management of their patients.Table of ContentsContributors, viii Preface to the First Edition, x Section 1 Infections 1 Infections of the urinary tract, 3Mark W. Ball 2 Antimicrobial Prophylaxis for Urologic Procedures, 12Jeffrey K. Mullins Section 2 Urinary lithiasis 3 Nephrolithiasis: Etiology, Stone Composition, Medical Management, and Prevention, 23Robert M. Turner II and Michelle Jo Semins 4 Nephrolithiasis: Evaluation and Surgical Treatment, 32Bishoy A. Gayed and Michelle Jo Semins Section 3 Reproductive and Sexual Function 5 Male infertility, 43Ahmed Magheli 6 Erectile dysfunction and Peyronie’s disease, 55Jeffrey K. Mullins Section 4 Emergency Urology 7 Genitourinary trauma, 67Adam Kern 8 Testicular torsion and trauma, 75.Adam Kern 9 Acute gross hematuria: etiology and management, 82Kenneth Tseng 10 Priapism, 88Debasish Sundi and Trinity J. Bivalacqua 11 Urinary fistulae, 96Adam Kern 12 Urethral stricture disease, 103Debasish Sundi and Arthur L. Burnett Section 5 Urine storage and emptying 13 Neurourology, 111Ifeanyichukwu Anusionwu 14 Urogynecology, 116Ifeanyichukwu Anusionwu 15 Interstitial cystitis and chronic pelvic pain, 123Ifeanyichukwu Anusionwu Section 6 Oncology 16 Prostate Cancer Screening and Diagnosis, 129John B. Eifler 17 Prostate Cancer: Localized, 139Stacy Loeb 18 Prostate cancer: treatment of metastatic disease, 149John B. Eifler 19 Benign Prostatic Hyperplasia, 157John B. Eifler 20 Bladder cancer: superficial, 166Ashley E. Ross and Trinity J. Bivalacqua 21 Invasive Bladder Cancer and Urinary Diversion, 173Ashley E. Ross and Trinity J. Bivalacqua 22 Penile and urethral cancer, 180Nicholas C. Field, Matthew Eric Hyndman 23 Ureteral and renal pelvic tumors, 189Elias Hyams and Brian Matlaga 24 Angiomyolipoma, oncocytoma and retroperitoneal fibrosis, 199Phillip M. Pierorazio 25 Malignant Renal parenchymal tumors, 208Phillip M. Pierorazio 26 Adrenal Disorders, 217Jeffrey K. Mullins 27 Testicular tumors, 228Varun Sharma and Markus Margreiter Section 7 Congenital and Acquired Disease 28 Obstructing Congenital Anomalies of the Urinary Tract, 239Kristina D. Suson 29 Developmental Abnormalities of the Genitalia: Disorders of Sexual Differentiation, Hypospadias, and Cryptorchidism, 247Eric Z. Massanyi 30 Pediatric Urinary Infections, Vesicoureteral Reflux, and Voiding Dysfunction, 254Eric Z. Massanyi 31 Pediatric Genitourinary Oncology, 261Eric Z. Massanyi 32 The Exstrophy–Epispadias Complex, 268Kristina D. Suson 33 Bladder Augmentation, bladder neck reconstruction and continent diversions in children, 276Angela D Gupta 34 End Stage Renal Disease and Transplantation, 280Angela D Gupta Addendum Uropharmacology, 285John B. Eifler Index, 289 Color plate section can be found facing page 166

Read more less

Book SynopsisDental emergencies are common and require rapid response. Order today and keep readily accessible in your dental practice! Filled with clinical examples and step-by-step procedures, Dental Emergencies covers the full range of both common and complex traumatic injuries, pain, and oral lesions.Table of ContentsList of Contributors ix Preface xi Acknowledgements xiii 1 Introduction, Infection Control and Prescribing 1 M. Greenwood Introduction to the dental emergency clinic 1 Infection and infection control 2 Prescribing 8 Conclusions 12 Further reading 12 2 History Taking and Clinical Examination of Patients on a Dental Emergency Clinic 13 I.P. Corbett, C.B. Hayward and M. Greenwood Introduction 13 History taking 13 Patient examination 18 Special tests 24 Record keeping 25 Consent 25 Conclusions 28 Further reading 28 3 Radiology and the Dental Emergency Clinic 29 R.I. Macleod Introduction 29 Patients in pain 33 Trauma radiology 35 Looking at radiographs 36 Conclusions 38 Further reading 38 4 Acute Oral Medical and Surgical Conditions 39 P.J. Thomson Introduction 39 Oro-facial swelling 39 Blistering disorders of the oral mucosa 45 Oral ulceration 47 Disturbed oro-facial sensory or motor function 49 Haemorrhage 50 Other acute conditions 51 Bony pathology 52 Summary 55 Further reading 55 5 Restorative Dental Emergencies 57 A. Moufti and C.B. Hayward Introduction 57 General principles 59 Pain management 59 Infections and soft tissue problems 65 Crack, fracture and mobility of teeth and dental restorations 71 Fractured and loose implants 81 Fractures and swallowing of removable prostheses 82 Conclusions 83 Further reading 83 6 Acute Presentations of Chronic Oro-Facial Pain Conditions 85 J. Durham Introduction 85 Oro-facial pain history 86 Examination of patients with oro-facial pain 89 Special investigations for oro-facial pain 90 Presentation, investigations and initial management of acute non-odontogenic oro-facial pain 92 Further reading 102 7 Traumatic Injuries to the Teeth and Oral Soft Tissues 103 U. Chaudhry and I.C. Mackie Assessment of the traumatised patient 103 Management of traumatic dental injuries 105 Injuries to the hard dental tissues and the pulp 105 Injuries to the hard dental tissues, the pulp and the alveolar process 112 Injuries to the periodontal tissues 116 Dento-alveolar fractures 127 Conclusions 127 Further reading 128 8 Pain Relief in the Dental Emergency Clinic 129 U.J. Moore Introduction 129 General mechanism of pain 129 Distribution of pain fibres in the mouth and jaws 134 Sources of pain in the mouth and jaws 135 Control of pain 136 Psychology of pain 137 Medication 139 The ladder of analgesia 144 Avoiding problems in prescribing analgesics 144 Further reading 147 9 Management of the Special Needs Patient 149 T. Nugent Introduction 149 Commonly seen conditions 151 Assessment 152 Medical history in the patient with special needs 153 Informed consent 154 Examination 155 Factors to consider in treatment 155 Conclusion 158 10 Making a Referral 159 I.P. Corbett and J. Greenley Introduction 159 When to refer 159 How to refer 160 Where to refer 161 The referral letter 161 Urgency 164 Cancer referrals 165 Copies of the referral letter 167 Summary 169 Further reading 170 11 Medical Emergencies in the Dental Emergency Clinic – Principles of Management 171 M. Greenwood Introduction 171 Contents of the emergency drug box 171 The ‘ABCDE’ approach to an emergency patient 174 Airway (A) 175 Use of defibrillation 180 Principles of management after the initial treatment of a medical emergency 181 Conclusions 182 Further reading 182 12 Examples of Specific Medical Emergency Situations 183 M. Greenwood Introduction 183 Vasovagal syncope (simple faint) 184 Hyperventilation 184 Asthma 185 Cardiac chest pain 187 Epileptic seizures 188 Diabetic emergencies 190 Allergies/hypersensitivity reactions 192 Adrenal insufficiency 196 Stroke 197 Local anaesthetic emergencies 197 Problems with haemostasis 200 Conclusions 203 Further reading 203 Appendix 1 Normal Reference Ranges 205 Appendix 2 Changes in Vital Signs in Patients with Infection 207 Appendix 3 Warfarin Protocol 209 Appendix 4 Aspects Relating to Local Anaesthetics 213 Appendix 5 NICE Guidelines for the Removal of Wisdom Teeth 215 Appendix 6 Protocol for Surgical Dental Treatment of Patients Taking Bisphosphonates 217 Appendix 7 Common ‘Recreational’ Drugs 221 Index 229

Read more less

Book SynopsisIn psychiatry, as in all of medicine, clinicians are frequently involved in training students and residents yet few have themselves been trained in pedagogy. Improving the quality of psychiatric education should both improve the quality of psychiatric care and make the profession more attractive to medical students.Trade Review"This book deserves our attention since it covers a very important topic and sheds light on common predicaments of our profession. There are summary tables in each section, which makes it an easy and interesting book to read. This is a bedside book for every psychiatrist who is responsible for educating others, particularly for the ones working in academic settings and training hospitals" (Turkish Journal of Psychiatry, August 2011) "It will be rewarding reading for any psychiatrist interested in education and required reading for medical school psychiatry leads." (The Psychiatrist, August 2011) "Written by experts in psychiatric education, this work addresses the well-understood methods for teaching and learning the practice of psychiatry." (Doody's, October 2011) "In this valuable international perspective on teaching psychiatry, Gask (U. of Manchester, UK), Coskun (U. of Kocaeli, Turkey), and Baron (U. of Southern California School of Medicine, Los Angeles, US) advocate improvements in psychiatric education to address the recruitment crisis in the field and help reduce the stigma attached to mental illness even among medical students." (Booknews, April 2011)Table of ContentsContributors vii Foreword ix 1 Overview: The Need for Improvements in Psychiatric Education 1Linda Gask, David Baron and Bulent Coskun 2 Recruitment of Psychiatrists: the Key Role of Education 5Cyril Höschl and Jon van Niekerk 3 Ethical Issues in Teaching Psychiatry 19Driss Moussaoui 4 Developing a Medical Student Curriculum in Psychiatry 27Nisha Dogra, Cyril Höschl and Driss Moussaoui 5 Teaching Behavioural Sciences 47Bulent Coskun 6 Problem-Based Learning and Psychiatric Education 61Raja Vellingiri Badrakalimuthu, Rob van Diest, Maarten Bak and Hugo de Waal 7 Psychiatric Residency Curriculum: Development and Evaluation 77Amanda B. Mackey and Allan Tasman 8 Acquisition of Psychiatric Interviewing Skills 97Linda Gask 9 Teaching Psychotherapy in the Classroom and in Supervision 109Glen O. Gabbard 10 Teaching Psychotherapy: Case Discussion Groups 117Mark Oliver Evans 11 Teaching Research Methods: ‘Doing Your Own Research’ 125David P. Goldberg 12 Teaching Psychiatry Students About Cultural Diversity 135Nisha Dogra and Niranjan Karnik 13 Teaching Psychiatry in Primary Care 153Linda Gask, Bulent Coskun and Rodolfo Fahrer 14 The Standardized Patient 167Michael Curtis and David Baron 15 Patients as Teachers: Involving Service Users 177Rex Haigh and Kath Lovell 16 Technology for Psychiatric Educators 191Sheldon Benjamin and Maria Margariti 17 Assessment in Psychiatric Education 213Brian Lunn, Maria R. Corral and Adriana Mihai 18 The Support and Welfare of the Student 231Michael F. Myers 19 Psychiatrist Educators 247David Baron and Bulent Coskun Index 261

Read more less

Book SynopsisIn recent years, there has been a growing awareness of the multipleinterrelationships between depression and various physicaldiseases. The WPA is providing an update of currently availableevidence on these interrelationships by the publication of threebooks, dealing with the comorbidity of depression with diabetes,heart disease and cancer.Trade Review"Depression and Diabetes is an outstanding book that provides and impressive amount of information on a major worldwide health problem that requires concerted efforts by the global community of health providers, including health care policy makers. The book is highly recommended and is well worth the short time commitment needed to read it." (Journal of Clinical Psychiatry, 2011) "Particularly helpful to mental health clinicians is the attention to both diabetes and mental health issues ... It explores an area of medicine that is important to our patients, their families, and all of us as we strive to provide better evidence-based treatments throughout the world." (Journal of Nervous and Mental Disease, 11 November 2011) "Depression and Diabetes does a good job in laying out the various biopsychosocial pathways by which diabetes might lead to depression or vice versa . . . the chapters in this book that will be most appreciated by clinical health psychologists and other practitioners who care for patients with diabetes are those involving treatment, either just the treatment of comorbid depression or concurrent treatment of both condition." (PsycCRITIQUES, 1 June 2011) "The present miniseries, Depression and Diabetes, Depression and Heart Disease and Depression and Cancer is a unique initiative to make physical diseases visible in psychiatry and to support the treatment ... To this reviewer the books have two strengths: their thematic broadness and the practical approach. The chapters about how to act clinically are excellent, pragmatic and consequently written .... The idea behind the series is excellent and the books are marvellous. After having read them no one will doubt that psychiatry is a medical speciality (that psychiatrists must be physicians first, psychiatrists next, that psychiatry must be done by psychiatrists and psychiatry must be lead by psychiatrists.)" (Acta Psychiatrica Scandinavica, 2011) "Diabetes and Depression will appeal to anyone with an academic interest in the links between diabetes and depression". (Diabetes Digest, 1 November 2010)Table of ContentsList of Contributors vii Preface ix 1 The Epidemiology of Depression and Diabetes 1 Cathy E. Lloyd, Norbert Hermanns, Arie Nouwen, Frans Pouwer, Leigh Underwood and Kirsty Winkley 2 Unraveling the Pathogenesis of the Depression–Diabetes Link 29 Khalida Ismail 3 Medical Costs of Depression and Diabetes 63 Leonard E. Egede 4 Treatment of Depression in Patients with Diabetes: Efficacy, Effectiveness and Maintenance Trials, and New Service Models 81 Wayne Katon and Christina van der Felz-Cornelis 5 Diabetes and Depression: Management in Ordinary Clinical Conditions 109 Richard Hellman and Paul Ciechanowski 6 Depression and Diabetes: Sociodemographic and Cultural Aspects and Public Health Implications 143 Juliana Chan, Hairong Nan and Rose Ting Acknowledgement 173 Index 175

Read more less

Book SynopsisThe new edition of this critically praised textbook continues to provide the most comprehensive overview of the concepts, methods, and research advances in the field; particularly the application of molecular genomics and of neuroimaging. It has been revised and enhanced to capitalize on the strengths of the first and second editions while keeping it up-to-date with the field of psychiatry and epidemiology. This comprehensive publication now includes chapters on experimental epidemiology, gene-environment interactions, the use of case registries, eating disorders, suicide, childhood disorders and immigrant populations, and the epidemiology of a number of childhood disorders. As in the first and second editions, the objective is to provide a comprehensive, easy to understand overview of research methods for the non-specialist. The book is ideal for students of psychiatric epidemiology, psychiatric residents, general psychiatrists, and other mental health professionals. The boTrade Review"The Textbook of Psychiatric Epidemiology is a timely, up-to-date, and comprehensive book covering all aspects of the science of epidemiology as related to psychiatric disorders. Overall, this is a well written, wel-organized book that I highly recommend to all psychiatrists and neuroscientists who are interested in the underpinning of psychiatric epidemiology." (Journal of Clinical Psychiatry, 2013) “Overall, this book provides a thorough and understandable introduction to the field of psychiatric epidemiology, suitable for students wishing to become familiar with up-to-date applications and findings in psychiatry as they relate to public health and epidemiology.” (Doody’s, 6 April 2012) "This 3rd edition is a welcome return for this informative textbook, which will be of interest to a wide readership through its extensive scope. It covers a range of areas relevant to epidemiology and beyond with what is now the standard format involving expert authors or teams." (Acta Psychiatrica Scandinavica, 2012) "So I started this review process with a great deal of skepticism. However, during this process I have ended up reading about areas outside my own main research field with much interest, and chapters within my own areas with much pleasure and admiration for the contributions; and, I have found myself recommending individual chapters again and again to students and other people with whom I, during this period, have discussed specific projects. So, much to my own surprise, I end up warmly recommending this book to anyone who has a professional interest in the epidemiology of, and risk factors for psychiatric disorders, and a recurring need for a fast reference to a very comprehensive array of knowledge." Read the full review. (Acta Neuropsychiatrica, 2012) Table of ContentsList of Contributors. 1 Introduction to epidemiologic research methods (Glyn Lewis). 1.1 What is epidemiology? 1.2 Causation in medicine. 1.3 Causal inference. 1.4 The future for psychiatric epidemiology. 2 Analysis of categorical data: The odds ratio as a measure of association and beyond (Garrett M. Fitzmaurice and Caitlin Ravichandran). 2.1 Introduction. 2.2 Inference for a single proportion. 2.3 Analysis of 2 x 2 contingency tables. 2.4 Analysis of sets of 2 x 2 contingency tables. 2.5 Logistic regression. 2.6 Advanced topics. 2.7 Concluding remarks. 2.8 Further reading. 3 Genetic epidemiology (Stephen V. Faraone, Stephen J. Glatt and Ming T. Tsuang). 3.1 Introduction. 3.2 The chain of psychiatric genetic research. 3.3 Psychiatric genetics and psychiatric epidemiology. 4 Examining gene–environment interplay in psychiatric disorders (Judith Allardyce and Jim van Os). 4.1 Introduction. 4.2 The process of genetic epidemiology. 4.3 Gene–environment interplay takes different forms. 4.4 Gene–environment correlation. 4.5 Gene–environment interaction. 4.6 Measurement of genotype, environmental exposure and pathological phenotype. 4.7 Models of GxE. 4.8 Which scale should we use to measure GxE? 4.9 Study designs for the detection of GxE. 4.10 Threats to the validity of epidemiological GxE studies. 4.11 Epigenetic mechanisms. 5 Reliability (Patrick E. Shrout). 5.1 Introduction. 5.2 The reliability coefficient. 5.3 Designs for estimating reliability. 5.4 Statistical remedies for low reliability. 5.5 Reliability theory and binary judgements. 5.6 Reliability statistics: General. 5.7 Other reliability statistics. 5.8 Summary and conclusions. 6 Moderators and mediators: Towards the genetic and environmental bases of psychiatric disorders (Helena Chmura Kraemer). 6.1 Introduction. 6.2 Current methodological barriers. 6.3 Moderation, mediation and other ways in which risk factors 'work together'. 6.4 Extensions. 6.5 Beyond moderators and mediators. 7 Validity: Definitions and applications to psychiatric research (Jill M. Goldstein, Sara Cherkerzian and John C. Simpson). 7.1 Introduction. 7.2 Validity of a construct. 7.3 Validity of the relationships between variables. 7.4 Summary. 8 Use of register data for psychiatric epidemiology in the Nordic countries (Jouko Miettunen, Jaana Suvisaari, Jari Haukka and Matti Isohanni). 8.1 Introduction. 8.2 Registers for use in psychiatric research. 8.3 Register research in Denmark. 8.4 Register research in Finland. 8.5 Register research in Norway. 8.6 Register research in Sweden. 8.7 Discussion. 9 An introduction to mental health services research (Anna Fernandez, Alejandra Pinto-Meza, Antoni Serrano-Blanco, Jordi Alonso and Josep Maria Haro). 9.1 Introduction. 9.2 What is mental health services research? 9.3 A framework for mental health services research. 9.4 Key concepts in mental health services research. 9.5 Examples of mental health services research studies. 9.6 Conclusion. 10 The pharmacoepidemiology of psychiatric medications (Philip S. Wang, Alan M. Brookhart, Christine Ulbricht and Sebastian Schneeweiss). 10.1 Introduction. 10.2 Overview of psychopharmacoepidemiology. 10.3 Sources of data. 10.4 Examples of recent psychopharmacoepidemiologic studies. 10.5 Conclusions. 11 Peering into the future of psychiatric epidemiology (Michaeline Bresnahan, Ezra Susser, Dana March and Bruce Link). 11.1 Introduction. 11.2 Levels of causation: A historical overview. 11.3 Levels of causation. 11.4 Causation over (life) time. 11.5 Examples. 11.6 Framing the future. 12 Studying the natural history of psychopathology (William W. Eaton). 12.1 Introduction. 12.2 Onset. 12.3 Course. 12.4 Outcome. 12.5 Methodological concepts for studying the natural history of psychopathology. 12.6 Conclusion. 13 Symptom scales and diagnostic schedules in adult psychiatry (Jane M. Murphy). 13.1 Introduction. 13.2 North American instruments for epidemiological research. 13.3 North American instruments for psychiatric services and primary care. 13.4 European instruments for psychiatric services and primary care. 13.5 European instruments for epidemiological research. 13.6 Summary. 14 The National Comorbidity Survey (NCS) and its extensions (Ronald C. Kessler). 14.1 Introduction. 14.2 The baseline NCS. 14.3 The NCS follow-up survey (NCS-2). 14.4 The NCS replication survey (NCS-R). 14.5 The NCS-R adolescent supplement (NCS-A). 14.6 The WHO WMH Surveys. 14.7 Overview. 15 Experimental epidemiology (John R. Geddes). 15.1 Introduction. 15.2 Limitations of non-randomised evidence. 15.3 RCTs: The translation of the experimental design into the real world. 15.4 Importance and control of systematic error or bias. 15.5 Importance and control of random error and noise. 15.6 Reporting the results of clinical trials—the CONSORT statement. 15.7 Different clinical questions will prioritise control of different threats to validity and confidence. 15.8 The classification of RCTs. 15.9 Effectiveness trials in schizophrenia. 15.10 Department of Veterans Affairs co-operative study on the cost-effectiveness of Olanzapine (Rosenheck). 15.11 The clinical antipsychotic trials of intervention effectiveness (CATIE) study. 15.12 Cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1). 15.13 European first-episode schizophrenia trial (EUFEST). 15.14 The size and cost of experimental studies in psychiatry. 15.15 Clinical trials in the future. 16 Epidemiology of Schizophrenia (William W. Eaton, Chuan-Yu Chen and Evelyn J. Bromet). 16.1 Introduction. 16.2 Methods. 16.3 The burden of schizophrenia. 16.4 Natural history. 16.5 Demographic correlates. 16.6 Social risk factors. 16.7 Biological risk factors. 16.8 Prevention. 16.9 Discussion. 17 Epidemiology of depressive disorders (Deborah S. Hasin, Miriam C. Fenton and Myrna M. Weissman). 17.1 Introduction. 17.2 Major depression. 17.3 Dysthymia. 17.4 Summary. 18 Epidemiology of anxiety disorders (Ewald Horwath, Felicia Gould and Myrna M. Weissman). 18.1 Introduction. 18.2 Anxiety disorders. 18.3 Panic disorder. 18.4 Agoraphobia. 18.5 Social phobia. 18.6 Generalised anxiety disorder. 18.7 Obsessive–compulsive disorder. 18.8 Anxiety and affective disorders and mass disasters. 18.9 Future developments. 19 Epidemiology of bipolar disorder in adults and children (Kathleen R. Merikangas and Mauricio Tohen). 19.1 Introduction. 19.2 Epidemiology of bipolar disorder. 19.3 Patterns of comorbidity of bipolar disorder. 19.4 Risk Factors. 19.5 Future directions. 19.6 Summary. 20 Epidemiology of eating disorders (Tracey D. Wade, Anna Keski-Rahkonen and James I. Hudson). 20.1 Introduction. 20.2 Case definition. 20.3 Major prevalence studies. 20.4 Incidence studies. 20.5 Comorbidity. 20.6 Mortality from eating disorders. 20.7 Risk factors. 20.8 Future directions. 21 Epidemiology of alcohol use, abuse and dependence (Deborah A. Dawson, Ralph W. Hingson and Bridget F. Grant). 21.1 Introduction. 21.2 Population estimates of per capita consumption. 21.3 Survey-based estimates of the prevalence of drinking. 21.4 Alcohol-related mortality and morbidity. 21.5 Alcohol and injury. 21.6 Alcohol and chronic disease. 21.7 Diagnostic classification of alcohol use disorders. 21.8 Population estimates, prevalence, incidence and natural course of alcohol use disorders. 21.9 Comorbidity of DSM-IV alcohol use disorders and other psychiatric disorders. 21.10 Summary. 22 Epidemiology of illicit drug use disorders (Wilson M. Compton, Marsha F. Lopez, Kevin P. Conway and Yonette F. Thomas). 22.1 Introduction. 22.2 Drug consumption. 22.3 Definitions. 22.4 Rates of DSM-IV abuse and dependence. 22.5 Global rates of drug use disorders. 22.6 Comorbidities with psychiatric conditions. 22.7 Genetic epidemiology. 22.8 Future opportunities. 22.9 Conclusions. 22.10 Disclaimer. 23 The epidemiology of personality disorders: Findings, methods and concepts (Michael J. Lyons, Beth A. Jerskey and Margo R. Genderson). 23.1 Introduction. 23.2 Substantive findings. 23.3 Course, prognosis and developmental issues. 23.4 Treated prevalence. 23.5 Prevalence of specific personality disorders. 23.6 Antisocial personality disorder. 23.7 Conceptual issues. 23.8 Models of personality disorder. 23.9 Methodological issues. 23.10 Future directions. 24 The epidemiology of depression and anxiety in children and adolescents (Kathleen Ries Merikangas and Erin F. Nakamura). 24.1 Introduction. 24.2 Magnitude of depression and anxiety in children and adolescents. 24.3 Correlates and risk factors. 24.4 Service patterns and impact. 24.5 Summary. 25 Epidemiology of attention deficit hyperactivity disorder (Stephen V. Faraone). 25.1 Introduction. 25.2 Prevalence of ADHD. 25.3 Pharmacoeconomics of ADHD. 25.4 Comorbid psychiatric disorders. 25.5 Demographic risk factors. 25.6 Genetic risk factors. 25.7 Environmental risk factors for ADHD. 25.8 Summary and conclusions. 25.9 Future directions. 26 The epidemiology of autism (Gregory S. Liptak). 26.1 Introduction. 26.2 Background. 26.3 Definition and diagnosis. 26.4 Natural history. 26.5 Prevalence. 26.6 Risk factors. 26.7 Genetic factors. 26.8 Public health impact. 26.9 Associations and causal factors. 26.10 Future directions. 26.11 Summary. 27 Mental illness, women, mothers and their children (Kathryn M. Abel and Vera A. Morgan). 27.1 Introduction. 27.2 The epidemiology of mental illness in women of reproductive age. 27.3 Fertility and fecundity in women with mental illness. 27.4 Maternal mental illness at the time of conception and during pregnancy. 27.5 Gene–environment interactions and offspring outcomes. 27.6 Obstetric complications and risk of adult onset mental disorder in offspring. 27.7 Parental condition. 27.8 Motherhood and perinatal mental illness. 27.9 Designing studies examining the relationship between maternal mental illness and outcomes for their children. 27.10 Conclusions. 28 Epidemiology of suicide and attempted suicide(Dianne Currier and Maria A. Oquendo). 28.1 Introduction. 28.2 Definitions. 28.3 Prevalence of suicide and attempted suicide. 28.4 Risk factors for suicide and attempted suicide. 28.5 Protective factors. 28.6 Conclusions. 29 Epidemiology and geriatric psychiatry (Celia F. Hybels and Dan G. Blazer). 29.1 Introduction. 29.2 Issues of case identification. 29.3 The distribution of cases. 29.4 Aetiological studies. 29.5 Outcome studies. 29.6 Historical trends in the epidemiology of psychiatric disorders in late life. 29.7 Use of health care services. 30 Recent epidemiological studies of psychiatric disorders in Japan (Masayoshi Kawai, Kenji J. Tsuchiya and Nori Takei). 30.1 Introduction. 30.2 Schizophrenia. 30.3 Affective disorders. 30.4 Autism and autism spectrum disorder. 30.5 Summary. 31 Epidemiology of migration and serious mental illness: The example of migrants to Europe (Monica Charalambides, Craig Morgan and Robin M. Murray). 31.1 Introduction. 31.2 Defining the constructs. 31.3 High rates of psychosis in migrants: A genuine finding or methodological artefact? 31.4 Possible explanations. 31.5 Biological considerations. 31.6 Cannabis use. 31.7 Adverse social experiences. 31.8 Mechanisms. 31.9 Implications. 32 Epidemiology of migration substance use disorder in Latin American populations and migration to the United States (Marıa Elena Medina-Mora, Guilherme Borges, Tania Real and Jorge Villatoro). 32.1 Introduction. 32.2 Definitions: What do we understand by migration? 32.3 Countries of origin: Social, political and other reasons that trigger migration. 32.4 Living conditions of migrants in the United States. 32.5 Alcohol and drug use in countries of origin and receiving communities. 32.6 Dependence and treatment rates. 32.7 The process of migrating. 32.8 Migration, substance use and access to services. 32.9 Returning migrants and families left behind. 32.10 Conclusions. 33 Early detection and intervention as approaches for preventing schizophrenia (Ming T. Tsuang, William S. Stone, Margo Genderson and Michael Lyons). 33.1 Introduction. 33.2 Modelling genetic and phenotypic heterogeneity. 33.3 Defining a syndrome of liability using cognitive and clinical characteristics of relatives. 33.4 Gene-based vs. genome-based research. 33.5 Future directions. 33.6 Clinical implications. Acknowledgements. References. Index.

Read more less

Book SynopsisSocial psychiatry is concerned with the effects of the social environment on the mental health of the individual, and with the effects of the person with a mental disorder on his/her social environment. The field encompasses social interventions, prevention and the promotion of mental health.Trade Review"This should be of interest not only to those in the mental health professions who are committed to the practice and investigation of social psychiatry but to all who are engaged in the mental health system irrespective of their theoretical persuasions." (Transcultural Psychiatry, July 2011) "Since it is claimed that depression is the fourth most common cause of health-related disability, there is a perceived need for effective psychological interventions that can be delivered within the community on a large scale. Low-cost ways of reducing the financial and human burden of common mental disorders are thoroughly explored in this book."(International Journal of Social Psychiatry, 2011) "The chapter by Dinesh Bhugra and Susham Gupta on culture and its influence on diagnosis and management could be a useful free-standing training manual for mental health professionals working in a cross-cultural or multicultural setting" (International Journal of Social Psychiatry, 2011)Table of ContentsList of Contributors ix Foreword xiiiMario Maj Preface xv Social Psychiatry: Alive and KickingDinesh Bhugra and Craig Morgan Part One Perspectives and Methods 1 1 The Historical Development of Social Psychiatry 3Julian Leff 2 Why Psychiatry Has to be Social 13Paul E. Bebbington 3 Categories and Continuums 31Peter Tyrer 4 Social, Biological and Personal Constructions of Mental Illness 39Derek Bolton 5 Social Science Perspectives: A Failure of the Sociological Imagination 51Craig Morgan and Arthur Kleinman 6 Concepts and Challenges in Capturing Dynamics of the Wider Social Environment 65Stephani L. Hatch and Dana March 7 Qualitative Research Methods 77Joanna Murray Part Two Components of the Social World 89 8 The Social Epidemiology of Mental Disorder 91Ronald C. Kessler, Philip S. Wang and Hans-Ulrich Wittchen 9 Families and Psychosis 103Juliana Onwumere, Ben Smith and Elizabeth Kuipers 10 Culture and Its Influence on Diagnosis and Management 117Dinesh Bhugra and Susham Gupta 11 Culture and Identity 133Julian Leff 12 Globalization and Psychiatry 141Rahul Bhattacharya, Susham Gupta and Dinesh Bhugra 13 Trauma and Disasters in Social and Cultural Context 155Laurence J. Kirmayer, Hanna Kienzler, Abdel Hamid Afana and Duncan Pedersen Part Three Social Determinants 179 14 Fundamental Social Causes of Health Inequalities 181Jo C. Phelan and Bruce G. Link 15 The Sociodevelopmental Origins of Psychosis 193Craig Morgan and Gerard Hutchinson 16 Depression 215Tom K. J. Craig 17 Common Mental Disorders 227Christoph Lauber 18 Suicide 237Gwendolyn Portzky and Kees van Heeringen 19 Personality Disorder 249Priya Bajaj and Mike Crawford 20 Drug Use, Drug Problems and Drug Addiction: Social Influences and Social Responses 259John Strang, Michael Gossop and John Witton 21 Eating Disorders 277Mervat Nasser 22 Social Factors that Influence Child Mental Health 285Nisha Dogra 23 Social Determinants of Late Life Disorders 295Robert Stewart Part Four Social Consequences and Responses 305 24 Responses to the Onset of Mental Health Problems: Issues and Findings from Research on Illness Behaviour and the Use of Health Services 307Bernice A. Pescosolido 25 Gender and Reproductive Health 321Louise Howard 26 Stigma and Discrimination 331Graham Thornicroft, Nisha Mehta, Elaine Brohan and Aliya Kassam 27 Taking Inequality’s Measure: Poverty, Displacement, Unemployment and Mental Health 341Kim Hopper 28 Health Economics and Psychiatry: The Pursuit of Efficiency 371Martin Knapp and Jennifer Beecham Part Five Social Interventions 385 29 Team Structures in Community Mental Health 387Tom Burns 30 Prevention 397Tristan McGeorge, Sean Cross and Rachel Jenkins 31 Principles of Social Intervention 411Richard Warner 32 Social Interventions for Psychosis 425David Kingdon, Yoshihiro Kinoshita and Stefan Gleeson 33 Social Management of Common Mental Disorders 439Patricia R. Casey 34 Problem-Solving Therapy for People with Personality Disorders 449Mary McMurran, Christine Maguth Nezu and Arthur M. Nezu 35 Social Support 461Traolach S. Brugha 36 Modern Social Networking and Mental Health 477Keir Jones, James Woollard and Dinesh Bhugra 37 The Psychiatric–Child Protection Interface: Research to Inform Practice 483Colin Pritchard Part Six Global Mental Health 499 38 Mental Health in Europe: Learning from Differences 501Mirella Ruggeri and Maria Elena Bertani 39 East Meets West: Current Mental Health Burdens in Greater China 517Roger M. K. Ng and Zhanjiang Li 40 Social Psychiatry in India 531R. Thara and R. Padmavati 41 Social Psychiatry in Africa: Evidence and Challenges 541Oye Gureje and Victor Makanjuola 42 Social Psychiatry in the Americas 551Pedro Ruiz Epilogue 559 43 Where Next for Social Psychiatry? 561Dinesh Bhugra and Craig Morgan Index 565

Read more less

Book SynopsisThe first book in a new series from the World Psychiatric Association, Schizophrenia: current science and clinical practice presents recent information on the diagnosis, neurobiological foundations, and management of schizophrenia. It evaluates the findings obtained with modern techniques like magnetic resonance imaging, genetics and network analyses. The book reviews the importance of neurocognitive functioning in schizophrenia and its predictive value for functional capacity. It covers the key areas of early recognition, prevention, rehabilitation and stigma. There is also a critical discussion of diagnostic classification and the revision of the two major international systems. Written by experts in the field who have a track record of being engaging authors, this book provides a rapid overview of the current state of the art in schizophrenia research and clinical management. It will be invaluable to all psychiatrists, psychologists, neuropharmacologists, researchers in pTrade Review“Professor Gaebel and contributing authors are to be congratulated for this outstanding text.” (Journal of Clinical Psychiatry, 6 June 2012) "Nonetheless, Schizophrenia: Current Science and Clinical Practice will be an asset to those who are seeking a current and sophisticated synthesis of the field, combined with stimulating discussions of some pivotal controversies in both research and treatment. Gaebel has assembled a distinguished group of contributors who are more than up to the task of grappling with the challenge of discerning the implications of cutting-edge research for clinical intervention." (PsycCRITIQUES, 11 January 2012) "I am not in a position to comment on most chapters, as I am not an expert in those fields, but all I can say is that I learnt a lot and that the book provided me with a good overview on different aspects of what we commonly call schizophrenia." (Acta Psychiatr Scandinavica, 2012) "The first chapter is an excellent and factual review of the diagnosis and classification systems that highlights the major validity issues. . .This new book is useful and current." (Doody's, 30 September 2011) "The book will be of interest to psychiatrists, psychologists, neuropharmacologists, researchers in psychiatry and psychopharmacology, and clinical and behavioral neuroscientists." (Book News, 1 August 2011) Table of ContentsList of Contributors. Preface. 1 Diagnosis and revision of the classification systems (Assen Jablensky). Introduction. Origin and evolution of the concept of schizophrenia. Kraepelin's 'clinical forms'. Bleuler's 'group of schizophrenias'. Leonhard's 'endogenous psychoses'. Classification of psychoses in French psychiatry. Other post-Kraepelinian and post-Bleulerian subtypes and dichotomies. The schizophrenia spectrum concept. Statistically derived clusters and symptom dimensions. Schizophrenia in ICD-10 and DSM-IV. Origins of the two classifications. Both DSM-IV and ICD-10 are descendants of the Kraepelinian nosology. Criteria for assessing the diagnostic classification of schizophrenia. Positive impact and unintended adverse effects. Clinical relevance and cognitive ease of use. Utility in research. Reliability. Concepts of validity. Predictive validity: course and outcome. Criterion validity: genetics. Aspects of culture. Reducing stigma. Revision of the classifications: prospects for schizophrenia. One classification or many? Critical issues in the revision process. Disease or a broad syndrome? 'Deconstructing' schizophrenia: categories or dimensions? Endophenotypes. The concept of utility. Conclusion. References. 2 Pathophysiology of schizophrenia (Peter Falkai, Andrea Schmitt and Tyrone D. Cannon). Introduction. Major findings and related pathophysiological hypotheses. Symptom domains and neurotransmitter hypotheses. From domains to disturbed neuronal networks. From networks to the cellular level. Hypothesis of disturbed synaptogenesis and neurogenesis. Effects of antipsychotics. Summary and conclusions. References. 3 Neurocognition, social cognition and functional outcome in schizophrenia (William P. Horan, Philippe-Olivier Harvey, Robert S. Kern and Michael F. Green). Introduction. Neurocognition in schizophrenia. Domains, measurement and magnitude of impairment. Neurocognition as a core deficit of schizophrenia. Associations with functional outcome. The NIMH-MATRICS initiative and current research directions. Social cognition. Domains, measurement and magnitude of impairment. Social cognition as a core feature of schizophrenia. Association with functional outcome. Current research directions. Relationships among neurocognition, social cognition and functional outcome. Distinctiveness of neurocognition and social cognition. Social cognition as a mediator. Future directions. References. 4 The genetics of schizophrenia (James T.R. Walters, Michael O'Donovan and Michael J. Owen). Introduction. Genetic epidemiology of schizophrenia. Family, twin and adoption studies of schizophrenia. Genetic epidemiology – informing diagnosis? Molecular genetics of schizophrenia. Linkage. Positional candidate studies. Functional candidate studies. Chromosomal abnormalities. Genome wide association studies. GWAS in schizophrenia. Copy number variation. The future of schizophrenia genetics. Schizophrenia genetics in the clinic? Conclusions. Acknowledgements. References. 5 Early recognition and prevention of schizophrenia (Patrick D. McGorry and Sherilyn Goldstone). The context for early recognition and prevention. The prodromal stage: definition and assessment. Treatment during the prodromal stage. The psychosis risk syndrome: a novel diagnostic entity? Ethical issues. Summary and conclusions. References. 6 Pharmacological treatment (Jonathan E. Sherin and Stephen R. Marder). Introduction. Current state of pharmacological treatment. Phases of schizophrenia. Acute phase treatment. Stabilization phase treatment. Maintenance phase treatment. Treatment resistant patients. Managing first episodes. Newer antipsychotics. Personalising drug treatment in schizophrenia. Cognition and negative symptoms as therapeutic targets. Glutamatergic targets. Dopamine targets. Cholinergic targets. Histamine targets. Summary. References. 7 Cognitive-behavioural interventions (Suzanne Jolley and Philippa Garety). Introduction. The development of cognitive behavioural approaches to schizophrenia-spectrum psychosis. Cognitive behavioural models of psychosis. Biopsychosocial vulnerability. Life events and schematic beliefs. The role of affect. The central role of appraisal. Reasoning biases. Anomalous experiences. The role of behaviour. Insight and illness appraisals. Cognitive behavioural therapy in schizophrenia. Psychotherapy in schizophrenia: more than unspecific learning? Combining psychotherapy and pharmacotherapy. Efficacy of cognitive behavioural therapy for psychosis (CBTp). Future developments. Conclusions. Acknowledgements. References. 8 Management, rehabilitation, stigma (Wulf Rossler). Introduction. Managing schizophrenia: integrative approaches. Burden for patients, families and communities. Gender issues. Mortality. Legal problems. Health care settings for schizophrenia patients: which setting is optimal? Psychiatric rehabilitation. The international classification of functioning, disability and health. Target population. Conceptual framework. Current approaches. Individual-centred rehabilitation. Cognitive behavioural therapy. Social skills training. Ecological approach to rehabilitation. Housing. Work. Participation in community life with full rights. The contribution of mental health professionals to stigma and discrimination. The role of the psychiatrist in the management and rehabilitation of schizophrenia patients. Outlook. References. Index.

Read more less

Book SynopsisLike all health professionals, speech and language therapists(SLTs) need to keep themselves up-to-date with the researchevidence base that is relevant to their field of practice and beable to show how this contributes to their clinicaldecision-making.Trade Review"Because of the importance and immediate reference of the topic to current clinical practice as well as the transferable methods described, this book would be a vaulable resource for a wide range of readers - students, newly qualified therapists, lecturers, experienced therapists and managers." (Speech & Language Therapy in Practice, 1 March 2011)Table of ContentsList of contributors viii Forewords xi Professor Sheena Reilly, Australia Professor Pam Enderby, United Kingdom About the editors xiv Acknowledgements xv Section One: Understanding EBP 1 1 Purpose of this book 3 Hazel Roddam and Jemma Skeat 2 What does EBP mean to speech and language therapists? 9 Hazel Roddam and Jemma Skeat 3 What are the barriers to EBP in speech and language therapy? 16 Jemma Skeat and Hazel Roddam Section Two: Developing knowledge and skills for EBP 25 4 Teaching undergraduates to become critical and effective clinicians 27 Bea Spek, The Netherlands 5 Promoting clinical effectiveness with postgraduate students 36 Paula Leslie and James L. Coyle, United States 6 Clinical effectiveness: not just a journal club 43 Satty Boyes and Gina Sutcliffe, United Kingdom 7 Using evidence-based practice in supervision 51 Hannah Crawford, United Kingdom 8 Meeting skill gaps and training needs (commentary on Section Two) 59 Hazel Roddam and Jemma Skeat Section Three: Creating a supportive context for EBP 63 9 The role of leadership in creating evidence-based services 65 Karen Davies, United Kingdom 10 Supporting staff to balance caseload demands 72 Sean Pert, United Kingdom 11 A model of clinician-researcher collaboration in a community setting 79 Parimala Raghavendra, Australia 12 Valuing evidence-based practice in the clinical setting – a showcase event 87 Siân E. Davies and Tracey C. Dean, United Kingdom 13 Launching and sustaining an evidence-based highly specialist service 94 Sheena Round and Sarah Beazley, United Kingdom 14 Strategic approaches to promoting the value of EBP (commentary on Section Three) 101 Hazel Roddam and Jemma Skeat Section Four: Making the evidence work for us 105 15 The importance of listening to the views of clients 107 Pirkko Rautakoski, Finland 16 Developing evidence-based clinical resources 114 Russell Thomas Cross, United States 17 Creating evidence-based policy to facilitate evidence-based practice 122 Angie Dobbrick, Australia 18 Building and supporting a multi-stream clinical evidence-based practice Network 129 Tracy Kelly, Rachel Miles Kingma and Rachelle Robinson, Australia 19 Equipping ourselves as evidence-based practitioners: tools and resources for EBP (commentary on Section Four) 139 Jemma Skeat and Hazel Roddam Section Five: Applying evidence to meet clinical challenges 143 20 A community-based project in rural Sri Lanka 145 Shalini Felicity Gomesz, Sri Lanka 21 Supporting communicative participation for children with complex communication needs: how the evidence contributes to the journey 151 Angela Guidera, Catherine Olsson and Parimala Raghavendra, Australia 22 Evidence-based diagnosis of speech, language and swallowing following paediatric stroke 157 Angela Morgan, Australia 23 Working with a dysfluent three-year-old from a bilingual family 163 Patricia Oksenberg, France 24 Supporting parents and teachers in managing autism: an example of an evidence-informed model for assessment and intervention 168 Anneli Yliherva, Finland 25 Communication therapy on the Stroke Care Unit 174 Daniel De Stefanis and Gracie Tomolo, Australia 26 Working with psychogenic dysphonia 179 Beth Higginbottom and Linda House, United Kingdom 27 Implementation of a free fluid protocol in an aged care facility 184 Amanda Scott and Leora Benjamin, Australia 28 Prosody intervention for children 189 Christina Samuelsson, Sweden 29 Supporting evidence-based practice for students on placement: making management decisions for two clients with Down Syndrome 195 Ruth Miller, United Kingdom 30 Bridging the research–clinical divide through postgraduate research training 201 Georgia D. Bertou, Greece 31 Many roads lead to EBP (commentary on Section Five) 206 Jemma Skeat and Hazel Roddam Section Six: Future directions for EBP in speech and language therapy 211 32 Wider consultation on embedding EBP in SLT practice 213 Hazel Roddam and Jemma Skeat 33 The role of reflective practice in supporting EBP 222 Jemma Skeat and Hazel Roddam 34 Embedding EBP: future directions 230 Hazel Roddam and Jemma Skeat Index 232

Read more less

Book SynopsisThe focus of this book is on speech production and speech processing associated with cleft palate, covering phonetic (perceptual and instrumental), phonological and psycholinguistic perspectives, and including coverage of implications for literacy and education, as well as cross-linguistic differences. It draws together a group of international experts in the fields of cleft lip and palate and speech science to provide an up-to-date and in-depth account of the nature of speech production, and the processes and current evidence base of assessment and intervention for speech associated with cleft palate. The consequences of speech disorders associated with cleft on intelligibility and communicative participation are also covered. This book will provide a solid theoretical foundation and a valuable clinical resource for students of speech-language pathology, for practising speech-language pathologists, and for others interested in speech production in cleft palate, including researchers aTable of ContentsList of Contributors xi Preface xvii Part One Speech Production and Development 1 Sara Howard and Anette Lohmander 1 Physical Structure and Function and Speech Production Associated with Cleft Palate 5 Martin Atkinson and Sara Howard 1.1 Introduction 5 1.2 The Hard and Soft Palates and the Velopharynx 6 1.3 The Tonsils and Adenoids 9 1.4 The Larynx 11 1.5 The Jaws, Dentition and Occlusion 12 1.6 Symmetry: Structure and Function 15 1.7 The Tongue 16 1.8 The Lips 18 1.9 Summary: Compensations Across Systems 19 References 19 2 The Development of Speech in Children with Cleft Palate 23 Kathy L. Chapman and Elisabeth Willadsen 2.1 Overview 23 2.2 The Impact of Clefting on Speech Production 24 2.3 Variables Impacting Speech Development for Young Children with Cleft Palate 25 2.4 Speech Development: Birth to Age Five 26 2.5 Conclusion 35 References 36 3 The Influence of Related Conditions on Speech and Communication 41 Christina Persson and Lotta Sjögreen 3.1 Introduction 41 3.2 Conditions Related to Structural Etiologies 42 3.3 Conditions Related to Neurological Aetiology 47 3.4 Conditions Related to a Combination of Structural and Neurological Aetiology 49 3.5 Clinical Implications 50 References 50 4 Surgical Intervention and Speech Outcomes in Cleft Lip and Palate 55 Anette Lohmander 4.1 Introduction 55 4.2 Basics of Surgery on Cleft Palate 57 4.3 Basics of Outcomes 64 4.4 Speech Outcomes 65 4.5 Conclusion 69 Appendix 4.A Review of Evidence and Methodology in Studies of Speech Outcome in Individuals Born with Cleft Lip and Palate 70 References 82 5 Secondary Management and Speech Outcome 87 John E. Riski 5.1 Introduction 87 5.2 Secondary Surgical Management of Velopharyngeal Incompetence 88 5.3 Secondary Pharyngeal Flap 88 5.4 Posterior Pharyngeal Wall Augmentation by Muscle Transposition 91 5.5 Studies Comparing Treatments of VPI 94 5.6 Posterior Pharyngeal Wall Augmentation by Implants and Injections 95 5.7 Velarplasty 96 5.8 Other Considerations in Managing VPI 97 5.9 Complications Secondary to Pharyngoplasties 99 5.10 Conclusions 99 References 100 6 Cleft Palate Speech in the Majority World: Models of Intervention and Speech Outcomes in Diverse Cultural and Language Contexts 105 Debbie Sell, Roopa Nagarajan and Mary Wickenden 6.1 Introduction 105 6.2 Speech Outcomes in a Majority World Context 106 6.3 Different Models of Provision 109 6.4 Attitudes/Cultural Aspects 115 6.5 Conclusion 119 References 119 Part Two Speech Assessment and Intervention 123 Anette Lohmander and Sara Howard 7 Phonetic Transcription for Speech Related to Cleft Palate 127 Sara Howard 7.1 Introduction 127 7.2 What is Phonetic Transcription? 128 7.3 Why Transcribe? 129 7.4 What to Transcribe and How to Transcribe It 130 7.5 Features of Cleft Speech Production 131 7.6 Pitfalls of Transcription 134 7.7 Conclusion 138 Appendices 139 References 142 8 Instrumentation in the Analysis of the Structure and Function of the Velopharyngeal Mechanism 145 Debbie Sell and Valerie Pereira 8.1 Introduction 145 8.2 Visualization of the Velopharyngeal Mechanism 147 8.3 Multiview Videofluoroscopy 147 8.4 Nasendoscopy Procedure 151 8.5 Magnetic Resonance Imaging (MRI) 155 8.6 Variability in Practice 158 8.7 Future 162 References 162 9 Cross Linguistic Perspectives on Speech Assessment in Cleft Palate 167 Gunilla Henningsson and Elisabeth Willadsen 9.1 Introduction 167 9.2 Vulnerable Speech Sounds 168 9.3 Language Background of the Listener Assessing the Speech of Children with Cleft Palate 170 9.4 What Is Known about More Unfamiliar Languages? 173 9.5 Cross Linguistic Speech Samples 173 9.6 Influence on Assessment of Language Acquisition in the Young Child with Cleft Palate 176 9.7 Conclusion 177 References 177 10 Voice Assessment and Intervention 181 Lesley Cavalli 10.1 Introduction 181 10.2 Defining a Voice Disorder 181 10.3 Assessment 184 10.4 Instrumental Assessment 189 10.5 Vocal Handicap Measures 190 10.6 Treatment 191 10.7 Conclusion 195 References 196 11 Nasality – Assessment and Intervention 199 Triona Sweeney 11.1 Introduction 199 11.2 Perceptual Assessment of Nasality and Nasal Airflow Errors 205 11.3 Instrumental Assessment of Nasality and Nasal Airflow Errors 207 11.4 Interpreting Results 211 11.5 Intervention 214 11.6 Conclusion 216 Appendix 11.A Temple Street Scale of Nasality and Nasal Airflow Errors 217 References 217 12 Articulation – Instruments for Research and Clinical Practice 221 Fiona E. Gibbon and Alice Lee 12.1 Introduction 221 12.2 Electropalatography (EPG) 222 12.3 Imaging Techniques 228 12.4 Motion Tracking 233 12.5 Conclusion 235 Acknowledgement 235 References 235 13 Psycholinguistic Assessment and Intervention 239 Joy Stackhouse 13.1 Introduction 239 13.2 What is a Psycholinguistic Approach? 240 13.3 A Psycholinguistic Assessment Framework 242 13.4 Intervention from a Psycholinguistic Perspective 245 13.5 Literacy: Phonological Awareness and Spelling 250 13.6 Summary 254 References 255 14 Early Communication Assessment and Intervention 259 Nancy Scherer and Brenda Louw 14.1 Introduction 259 14.2 Assessment 260 14.3 Intervention 267 References 272 15 Phonological Approaches to Speech Difficulties Associated with Cleft Palate 275 Anne Harding-Bell and Sara Howard 15.1 Introduction 275 15.2 Variability, Variation and Compensation 277 15.3 Classification of Speech Difficulties Related to Cleft Palate 278 15.4 Phonological Assessment of Speech Data Related to Cleft Palate 278 15.5 Phonological Consequences of Speech Production Related to Cleft Palate 279 15.6 Intervention 283 15.7 Summary 287 References 288 16 Speech Intelligibility 293 Tara L. Whitehill, Carrie L. Gotzke and Megan Hodge 16.1 Introduction 293 16.2 Definition of Intelligibility and Related Concepts 294 16.3 Measurement Issues 294 16.4 Studies of Intelligibility in Speakers with Cleft Palate 296 16.5 Current and Future Developments 298 16.6 Conclusion 300 References 301 17 Communicative Participation 305 Christina Havstam and Anette Lohmander 17.1 Introduction 305 17.2 ICF 306 17.3 Communicative Participation 307 17.4 Conclusions and Clinical Implications 312 References 312 18 Evaluation and Evidence-Based Practice 317 Linda D. Vallino-Napoli 18.1 Introduction 317 18.2 Intervention for Speech Disorders 318 18.3 Evidence-Based Practice 319 18.4 The Systematic Review Process 323 18.5 Evidence Findings Establishing Therapy Effectiveness 325 18.6 Instrumentation – Visual Feedback 349 18.7 Surgery 350 18.8 Comments about Intervention Effectiveness 351 18.9 Intervention and the International Classification of Function (ICF) 352 18.10 Research Designs for Intervention Studies 352 18.11 Conclusions 352 Appendix 18.A Commonly Used Evidence Hierarchies for Intervention Studies 354 References 354 Index 359

Read more less

Book SynopsisTwo key challenges face mental health practitioners: making the correct psychiatric diagnosis and choosing the most appropriate treatment option. This book aims to help with both. Clinical Guide to the Diagnosis and Treatment of Mental Disorders - Second Edition combines clinically-relevant information about each of theDSM-IV-TR diagnoses with clear, detailed information on treatment options, giving full clinical management advice. Once again, the editors, both leading psychiatrists, have condensed the chapters on Disorders from Tasman et al's acclaimed two volume textbook of Psychiatry (now in its Third Edition), retaining only the content they deem particularly relevant to the clinician for ease of use. Each disorder is discussed under the headings of Diagnosis (including Assessment Issues, Comorbidity, Course, and Differential Diagnosis, giving diagnostic decision trees where relevant) and Treatment (listing all therapeutic options, giving practical advice fTrade Review"In my opinion, this book would be worth borrowing from the library in order to read specific chapters of interest; perhaps, the common mental health conditions or a rarity recently encountered in clinic." (Occupational Medicine, 8 March 2011) "The main addition to this edition is a useful introductory chapter on the psychiatric interview, with comments on "compiling the psychiatric database" (which seems to be what used to be called the patient's notes). I was also glad to see rather more mentions of evidence-supported psychological therapies in among the recommended drug treatments than in the previous edition." (Journal of Mental Health, August 2010)Table of ContentsPreface xxvii Chapter 1 The Psychiatric Interview 1 Chapter 2 Childhood Disorders: Intellectual Disability 17 Chapter 3 Childhood Disorders: Learning and Motor Skills Disorders 31 Chapter 4 Childhood Disorders: Communication Disorders 41 Chapter 5 Childhood Disorders: The Pervasive Developmental Disorders 49 Chapter 6 Childhood Disorders: Attention-Deficit and Disruptive Behavior Disorders 61 Chapter 7 Childhood Disorders: Feeding and Related Disorders of Infancy or Early Childhood 73 Chapter 8 Childhood Disorders: Tic Disorders 81 Chapter 9 Childhood Disorders: Elimination Disorders and Childhood Anxiety Disorders 87 Chapter 10 Stereotypic Movement Disorder and Reactive Attachment Disorder 99 Chapter 11 Delirium, Dementia, and Other Cognitive Disorders 105 Chapter 12 Mental Disorders Due to a General Medical Condition 131 Chapter 13 General Approaches to Substance and Polydrug Use Disorders 145 Chapter 14 Substance-Related Disorders: Alcohol 153 Chapter 15 Substance-Related Disorders: Amphetamine 167 Chapter 16 Substance-Related Disorders: Caffeine 173 Chapter 17 Substance-Related Disorders: Cannabis 181 Chapter 18 Substance-Related Disorders: Cocaine 185 Chapter 19 Substance-Related Disorders: Hallucinogens and MDMA 195 Chapter 20 Substance-Related Disorders: Inhalants 203 Chapter 21 Substance-Related Disorders: Nicotine 211Treatment 214 Chapter 22 Substance-Related Disorders: Opioids 221 Chapter 23 Substance-Related Disorders: Phencyclidine 231 Chapter 24 Substance-Related Disorders: Sedatives, Hypnotics, and Anxiolytics 235 Chapter 25 Schizophrenia and Other Psychoses 245 Chapter 26 Mood Disorders: Depressive Disorders 279 Chapter 27 Mood Disorders: Premenstrual Dysphoric Disorder 303 Chapter 28 Mood Disorders: Bipolar Disorder 309 Chapter 29 Anxiety Disorders: Panic Disorder With and Without Agoraphobia 323 Chapter 30 Anxiety Disorders: Social and Specific Phobias 331 Chapter 31 Anxiety Disorders: Obsessive–Compulsive Disorder 347 Chapter 32 Anxiety Disorders: Traumatic Stress Disorders 359 Chapter 33 Anxiety Disorders: Generalized Anxiety Disorder 373 Chapter 34 Somatoform Disorders 383 Chapter 35 Factitious Disorders 409 Chapter 36 Dissociative Disorders 417 Chapter 38 Eating Disorders 443 Chapter 39 Sleep and Sleep–Wake Disorders 453 Chapter 40 Impulse Control Disorders 475 Chapter 41 Adjustment Disorders 489 Chapter 42 Personality Disorders 493 Index 511

Read more less

Book SynopsisMental health concerns are the most serious and prevalent healthproblems among students in higher education. Increasingly effectivepsychopharmacological and psychotherapeutic treatments havefacilitated matriculation for students with histories of anxiety,mood, personality, eating and substance abuse disorders.Trade Review"Mental Health Care in the College Community is a beautifully organized resource that is encyclopedic in its scope and detail. It offers administrators the why and how-to of creating state-of-the-art services that include crisis intervention, triage, psychotherapy, medication consultation, testing, referral, outreach, working with parents, and training psychiatry residents and psychology and social work interns. The authors are attuned to the specific needs of the college environment, among the most pressing of which is timeliness." (Psychiatric Services, American Psychiatric Association, August 2011) "What makes the volume cohesive is the prominence given to the application of the community mental health and public health models to mental health promotion and care on college campuses." (Journal of the American Academy of Child and Adolescent Psychiatry, March 2012) "Kay and Schwartz’s text breaks new ground in the attempt to assemble a comprehensive, yet compact resource for college mental health clinicians and health services administrators. I expect that we will hear further from this cohort of clinical innovators" (Journal of Clinical Psychiatry, December 2011) "This book should be on the shelf of every clinician and administrator working in or with a college or university health clinic. Clinicians and trainees in departments of psychiatry, social work, psychology, and nursing would be well advised to read this book from cover to cover" (Michelle Riba, Psychiatry: Interpersonal Biological Processes October 2011) "I would encourage any individual working at the college or university level that comes into contact with students to read Mental Health Care in the College Community" (Synergy, NASPA Newsletter, February 2011) "I read this text with the same mantra running through my mind: “This book IS good for me, despite my reaction to its psychiatric lens.” Indeed, this book is very, very good. There is a tremendous amount of information culled from a variety of sources (bear in mind that articles in this field are published in many different journals), and this information is seasoned well with the authors' clinical and administrative experiences ... offers a smorgasbord of pertinent, informed, and thoughtful chapters on working in the college setting." (Journal of College Student Psychotherapy, 2011) "Mental Health Care in the College Community provides an enormous amount of valuable information on a number of diverse topics pertaining to the campus setting. Working with parents, different model of care, suicide prevention, training programs, and working with special populations are just a few..." (American Journal of Psychiatry, 2011) "This thorough review and discussion of intervention studies could be helpful to student affairs departments (e.g., residential living, judicial affairs) in making decisions about which approach best fits their campus." (PsycCRITIQUES, November 2010) "... Mental Health Care in the College Community is an excellent overview of the key aspects of college mental health services provision. It will be of great help to administrators as they evaluate their existing mental health services or plan for their improvement and expansion." (MIWatch.org, 2010) "I would like to thank you and Dr. Schwartz for your excellent work on your book Mental Health Care in the College Community. I am a psychologist who has held leadership roles in community mental health centers and hospitals for 20 years.... Finding your book was a godsend in quickly bringing me up to speed on the issues.... I look forward to joining the ranks of college counseling directors and furthering the development of this important field." (Gary Dunn, 2011) "Mental Health Care in the College Community will be of interest to counselling centre clinicians and also to postgraduate students as they work to understand how students' mental health impacts the university community" (Early Interventions in Psychiatry, 2011) "For readers unfamiliar with mental health care at higher education institutions, the book is an effective guide to better understanding how counselling services are provided in these settings. The book may also serve as a textbook in graduate counseling and higher education courses that examine the delivery of counselling services at various colleges and universities" (Community College Review, November 2011)Table of ContentsPreface. List of Contributors. 1 The Rising Prominence of College and University Mental Health Issues (Jerald Kay). 1.1 Introduction. 1.2 How prevalent are emotional disturbances and mental disorders? 1.3 Study limitations. 1.4 A developmental approach to college mental health. 1.5 Ethical and legal issues. 1.6 Conclusion. 2 History of College Counseling and Mental Health Services and Role of the Community Mental Health Model (Paul Barreira and Malorie Snider). 2.1 Introduction. 2.2 Early development of college and university counseling centers and mental hygiene programs: pre-1945. 2.3 Professionalism and response to increase in student enrolment. 2.4 Formalization of roles and attention to developmental issues and prevention. 2.5 Community Mental Health Movement. 2.6 An example of the early application of community mental health at colleges and universities: Dana Farnsworth. 2.7 Potential modern applications of the CHMmodel to educational settings. 2.8 Conclusion. References. 3 The Reporting Structure and Relationship of Mental Health Services with Health Services (Gregory T. Eells and Victor Schwartz). 3.1 Introduction. 3.2 Review of literature. 3.3 Administrative integration issues. 3.4 Clinical issues. 3.5 Recommendations. 3.6 Conclusion. 4 Components of an Effective College Mental Health Service (Gregory T. Eells and Robert A. Rando). 4.1 Introduction. 4.2 Leadership philosophy and staff morale. 4.3 Administrative issues. 4.4 Clinical services. 4.5 Working with outside community mental health resources. 4.6 Conclusion. Appendix A: Triage form (Adapted from Cornell University). 5 Essential Services in College Counseling (Richard J. Eichler and Victor Schwartz). 5.1 Introduction. 5.2 Access to care. 5.3 Clinical consultation, treatment planning and referral. 5.4 Personal counseling and brief psychotherapy. 5.5 Medication services. 5.6 Referring students for consultation. 5.7 Group therapy in college mental health services. 5.7.1 Types of groups. 5.8 Psychological testing and assessment. 5.9 Community outreach. 5.10 Concluding remarks. Appendix A: The relationship between predictive validity and base rate. 6 The Counseling Center Team (Paul Grayson). 6.1 Introduction. 6.2 The team. 6.3 Challenges to morale and teamwork. 6.4 The director’s responses. 7 Legal and Ethical Issues in College Mental Health (Karen Bower and Victor Schwartz). 7.1 Introduction. 7.2 Conceptual framework. 7.3 Legal framework. 7.4 Application. 7.5 Conclusion. 8 Working with the Campus Community (Lorraine D. Siggins). 8.1 Introduction. 8.2 Some developmental considerations. 8.3 The evolution of the college mental health service mission. 8.4 The college mental health service and the university community. 8.5 Outreach educational and consultative services to students. 8.6 Relationship of college mental health service to the faculty, university administration and deans of student life. 8.7 Confidentiality. 8.8 Conclusion. 8.9 Appendix A: A model “at risk/student support program” in a small residential campus. 9 Crisis and Crisis Intervention on College Campuses (Morton M. Silverman and Rachel Lipson Glick). 9.1 What is a crisis? 9.2 Crisis intervention. 9.3 Common crises and suggested responses. 9.4 When does a crisis become a psychiatric emergency? 9.5 Disasters and other crises that affect multiple students. 9.6 Working with campus leadership to prevent crisis and improve mental health. 9.7 Conclusion. 10 Working with Parents and Families of Young Adults (Kristine A. Girard). 10.1 Introduction. 10.2 Young adult development. 10.3 Generational effects. 10.4 The baby boomers. 10.5 Generation X. 10.6 The millennial generation. 10.7 Privacy standards in higher education. 10.8 Influence of case law on privacy. 10.9 Privacy meets generational attitudes. 10.10 Privacy in the transition from secondary schools to higher education. 10.11 The risk management team. 10.12 Health insurance. 10.13 Family therapy in the university health service. 10.14 Required medical withdrawal. 10.15 Behavioral problems in the residential community. 10.16 Mental health prevention. 10.17 Crisis management. 10.18 Conclusion. 11 Psychiatry Residency Training in College Mental Health Services (Jerald Kay and Victor Schwartz). 11.1 Introduction. 11.2 Benefits to services. 11.3 Benefits to trainees. 11.4 Benefits to training programs. 11.5 Characteristics of a rotation. 11.6 Centrality of supervision. 11.7 Didactic curriculum. 11.8 Developmental psychopathology. 11.9 Psychopharmacology. 11.10 The resident's clinical theoretical framework. 11.11 Increasing visibility of social media. 11.12 Fellowships in CMH. 11.13 Conclusion. Appendix A: Helpful hints for supervisors. Appendix B: PGY IV (Post Graduate Year Four) psychiatric resident rotation, student mental health rotations, Wright State University, University of Dayton. 12 Psychology and Social Work Training in University Mental Health (David A. Davar). 12.1 Introduction. 12.2 Administrative matters. 12.3 Ethical and legal considerations. 12.4 Recruitment and selection of trainees. 12.5 Running a successful training program. 12.6 From theory to college counseling practice: CAPS orientation for new trainees. 12.7 From theory to college counseling practice. 12.8 Experiential learning: trainee epistemology. 12.9 Organization of training. 12.10 Teaching the intake interview in the college setting. 12.11 Nurturing competency, addressing deficiency. 12.12 Recognizing and addressing deficiencies. 12.13 Social work and psychology therapists-in-training. 12.14 Conclusion. Appendix A: Sample syllabus for counseling center trainees. 13 Special Populations (Beverly J. Fauman and Marta J. Hopkinson). 13.1 Introduction. 13.2 Athletes. 13.3 International students. 13.4 Returning students. 13.5 Students with chronic illnesses. 13.6 Graduate students. 13.7 Transfer students. 13.8 Lesbian, gay, bisexual, transgendered and questioning students. 13.9 Veterans. 13.10 Victims of sexual assault. 13.11 Conclusion. 14 Using A Public Health Approach to Address Student Mental Health (Laurie Davidson and Joanna H. Locke). 14.1 Introduction. 14.2 A public health approach to campus mental health. 14.3 Building momentum and infrastructure. 14.4 Thinking and planning strategically. 14.5 Strategies for promoting mental health and preventing suicide among college students. 14.6 Conclusion. 15 Magnitude and Prevention of College Alcohol and Drug Misuse: US College Students Aged 18-24 (Ralph W. Hingson and Aaron M. White). 15.1 Introduction. 15.2 Methods: calculating changes in alcohol-related mortality. 15.3 Study results. 15.4 Discussion: estimates of the magnitude of college drinking problems. 15.5 Implications. 15.6 Interventions to reduce college drinking. 15.7 Conclusions. 16 Conducting Research in College and University Counseling Centers (Chris Brownson). 16.1 Introduction. 16.2 Types of research in university and college counseling centers. 16.3 Practical aspects of conducting research in counseling centers. 16.4 Future directions and conclusion. 17 International Perspectives: College Mental Health in the United Kingdom (Mark Phippen). 17.1 Introduction. 17.2 Setting the scene. 17.3 Support systems in UK universities - Student Services. 17.4 Student mental health - a growing issue. 17.5 The experience of international students in the United Kingdom. 17.6 Conclusion - where does this leave university counselling? References. Index.

Read more less

Book SynopsisAcross all cultures parenting is the foundation of family life. It is the domain where adult mental health meets infant development. Beginning in pregnancy, parenting involves many conscious and unconscious processes which have recently been shown to affect a child's development significantly.Trade Review"..this offers a comprehensive, evidence-based, holistic perspective on a crucial time in infant and adult life which could easily be a key text for any mental health professional working in child and family or adult services." (Journal of Mental Health, 2011) "The authors of the various chapters present a very updated and thorough review of scientific knowledge, in a clear and easily readable manner. The book is indeed suited for adult or child mental health professionals who do not have a specific specialty in working with infants, and vice versa, for infant mental health professionals with less experience in working with older children and adults." (The Signal, 1 May 2011) "The authors of the various chapters present a very updated and thorough review of scientific knowledge, in a clear and easily readable manner. The book is indeed suited for adult or child mental health professionals who do not have a specific specialty in working with infants, and vice versa, for infant mental health professionals with less experience in working with older children and adults. In this manner it stimulates awareness and collaboration between clinicians who treat different family members of the newly born infant. Such a bridge will surely enhance well being and treatment success. It will also promote collaborations between researchers who study different aspects of behavior and development in different age groups - to the benefit of scientific knowledge and clinical practice." (World Association for Infant Mental Health Newsletter, May 2011)Table of ContentsForeword. List of contributors. I Introduction. I.1 A historical overview: infants, parents, and parenting from ancient times to nowadays. I.2 Definition of some major concepts. I.3 Structure of the book. I.4 References. SECTION 1 Parental Orientations Normal processes. 1 Mothers' and fathers' orientations: patterns of pregnancy, parenting and the bonding process (Joan Raphael-Leff). 1.1 Introduction. 1.2 Pregnancy and the 'placental paradigm'. 1.3 The model of maternal orientations. 1.4 Mothering. 1.5 Postnatal disturbances. 1.6 Contagious arousal. 1.7 Paternal orientations. 1.8 Conclusion. 2 The competent fetus (Sam Tyano and Miri Keren). 2.1 Introduction. 2.2 Continuity from intrauterine life to infancy. 2.3 The competent fetus and its receptive sensorial capacities. 2.4 Fetuses remember and therefore can learn . . . . 2.5 Fetuses can feel pain. 2.6 Fetal psychology: an emerging domain. 2.7 Conclusion: the fetus can no longer be thought as a 'witless tadpole'. Challenging pregnancies. 3 Single parenthood: its impact on parenting the infant (Sam Tyano and Miri Keren). 3.1 Introduction. 3.2 Single-parent families come in a variety of profiles. 3.3 Single parenthood as risk factor for parental mental health. 3.4 Risk factors for mental health problems among single mothers. 3.5 Single-father families versus single-mother families. 3.6 Single custodial parenthood. 3.7 Psychological characteristics of single mothers by choice. 3.8 A double-edge risk situation: being a single parent of an infant at risk. 3.9 Clinical implications. 3.10 Summary. 4 Surrogate mothers (Olga B.A. van den Akker). 4.1 Introduction. 4.2 Characteristics, motivations and experiences. 4.3 Attachment, bonding and pregnancy. 4.4 Relinquishing the baby and the social context. At-risk pregnancies. 5 The impact of stress in pregnancy on the fetus, the infant, and the child (Miri Keren). 5.1 Introduction. 5.2 Data from animal studies. 5.3 Human studies of the impact of maternal stress on offspring. 5.4 Discussion. 5.5 Conclusion: implications for social health policy. 6 Unintended pregnancies (Myriam Szejer). 6.1 Introduction. 6.2 The insistence of desire. 6.3 Abortion. 6.4 Rape, incest and denials of pregnancy. 6.5 Pregnancy and mental illness. 7 Clinical challenges of adolescent motherhood (George M. Tarabulsy, Annie Bernier, Simon Larose, Fanie Roy, Caroline Moisan and Claire Baudry). 7.1 Introduction. 7.2 Early challenges faced by young mothers. 7.3 Adolescent mother-infant interaction and the elaboration of attachment. 7.4 Intervention with adolescent mothers and their infants. 8 Psychopathological states in the pregnant mother (Carol Henshaw MD FRCPsych FHEA). 8.1 Introduction. 8.2 General guidelines. 9 When something goes wrong with the fetus: rights, wrongs and consequences (Julio Arboleda-Florez). 9.1 Reproduction and threats to the unborn. 9.2 The rights of the fetus and of the newborn. 9.3 Parental reactions. 9.4 The fate of persons with developmental disabilities. 10 Multiple fetuses pregnancy and other medical high-risk pregnancies (Micheline Garel, Elise Charlemaine and Sylvain Missonier). 10.1 Medical high-risk pregnancies: definition. 10.2 Psychological aspects of multiple pregnancies. 10.3 Pregnancy and HIV, a public health problem. Assessment of prenatal parenting. 11 Prenatal self-report questionnaires, scales and interviews (Massimo Ammaniti and Renata Tambelli). 11.1 Introduction. 11.2 Semi-structured interviews. 11.3 Self-report questionnaires and scales. 11.4 Inventories. 12 Observational tool: the prenatal Lausanne Trilogue Play (Elisabeth Fivaz-Depeursinge, France Frascarolo and Antoinette Corboz-Warnery). 12.1 Introduction. 12.2 The Lausanne Trilogue Play paradigm. 12.3 The prenatal LTP. 12.4 Discussion. Treatment of abnormal states during pregnancy. 13 Psychopharmacological treatments during pregnancy: risks and benefits for the mother and her infant (Martin St-Andre and Brigitte Martin). 13.1 Introduction. 13.2 Depression and anxiety during pregnancy. 13.3 Bipolar disorder. 13.4 Schizophrenia. 13.5 Post-partum psychosis. 14 Psychotherapeutic, psychosocial, individual and family interventions for abnormal states during pregnancy (Prabha S. Chandra, Geetha Desai and Veena A. Satyanarayana). 14.1 Introduction. 14.2 Maternal-fetal attachment disorders. 14.3 Anxiety disorders. 14.4 Eating disorders. 14.5 Depression. 14.6 Suicide. 14.7 Substance use. SECTION 2 Delivery and birth. 15 Perinatal loss: its immediate and long-term impact on parenting (Miri Keren). 15.1 Introduction. 15.2 Historical and cultural perspectives. 15.3 Psychological effects of perinatal death on mothers. 15.4 Psychological effects of perinatal death on fathers. 15.5 Impact of perinatal loss on the couple. 15.6 Impact of perinatal loss on the subsequent pregnancy. 15.7 Clinical implications. SECTION 3 Parenting of the infant during the first year of life Normal processes. 16 Transition to parenthood (Antoine Guedeney and Susana Tereno). 16.1 Introduction. 16.2 Pregnancy and emotional upheaval: risks and resiliency. 16.3 The psychological unfolding of pregnancy. 16.4 Psychopathology in pregnancy. 16.5 Prevention and early intervention. 16.6 CAPEDP-Attachment: a French project to promote parental skills and decrease disorganized attachment. 17 Role of parenting in the development of the infant's interpersonal abilities (Deborah Weatherston and Hiram E. Fitzgerald). 17.1 Introduction. 17.2 Transformative theoretical concepts of human relationships. 17.3 Infant mental health service structure. 18 Welcoming a stranger: cultural and social aspects of parenting (Nathalie Zajde and Catherine Grandsard). 18.1 Introduction. 18.2 Jimmy. 18.3 Ethnopsychiatry. 18.4 Ethnopsychiatric therapy sessions. 18.5 Treatment. 18.6 Psychotherapy and diplomacy. 18.7 The conflict between the two families. 18.8 Sorcery: from the Antilles to the Congo. 18.9 Pentecostal churches in the Congo. 18.10 Misunderstanding no. 1. 18.11 The Bakongo kinship and parenting system. 18.12 Misunderstanding no. 2. 18.13 To whom does the child belong? 18.14 Back to the treatment. 18.15 Identifying baby Jimmy. 18.16 Epilogue. 19 Filicide: parents who murder their child (Sam Tyano and John Cox). 19.1 Introduction. 19.2 Prevalence of filicide among Western societies. 19.3 Filicide and the child's age. 19.4 Filicide and parent's gender. 19.5 Parental motivations for committing filicide: at the psychiatric level. 19.6 Parental motivations for committing filicide: at the psychodynamic level. 19.7 Characteristics of the child at risk for filicide. 19.8 Clinical implications. Parental risk factors for parenthood. 20 Maternal postnatal mental disorder: how does it affect the young child? (John Cox and Joanne Barton). 20.1 Introduction. 20.2 Postnatal mental illness: immediate effect on parenting. 20.3 Mother-infant relationships. 20.4 Risk and resilience. 20.5 Infant outcome and child development. 20.6 Child mental health problems. 20.7 Child abuse and neglect. 20.8 Family aspects. 20.9 Considering the child in the management of maternal mental illness. 21 Psychopathological states in the father and their impact on parenting (Michael W. O'Hara and Sheehan D. Fisher). 21.1 Introduction. 21.2 Prevalence of psychiatric disorders in men. 21.3 Paternal psychopathology and child internalizing and externalizing problems. 21.4 How depressive symptoms may affect parenting. 21.5 Paternal psychopathology and parenting. 21.6 Summary. 21.7 Research agenda. 22 The impact of trauma on parents and infants (Joy D. Osofsky, Howard J. Osofsky and Erika L. Bocknek). 22.1 Introduction. 22.2 The problem of abuse and neglect. 22.3 Other trauma exposure in young children. 22.4 Lessons learned. 23 Substance problems: bridging the gap between infant and adult (Ilana Crome). 23.1 Introduction. 23.2 The prevention and policy framework. 23.3 Epidemiology: the magnitude of the problem. 23.4 Health and welfare: context and consequences. 23.5 Assessment and treatment: uniting families. 23.6 Specific interventions for pregnant substance misusers. 23.7 Pharmacological treatments for pregnant substance misusers. 23.8 Catalysing change by implementation of research: service models. Environmental risk factors for parenthood. 24 Foster parenthood (Yvon Gauthier). 24.1 Introduction. 24.2 Foster children symptomatology. 24.3 The use of attachment theory. 24.4 Foster children's special needs. 24.5 How to help foster parents to provide best care for the fostered child. 24.6 Kin vs. non-kin foster parents. 24.7 Visits to the biological parents. 24.8 Need for permanency. 25 Parenting the chronically ill infant (Barbara G. Melamed). 25.1 Introduction. 25.2 Asthma. 25.3 Congenital heart disease. 25.4 Cystic fibrosis. 25.5 Very low birth weight infants. 25.6 Conclusions and future studies. 26 Parenting an infant born of rape (Frances Thomson Salo). 26.1 Case vignette 1. 26.2 Case vignette 2. 26.3 Case vignette 3. 26.4 Introduction. 26.5 Context. 26.6 Outcomes of pregnancy. 26.7 Perinatal period. 26.8 Maternal representation of the infant. 26.9 Maternal attachment. 26.10 Infant attachment. 26.11 Representations of the father and disclosure to the infant. 26.12 Adoptive and foster parenting. 26.13 Siblings. 26.14 Being parented in ongoing difficulty. 26.15 Support and therapeutic intervention for the family. 26.16 The infant's view of their life. 27 Parenting an infant with a disability (Sheila Hollins, Stella Woodward and Kathryn Hollins). 27.1 Introduction. 27.2 Parental expectations. 27.3 Antenatal diagnosis. 27.4 Case vignette 1. 27.5 Case vignette 2. 27.6 Postnatal diagnosis. 27.7 Case vignette 3. 27.8 Case vignette 4. 27.9 Diagnostic uncertainty. 27.10 Parental responses. 27.11 Parent-infant relationship development. 27.12 Case vignette 5. 27.13 Case vignette 6. 27.14 Depression in parents of children with a disability. 27.15 Responses of family, friends and wider society. 27.16 Economic and social implications. 27.17 Positive implications. 27.18 Supporting parents. 28 Being a parent with a disability (Adil Akram and Sheila Hollins). 28.1 Being a disabled parent. 28.2 The UK context. 28.3 Parents with physical disability. 28.4 Parents with intellectual disability. 28.5 Parents with mental illness. 28.6 A recovery perspective on disabled parents with mental illness. 28.7 The social model of disability. 28.8 Cultural representations of parents with disabilities. 28.9 UK policy perspectives. 28.10 Solutions to support disabled adults as parents. 28.11 Involving disabled parents in research. 29 Parenthood: the impact of immigration (Olivier Taıeb, Thierry Baubet, Dalila Rezzoug and Marie Rose Moro). 29.1 Introduction. 29.2 The ingredients of parenthood. 29.3 Pregnancy and childbirth in exile. 29.4 The infant, a cultural being. 29.5 Conclusions: parents in exile. 29.6 References. 30 Parenting and poverty: a complex interaction (Mark Tomlinson). 30.1 Introduction. 30.2 Poverty. 30.3 Upstream and downstream factors. 30.4 Parenting and its determinants. 30.5 Parenting and poverty. 30.6 Maternal depression. 30.7 Poverty, parenting, depression and infant attachment. 30.8 Malnutrition and non-organic failure to thrive. Assessment of parenthood. 31 Assessment of parenting (Marc H. Bornstein and Magdalen Toole). 31.1 Introduction. 31.2 Self-report measures. 31.3 Reports by others. 31.4 Observational methods. 31.5 Experimental testing. 31.6 Parental influence. 32 Principles of effective co-parenting and its assessment in infancy and early childhood (James P. McHale and Elisabeth Fivaz-Depeursinge). 32.1 Introduction. 32.2 What is effective co-parenting? 32.3 Co-parenting as a triangular concept. 32.4 Co-parenting and division of labor. 32.5 Co-parenting and children's adjustment. 32.6 What do mental health professionals need to know? The essentials. 32.7 Instruments of choice: observational, interview and self-report survey data. 33 Legal assessment of parenting competency (Jean-Victor P. Wittenberg). 33.1 Introduction. 33.2 Definitions of maltreatment. 33.3 Assessment is an intervention. 33.4 Infants and toddlers are a special group. 33.5 Models of parenting capacity assessment. 33.6 Core competencies for professionals doing parenting capacity assessments with infants. Treatment of dysfunctional parenting. 34 Psychotropic drugs and lactation: to nurse or not to nurse (Zivanit Ergaz and Asher Ornoy). 34.1 Drug excretion into breast milk: general considerations. 34.2 Benzodiazepines. 34.3 Phenothiazines. 34.4 Butirophenones. 34.5 Atypical neuroleptics. 34.6 Antimanic drugs. 34.7 Anticonvulsants that are also mood-stabilizers. 34.8 Central nervous system stimulants. 34.9 Tricyclic antidepressants. 34.10 Tetracyclic antidepressants. 34.11 Selective serotonin reuptake inhibitors. 34.12 Serotonin and norepinephrine reuptake inhibitors. 34.13 Noradrenaline reuptake inhibitors. 35 Parent-infant psychotherapies and indications for inpatient versus outpatient treatments (Kaija Puura and Palvi Kaukonen). 35.1 Introduction. 35.2 Different forms of parent-infant psychotherapy. 35.3 Indications for inpatient versus outpatient treatment. 35.4 When parents reject treatment. Pathological parenting: from the infant's perspective. 36 The symptomatology of a dysfunctional parent-infant relationship (Campbell Paul). 36.1 Introduction. 36.2 'Good-enough' parenting. 36.3 Parenting in the context of mental illness. 36.4 Qualities of infant-parent interaction. 36.5 Assessing infant-parent interaction. 36.6 The infant response in the context of a dysfunctional relationship. 36.7 Implications for prevention and intervention. 36.9 Acknowledgements. Concluding chapter. 37 Mental health of parents and infant health and development in resource-constrained settings: evidence gaps and implications for facilitating 'good-enough parenting' in the twenty-first-century world (Jane Fisher, Atif Rahman, Meena Cabral de Mello, Prabha S. Chandra and Helen Herrman). 37.1 Introduction. 37.2 Social model of mental health. 37.3 Parenting and mothers' social position. 37.4 Human rights, mental health and child health and development. 37.5 Promotion of infant health and development and prevention of maternal mental health problems. 37.6 Preventing and ameliorating maternal mental health problems and potential benefits for infant health and development. 37.7 Addressing the social determinants of compromised early childhood development and maternal mental health problems. 37.8 Implications for facilitating 'good-enough parenting' in the communities of the twenty-first century. 37.9 Conclusion. 37.10 References 440 Index.

Read more less

Book SynopsisThis book is well established as the classic reference for professionals requiring up to date information on hearing and deafness. It is designed to serve as an introduction and as an inspiration to those entering the field to develop their expertise and insight. This Seventh Edition of Ballantyne's Deafness has been substantially revised and updated to reflect significant developments in the field. In addition, brand new chapters and/or sections have been added on auditory processing, pharmacology, balance, hearing therapy and functional imaging.Table of ContentsList of contributors. Foreword 1 (Neil Weir). Foreword 2 (Roger Gray). Preface (John Graham and David Baguley). List of abbreviations. 1. Introduction: hearing and deafness (David Baguley and John Graham). 2. The prevalence of deafness and hearing impairment Adrian Davis. 3. The structure and function of the ear (Tony Wright). 4. Central auditory system (David McAlpine). 5. An introduction to acoustics: clinical implications (Richard Knight). 6. Subjective audiometry (Judith Bird and Rachel Humphriss). 7. Objective audiometry (Neil Donnelly and William Gibson). 8. The radiological assessment of hearing loss (Simon Lloyd and Patrick). 9. The aetiology and management of conductive hearing loss in children and adults (Will Hellier). 10. Acquired sensorineural hearing loss (Martin Burton). 11. Genetics causes of hearing and balance disorders (Henry Pau and Sarah Healy). 12. The causes, identification and confirmation of sensorineural hearing loss in children (Shakeel Saeed, Rachel Booth, and Penny Hill). 13. Habilitation of children with permanent hearing impairment (Josephine Marriage). 14. Noise and hearing (Mark Lutman). 15. Non-organic hearing loss (Catherine Lynch and Sally Austen). 16. Tinnitus and hyperacusis (Don McFerran). 17. Psychological aspects of acquired hearing impairment (Laurence McKenna and Anne O’Sullivan). 18. Mental health and prelingual deafness (Sally Austen). 19. Hearing aids (Graham Frost). 20. Cochlear implants (Huw Cooper). 21. Implantable devices: Bone anchored hearing aids and middle ear implants (Richard Irving). 22. Auditory processing disorders (Doris-Eva Bamiou). 23. Adult audiological rehabilitation (Lucy Handscomb). 24. Disorders of balance (Peter Rea).

Read more less

Book SynopsisThe 'Recovery Movement' is an attempt to consider people with mental illnesses first and foremost as individuals. Governments and planning bodies have made commitments to develop mental health policy and services towards recovery as a treatment option.Trade Review"Overall, this book would be useful for students and practitioners who are familiar with the literature on recovery." (Mental Health Practice, 1 November 2011) "This is an important contribution from international leads, which offers the reader interested in recovery an awareness of its substantial ethical and political foundations and the need to sustain a civil rights perspective." (British Journal of Psychiatry, 2011) "Just as Tuke and the late 18th century reformers were bold in their vision of moral treatment, we need to be bold about recovery. Davidson et al. provide some of the conceptual and political framework for that vision, and it is these aspects of their book that will help practitioners build recovery focused mental health services." (Metapsychology, February 2011)"This book should be required reading for any young professional entering the mental health field. Education in the history of the development of applied psychology will often give the reader a self-satisfied glow. We know so much more now than in the days of insulin shock therapy, hydrotherapy, and psychoanalysis. The Roots of the Recovery Movement in Psychiatry: Lessons Learned drives home the point that we can learn as much from the successes of our predecessors as we can from their mistakes". (American Psychological Association, 17 November 2010) "This book is a wonderful contribution to the literature attempting to untangle the web of what recovery truly means to individuals and how care can continue to evolve to meet the fundamental rights of human beings with serious mental illnesses." (Psychiatric Rehabilitation Journal, Summer 2010)"However the book is not limited to the study of psychiatry- it illustrates how psychiatry has been influenced by other disciplines such as philosophy, sociology, psychology, political theory, and civil rights. This is the major strength of this book." (British Journal of Wellbeing, September 2010)Table of ContentsForeword Acknowledgements 1 Introduction 1.1 What is the recovery movement in psychiatry? 1.2 Rationale for the book 1.3 From traitement moral to moral treatment 1.4 Reciprocity in community-based care 1.5 The everyday and interpersonal context of recovery 1.6 Closing the hospital 1.7 The rights and responsibilities of citizenship 1.8 Agency as a basis for transformation 1.9 Why these figures and not others? 1.10 Conclusion 2 FromTraitement Moral to Moral Treatment 2.1 The birth of psychiatry as a medical speciality 2.2 Philippe Pinel and Jean-Baptise Pussin 2.3 Traitement moral 2.4 Pinel’s psychological interventions 2.5 The Retreat at York 2.6 Moral treatment or moral management? 2.7 From treatment to education 2.8 Re-shaping character 2.9 The demise of moral treatment 2.10 Summary of lessons learned 3 Reciprocity in Community-based Care 3.1 The advocacy of dorothea dix 3.2 The legacy of dorothea dix 3.3 Jane Addams’ community alternative 3.4 A series of unfortunate, but influential, events 3.5 The founding of the first american ‘settlement’ 3.6 Forty years at hull-house 3.7 Distilling the active ingredients 3.8 Interventions with individuals 3.9 Interventions with collectives 3.10 Applications to mental health 3.11 Summary of lessons learned 4 The Everyday and Interpersonal Context of Recovery 4.1 The birth of psychiatry as a community-based practice 4.2 Beyond the illness paradigm (by John Strauss, part 1) 4.3 Growing up inside meyer’s ‘common sense’ psychiatry (by John Strauss, part 2) 4.4 Subjectivity and the person (by John Strauss, part 3) 4.5 Blending science and art in a human science (by John Strauss, part 4) 4.6 From a psychiatry based in death to a psychiatry based in life 4.7 Problems in everyday living and their resolution 4.8 Opportunity and occupation 4.9 The interpersonal context of recovery 4.10 Summary of lessons learned 5 Closing the Hospital 5.1 The failure of the asylum 5.2 Erving Goffman and the presentation of self 5.3 The hospital as ‘total institution’ 5.4 Franco Basaglia and the Italian mental health reform movement 5.5 De-institutionalization the Italian way 5.6 Bracketing the illness 5.7 ‘Freedom is therapeutic’ 5.8 Avoiding the re-creation of the asylum in the community 5.9 Social inclusion 5.10 Summary of lessons learned 6 The Rights and Responsibilities of Citizenship 6.1 Recovery as a civil rights movement 6.2 The incomplete world of Martin Luther King, Jnr 6.3 Can rights be given? 6.4 Recovery delayed is recovery denied 6.5 Colour blindness and capitalism 6.6 The complete subject of Gilles Deleuze 6.7 Oedipus and anti-oedipus 6.8 Schizophrenic speech and Watergate 6.9 Community inclusion vs community integration 6.10 Summary of lessons learned 7 Agency as the Basis for Transformation 7.1 The need for a new conceptual framework 7.2 Beyond de-institutionalization and community tenure 7.3 Rights and recovery 7.4 The capabilities approach of Amartya Sen 7.5 Applying a capabilities approach to the work of transformation 7.6 Human agency and mediation: the work of Lev Vygotsky 7.7 Action theory, the zone of proximal development and scaffolding 7.8 Applying activity analysis: the case of fossilized behaviour 7.9 Applying activity analysis: using the zone of proximal development 7.10 Summary of lessons learned 8 Conclusion References Index

Read more less

Book SynopsisIn recent years, many factors have combined to change the operating environment of the international pharmaceutical industry leading to greater specialization and sophistication. This work deals with this topic.Table of ContentsList of Contributors. Preface. Preface to the First Edition. Acknowledgements. I: Background to Medicines Research and Development. Pharmaceutical Medicine—A Specialist Discipline (F. Gabbay). The Contribution of Academic Clinical Pharmacology to Medicine Research (C. George). A Career in Drug Discovery (D. Ellis). II: Careers in Pre-Clinical and Clinical Research. A Career in Clinical Pharmacology (R. Yates). Career Opportunities for Physicians in the Pharmaceutical Industry (B. Spilker). The Clinical Research Associate (G. Hayes). Clinical Trial Administrator and Study Site Co-ordinator—Key Roles in Clinical Research (N. Murgatroyd, et al.). Statisticians in the Pharmaceutical Industry (C. Hilton and T. Lewis). Careers in Data Management (S. Varley). Working in a Contract Research Organisation (J. Barrett). III: Careers in Sales and Marketing. A Career in Product Management (R. Carlisle). A Career in Medical Sales and Medical Sales Management (R. Carlisle). IV: General Careers with the Pharmaceutical Industry. The Role of the Pharmacist in Healthcare (D. Jordan). Careers for Nurses with the Pharmaceutical Industry (J. Kenkre). The Toxicologist in Pharmaceutical Medicine (G. Diggle). A Career in Clinical Quality Assurance (R. Hattemer-Apostel). A Career in Product Registration and Regulatory Affairs (P. Turmer). Careers in Drug Safety and Pharmacovigilance (P. Barnes). Careers in Medical Information (J. Taylor). Medical Writing as a Career (B. Mullinger). Career Opportunities in Medicines Regulation—The Medical Assessor (N. Baber). Pharmaceutical Law - A Growing Legal Specialty (I. Dodds-Smith) Industry Careers for Pharmacoeconomists (N. Bosanquet). Consultant in Pharmaceutical Medicine (B. Gennery). V: Career Progression. Landing that Job—Recruitment, CVs and Interviews (S. Ransom). Career Development in Pharmaceuticals (R. Stephens). Opportunities for Education and Training in the Pharmaceutical Industry (P. Stonier and G. Hayes). Useful Information. Index.

Read more less

Book SynopsisMaxillary sinus elevation, followed by placement of a wide variety of grafting materials, has been the generally accepted surgical protocol for the development of bone in the sinus cavity.Table of ContentsContributors vii Acknowledgments ix Introduction xi Chapter 1 Anatomy and Physiology of the Maxillary Sinus 1Harold A. DeHaven, Jr. Chapter 2 The Applications and Limitations of Conventional Radiographic Imaging Techniques 9Hua-Hong Chien and Curtis S.K. Chen Chapter 3 The Applications and Limitations of Advanced (3-Dimensional) Radiographic Imaging Techniques 31Chih-Jaan Tai, Dimitris N. Tatakis, and Hua-Hong Chien Chapter 4 Conventional Instruments Preparation and Preclinical Training of the Lateral Window Technique 57Daniel W.K. Kao Chapter 5 Clinical Procedures of the Lateral Window Technique 67Daniel W.K. Kao Chapter 6 Avoiding and Managing Complications for the Lateral Window Technique 79Paul A. Levi and Eduardo Marcuschamer Chapter 7 Advanced Techniques of the Lateral Window Technique 105Daniel W.K. Kao and Mana K. Nejadi Chapter 8 Basic Instruments and Materials of the Transalveolar Approach: Osteotome Technique 113Daniel W.K. Kao and Elana E. Walker Chapter 9 Clinical Procedures of the Transalveolar Osteotome Approach 117Daniel W.K. Kao Chapter 10 Postoperation Management of the Transalveolar Osteotome Approach 127Gail G. Childers Chapter 11 Advanced Techniques of the Transalveolar Approach 135Daniel W.K. Kao Chapter 12 Decision Tree for Maxillary Sinus Elevation Options 149David Minjoon Kim and Daniel Kuan-te Ho Chapter 13 Choices of Bone Graft Materials 157David Minjoon Kim and Daniel Kuan-te Ho Chapter 14 Review of Dental Implant Success and Survival Rates 165Wai S. Cheung Index 179

Read more less

Book SynopsisEdited by members of the American Society for Adolescent Psychiatry, this is a practical guide to the management of an adolescent drug use and addiction. It provides the knowledge and tools for successful prevention and intervention efforts in adolescents.Trade Review“In conclusion, this book provides a useful overview of the broad range of issues relevant to working with adolescent addiction. It will be particularly helpful for psychiatrists and other medical professionals who have little experience working with this population by way of alerting them to treatment related issues for consideration.” (Early Intervention in Psychiatry, 15 April 2014) “This is an important resource for those in the field of adolescent mental health. It is not overly weighted with medical terminology, and the authors have done an excellent job of providing information with the depth that clinicians will find useful without being so clinical that the other intended readers would be lost. They have done a thorough job of providing more than just cursory information on the presentation, diagnosis, and treatment of adolescents with substance abuse problems. Although the issue of substance abuse is multifaceted, with many physiological and environmental factors at play, the book does a commendable job of organizing and outlining the evaluation and treatment modalities of substance abuse in the adolescent population.” (Doody’s, 11 October 2013) “Nevertheless, this is the best compendium of evidence in the round in this field and an excellent reference book.” (Addiction, 1 September 2013) "The wealth of information is brought together by a consummate clinician who cares profoundly for the young people who have come to him – whether for court reports or treatment – and who is determined to make a difference. The clinical eye that chose the authors and edited the whole has provided just what politicians as well as clinical and criminal justice practitioners are so often calling for – an evidence base for appropriate action. It should be widely read by those practitioners but also influence policy and improve life prospects for many, many young people." (From the Foreword by Pamela J. Taylor and John Gunn, 2012)Table of ContentsList of Contributors xi Preface xv Foreword xvii THE SCOURGE OF ADOLESCENT ADDICTION 1 Edited by Richard Rosner 1 The Scourge of Addiction: What the Adolescent Psychiatrist Needs to Know 3 Richard Rosner 2 Adolescent Addictions in the United Kingdom 9 Tahira Akbar, Alex Baldacchino, and Ilana Crome ASSESSMENT OF THE SUBSTANCE-ABUSING ADOLESCENT 25 Edited by Robert Weinstock and Manuel Lopez-Leon 3 Clinical Assessment of Addiction in Adolescents 27 FarzinYaghmaie and Robert Weinstock 4 Emergency Room and Medical Evaluation 36 Christopher William Racine and Stephen Bates Billick 5 Psychological Assessment 48 Lauren Reba-Harrelson and Daniel A. Martell 6 Cultural Assessment 61 Karen B. Rosenbaum and Roxanne M. Lewin 7 Psychosocial Assessment of the Substance-Abusing Adolescent 68 Eve Maram 8 The Neurobiology of Adolescent Addiction 78 Michael Boucher and Preetpal Sandhu 9 Psychiatric Comorbidities in Adolescent Substance Use Disorders 88 Todd Zorick 10 Toxicology of Substances of Abuse 99 Eleanor Vo and Dean De Crisce RISK AND PREVENTION 123 Edited by Avram H. Mack 11 Prevention of Adolescent Psychoactive Substance Use 125 Maria E. McGee and Avram H. Mack 12 Developmental Risks for Substance Use in Adolescence: Age as Risk Factor 132 Manuel Lopez-Leon and Jesse A. Raley 13 Genetic Risk Factors for Substance Use During Adolescence 139 Hallie A. Lightdale 14 Familial and Other Social Risk Factors in Adolescent Substance Use 147 Michael Brendler 15 Externalizing Disorders 154 Yasmin Jilla 16 Internalizing Disorders Among Adolescents: A Risk for Subsequent Substance Use 161 Tiffany G. Townsend and Dionne Smith Coker-Appiah 17 Risk due to Medical, Neurological, and Neurodevelopmental Conditions 170 Malena Banks and Matthew Biel CLINICAL CONDITIONS 177 Edited by Charles Scott 18 Adolescent Alcohol Use 179 Karen Miotto, Andia Heydari, Molly Tartter, Ellen Chang, Patrick S. Thomas and Lara A. Ray 19 Stimulants 190 John W. Tsuang and Kathleen McKenna 20 Cannabis Use Disorders 202 Jan Copeland and John Howard 21 Hallucinogens and Related Compounds 213 Charles S. Grob and Marlene Dobkin de Rios 22 Opioids and Sedative-Hypnotics 223 Ann Bruner, Asad Bokhari, and Marc Fishman 23 Nicotine Use Disorders 237 Kevin M. Gray, Matthew J. Carpenter, and Himanshu P. Upadhyaya 24 Emerging Clinical Conditions 247 Christopher R. Thompson and Lauren Reba-Harrelson TREATMENT 265 Edited by Timothy W. Fong 25 Adolescent Substance Abuse Treatment Outcomes 267 Rachel Gonzales, Mary Lynn Brecht, and Richard A. Rawson 26 Translating Evidence-Based Therapies into Outpatient Practice 271 Ara Anspikian 27 Albert Ellis’ Rational Emotive Behavior Therapy 282 Richard Rosner 28 Relapse Prevention 289 Richard Rosner 29 Adolescent Intensive Outpatient Treatment 295 Tiffany Tsai 30 Adolescent Behaviors Out of Control: An Introduction to Adolescent Residential Treatment 301 Reef Karim 31 Adolescent Group Treatments: Twelve-Step and Beyond 306 Jeremy Martinez 32 Psychopharmacology for the Addicted Adolescent 311 Timothy W. Fong 33 What’s Old is New: Motivational Interviewing for Adolescents 321 Lois T. Flaherty SPECIAL ISSUES IN ADOLESCENT ADDICTION 327 Edited by Stephen Bates Billick and Dean De Crisce 34 Substance Abuse Impact on Adolescent Brain Development 329 Adam Raff 35 Neuropsychological Effects of Substance Abuse in Adolescents 340 Diane Scheiner, Ari Kalechstein, and Wilfred G. van Gorp 36 Trauma and Adolescent Addiction 350 Michal Kunz 37 Sexual Addiction and Hypersexual Behaviors in Adolescents 362 Dean De Crisce 38 Sexting, Cybersex, and Internet Use: the Relationship Between Adolescent Sexual Behavior and Electronic Technologies 377 Abigail M. Judge and Fabian M. Saleh 39 The Therapeutic Community for the Adolescent Substance Abuser 390 Gregory C. Bunt and Virginia A. Stanick 40 Treatment Issues for Youths with Substance Abuse in Juvenile Detention 405 Eraka Bath, Le Ondra Clark, and Julie Y. Low FORENSIC CONSIDERATIONS 417 Edited by Robert Lloyd Goldstein 41 Forensic Psychiatry for Adolescent Psychiatrists: An Introduction 419 Richard Rosner 42 Ethical Considerations in Adolescent Addiction 423 Robert Weinstock 43 Informed Consent, Parental Consent, and the Right to Refuse Treatment 430 Jack A. Gottschalk and Daniel P. Greenfield 44 Third Party Liability for Supplying Adolescents with Illegal Substances 438 Daniel P. Greenfield and Jack A. Gottschalk 45 Older Adolescents in Drug Court: Hammering the Revolving Door Shut 445 Laura A. Ward 46 Confidentiality and Informed Consent Issues in Treatment for Adolescent Substance Abuse 457 Robert Lloyd Goldstein 47 Saving Adolescents 464 Richard Rosner Index 471

Read more less

Book SynopsisWritten by leading experts in the field, Cardiovascular Diseases and Health in the Older Patient covers the epidemiology, pathophysiology and management of cardiovascular disease in the older patient.Trade Review“Because it specifically addresses cardiovascular disease in the elderly this is a useful addition to the literature.” (Doody's, 9 August 2013)Table of ContentsList of Contributors, vii Foreword, ix Introduction, xi 1 Epidemiology of Heart Disease, 1 Ahmed H. Abdelhafiz 2 Cardiac Ageing and Systemic Disorders, 29 David J. Stott and Terence J. Quinn 3 Hypertension, 44 Anthony S. Wierzbicki and Adie Viljoen 4 Lipid Management, 68 Adie Viljoen and Anthony S. Wierzbicki 5 Arrhythmias, 90 Abhay Bajpai and A. John Camm 6 Hypotension, 135 Suraj Alakkassery 7 Ischaemic Heart Disease, 152 Wilbert S. Aronow 8 Heart Failure, 172 Michael W. Rich 9 Cardiac Surgery, 202 Ulrich O. von Oppell and Adam Szafranek 10 Cardiac Rehabilitation, 234 Niccol`o Marchionni, Francesco Fattirolli, Francesco Orso, Marco Baccini, Lucio A. Rinaldi and Giulio Masotti 11 Acute Stroke Care and Management of Carotid Artery Stenosis, 261 David Doig and Martin M. Brown 12 Stroke Rehabilitation, 299 Lalit Kalra 13 Communication Disorders and Dysphagia, 329 Pamela M. Enderby 14 Peripheral Arterial Disease, 345 Leocadio Rodr´ýguez-Ma ˜ nas, Marta Castro Rodr´ýguez and Cristina Alonso Bouz´on 15 Venous Thromboembolism, 366 Gordon D.O. Lowe 16 Planning Cardiovascular Investigations and Management of Older People, 376 Jennifer K. Harrison, Terence J. Quinn and David J. Stott Index, 395

Read more less

Book SynopsisThis book fulfils an urgent need for an updated text on pediatric psychopharmacology. It takes a unique approach in discussing recent findings within the context of current issues, including economic and political ones. The book covers the emerging question of treating children who do not yet meet diagnostic criteria for psychosis, e.g, schizophrenia or bipolar disorder, but who are deemed to be at high risk. This is an active area of debate: such children are being treated in certain centers, while others reject this completely. The book addresses the antidepressant controversy, the placebo response and unique strategies for delineating this, and ways to optimize the differential between active medication and placebo. It reviews the impact of recent American Heart Association guidelines for monitoring children on stimulants and other psychotropics. It adheres closely to DSM-IV diagnostic criteria throughout. The book describes the use of newly approved drugs such as Lexapro for treatiTrade Review “Pharmacotherapy of Child and Adolescent Psychiatric Disorders is a book to have available on your desk, not just in your library. It provides ready access to the wealth of practical information and insight for the range of health and mental health professionals. It is highly recommended for trainees and anyone who is prescribing psychotropic medications to the pediatric population and young adults.” (Journal of Clinical Psychiatry, 7 July 2012) Table of ContentsList of Contributors, xv Foreword, xix Chapter 1 Historical Perspectives on Child and Adolescent Psychopharmacology, 1 Samuel Gershon References, 4 Chapter 2 Pharmacoepidemiology of Psychotropic Medications in Youth, 7 Daniel J. Safer & Julie Magno Zito Introduction, 7 Prevalence and trends for medications prescribed for ADHD, 8 Nonstimulant medications for ADHD, 11 Antidepressant medication, 11 Antipsychotic medication, 13 Alpha-agonists, 14 Anticonvulsant "mood stabilizers", 15 Concomitant psychotropic medication, 15 Preschool psychotropic medication use, 17 International patterns of psychotropic medication for youth, 17 Conclusion, 18 References, 18 Chapter 3 Off-Label Prescribing of Drugs in Child and Adolescent Psychiatry, 25 C. Lindsay DeVane Introduction, 25 Extent of off-label prescribing, 27 Need for psychoactive drug treatments for children and adolescents, 31 Legislation supporting pediatric drug development, 33 Recommendations to follow when considering off-label prescribing, 35 References, 36 Chapter 4 The Use of Generic Drugs in Pediatric Psychopharmacology, 39 Richard I. Shader & Christopher-Paul Milne What is a generic drug?, 39 Why are we discussing generic drugs?, 39 Basic requirements for generic drugs, 40 The status of regulations regarding generic drugs and children, 41 Abbreviated new drug application (ANDA) requirements, 42 Pediatric assessments of adult drugs (history up to current status), 43 Best Pharmaceuticals for Children Act, 44 Pediatric Research Equity Act, 45 Intersection of requirements for generics and pediatric assessment, 46 Future directions, 48 Concluding thoughts, 49 References, 49 Chapter 5 Psychoactive Drug Use in Children: Basic Concepts in Clinical Pharmacology, 51 David J. Edwards Introduction, 51 Basic concepts in pharmacokinetics, 52 Dosing considerations for psychoactive drugs in children, 55 Summary, 60 References, 60 Chapter 6 Psychostimulants, 65 Steven R. Pliszka Introduction, 65 Epidemiology of stimulant use, 66 Structure and biochemical mechanism of action, 66 Neuroimaging studies of stimulant effects, 67 Studies of short-term efficacy, 72 Studies of long-term efficacy, 76 Clinical use, 79 Common side-effects, 84 Cardiovascular safety issues, 86 Growth suppression, 88 Substance use and diversion, 88 Comparison with nonstimulant treatment, 89 Treatment of comorbidity, 92 Pharmacogenetics, 93 Conclusions, 94 References, 94 Chapter 7 Tricyclic Antidepressants and Monoamine Oxidase Inhibitors for the Treatment of Child and Adolescent Psychiatric Disorders, 105 Charlotte M. Heleniak, Tejal Kaur, Kareem D. Ghalib & Moira A. Rynn Tricyclic antidepressants (TCAs), 105 Drug interactions, contraindications, 116 Monoamine oxidase inhibitors (MAOIs), 117 General summary, 122 References, 123 Chapter 8 Selective Serotonin Reuptake Inhibitors (SSRIs), 131 Dara Sakolsky & Boris Birmaher Pharmacokinetics, 131 Initiation and titration, 133 Indications and efficacy, 134 Adverse effects, 146 Withdrawal, 149 References, 149 Chapter 9 Novel (Atypical) Antidepressants, 155 Heidi R. Bruty, Graham J. Emslie & Paul Croarkin Novel (atypical) antidepressants, 155 General overview, 155 Bupropion, 157 Duloxetine, 162 Mirtazapine, 164 Trazodone, 166 Venlafaxine, 170 Desvenlafaxine, 173 Alternative treatments, 174 Summary, 175 References, 176 Chapter 10 Antipsychotic Agents, 181 Brieana M. Rowles, John L. Hertzer & Robert L. Findling Introduction, 181 Chemical properties, 182 Typical antipsychotics, 183 Atypical antipsychotics, 186 Ethical issues: treatment of at-risk populations, 212 Conclusions, 213 References, 213 Chapter 11 Lithium, 221 Garrett M. Sparks & David A. Axelson Introduction, 221 Pharmacology, 222 Potential mechanisms of action, 222 Evidence for the use of lithium in children and adolescents, 232 Dosing and drug monitoring, 239 Contraindications, precautions, and drug interactions, 242 Side-effects, 246 References, 250 Chapter 12 Anticonvulsants Used in Child and Adolescent Psychiatric Disorders, 261 Mani Pavuluri & Tushita Mayanil Introduction, 261 Divalproex sodium, 261 Carbamazepine, 271 Oxcarbazepine, 275 Lamotrigine, 279 Gabapentin, 284 Topiramate, 285 Conclusion, 288 References, 288 Chapter 13 Anxiolytics, 301 Barbara J. Coffey & Amanda L. Zwilling Chemical properties, 301 Indications, 305 Contraindications, 320 Adverse effects, 321 Overdose, 324 Abuse/dependence, 324 Drug interactions, 325 Available preparations and cost, 325 Initiation and maintenance of treatment, 325 Management of specific side-effects, 330 How to withdraw medication, 332 References, 332 Chapter 14 Adrenergic Agents in Child and Adolescent Psychiatry, 341 Lawrence David Scahill Clonidine and guanfacine, 341 Guanfacine, 349 Beta-blockers, 355 Acknowledgements, 361 References, 361 Chapter 15 Atypical Psychopharmacologic Strategies, 365 Jess Shatkin & Aron Janssen Opiate antagonists, 365 Memantine, 368 Riluzole, 369 Secretin, 371 Topiramate, 372 Herbal medications and dietary supplements, 373 Ginkgo (Ginkgo biloba), 375 Melatonin, 381 Omega-3 fatty acids, 383 St. John's wort (Hypericum perforatum), 384 Valerian (Valeriana officinalis), 387 Conclusion, 388 References, 389 Chapter 16 Psychopharmacology in Preschool Children, 399 Mini Tandon & Joan Luby Introduction, 399 Developmental considerations, 400 Rise in psychopharmacology use, 402 Psychotherapy before psychopharmacology, 403 When psychopharmacology may be considered as a first line: pragmatic considerations, 404 Psychopharmacology in preschool disorders: administration and monitoring, 404 Off-label prescribing: special considerations, 407 Use of psychotropics in specific disorders, 408 Summary, 415 References, 415 Chapter 17 Combination Pharmacotherapy for Psychiatric Disorders in Children and Adolescents, 421 Gagan Joshi & Anna M. Georgiopoulos Bipolar disorder, 422 Major depressive disorder, 429 Attention-deficit hyperactivity disorder, 431 Obsessive-compulsive disorder, 433 Tics and Tourette's syndrome, 434 Pervasive developmental disorders, 434 Conclusion, 434 References, 435 Index, 439

Read more less